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ABSTRACT 
 
 1-Aza-2-azoniaallene salts are reactive intermediates that undergo [3+2] 
cycloaddition with many different types of multiple bonds. For the past several years, the 
Brewer group has studied the reactivity of these intermediates in intramolecular reactions, 
and have discovered that these cationic heteroallenes can react through a variety of other, 
mechanistically distinct, pathways to give different classes of nitrogen heterocycles. For 
example, prior work in the Brewer group revealed that 1-aza-2-azoniaallene salts could 
react in an intramolecular [4+2] cycloaddition reaction to give protonated azomethine 
imine salts containing a 1,2,3,4-tetrahydrocinnoline scaffold. Further study of the scope 
and limitations of this Diels-Alder-like reaction are described herein. These studies 
primarily focused on how varying the N-aryl ring and alkene substituents affected the 
reaction. We discovered that in several instances, the metal mediated reaction did not 
facilitate the cycloaddition very well, so we searched for alternative ways to facilitate the 
reaction. We discovered that a non-metallic Lewis acid (TMSOTf) provided very clean 
products with -chloroazo compounds.  hypothesized that changing the leaving group 
adjacent to the azo might further improve the reaction. With this in mind, I developed a 
technique to prepare-trifluoroacetoxyazo compounds by treating aryl hydrazones with 
trifluoroacetoxy dimethylsulfonium trifluoroacetate. This technique is compatible with all 
types of functional groups including nitro aryl compounds, which gave low yields of the 
corresponding chloroazo derivatives. Importantly, these -trifluoroacetoxyazo 
compounds gave even better cycloaddition results when treated with TMSOTf, and this 
method is more practical, more environmentally friendly, and greener than the metal 
mediated technique. This process even returned sterically hindered products in high yield, 
and provide a dearomatized non-protonated azomethine imine salt, which further verified 
the proposed mechanism of the [4+2] cycloaddition. 
Azomethine imines are well known to undergo 1,3-dipolar cycloadditions with 
alkenes. We wondered if the protonated azomethine imine salts generated by the [4+2] 
cycloaddition could be used in a subsequent base-mediated [3+2] cycloaddition to 
generate structurally complex tetra- or pentacyclic products. We were pleased to find that 
the protonated azomethine imines indeed reacted smoothly with a variety of π-system in 
the presence of triethylamine to give the corresponding cycloadducts in high yields with 
moderate to high diastereoselectivities. In an attempt to understand the 
diastereoselectivity of these [3+2] cycloadditions better, I modeled them computationally. 
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CHAPTER 1: INTRAMOLECULAR CYCLOADDITION REACTIONS OF 
HETEROALLENE SALTS 
1.1 Introduction 
The chemistry of heterocycles, cyclic compounds that contain at least one non-carbon 
atom (typically, oxygen, nitrogen, or sulfur) within the ring, is an important branch of 
organic chemistry. Heterocycles are present in a wide variety of natural products, 
pharmaceuticals, agrochemicals, biomolecules, biologically active molecules, polymers, 
nanoparticles, and dyes. Heterocyclic compounds containing nitrogen make up the 
greatest class of biologically active compounds,1,2 and nitrogen heterocycles play a major 
role in living things. For example, genetic material (DNA) is composed of nitrogen 
containing heterocyclic bases purines and pyrimidines, and most drugs, such as penicillin, 
erlotinib (cancer), nevirapine (HIV), penciclovir (herpes), and imatinib (cancer), are 
nitrogen heterocycles (Figure 1.1). 
 
Figure 1.1. Chemical structures of nitrogen heterocyclic drugs. 
Many heterocyclic natural products have been isolated from various sources including 
plants, animals, marine organisms, and microbial metabolites. Nitrogen containing 
 2 
natural products (alkaloids) and their synthetic analogs play a significant role in drug 
discovery. For example, ceftriaxone is an antibiotic useful for the treatment of many 
bacterial infections. It is derived from cephalosporin C, which is a natural product that 
can be isolated from Cephalosporium acremonium (Figure 1.2).3,4,5  
 
Figure 1.2. Cephalosporin C and its derivative ceftriaxone. 
Over the past decades, a lot of synthetic strategies have been developed to prepare 
biologically active compounds, natural products, and their derivatives. However, 
developing new green and concise synthetic routes to novel nitrogen heterocycles, 
particularly structurally complex ones, is still very significant. With this in mind, my 
research has focused on developing new strategies to synthesize structurally complex tri- 
and tetracyclic nitrogen heterocycles, such as protonated azomethine imines, via a green 
approach. The methodology I developed takes advantage of the reactivity of 1-aza-2-
azoniallene salts, which are highly reactive species that will be discussed in depth in the 
next several sections of this thesis. In addition, I have developed a method to take 
advantage of the protonated azomethine imine products in a subsequent 1,3-dipolar 
cycloaddition, which give structurally complex tetra- and pentacyclic nitrogen 
 3 
heterocycles. Overall, this methodology provides access to structurally unique 
heterocycles that may find use in biological studies. 
1.2 Heteroallene salts 
A 1-aza-2-azoniaallene salt (e.g. 1.1, Figure 1.3) is a cationic heteroallene that has a 
central nitrogen which has double bonds to both a nitrogen and a carbon atom. These 
heteroallene salts are only stable in solution at low temperatures.6,7 All attempts so far to 
isolate these salts have failed.8,9 
 
Figure 1.3. General structure of a 1-aza-2-azoniaallene salt. 
Due to the presence of a +1 formal charge on 1-aza-2-azoniaallenes, they can be 
represented by three different structures (Figure 1.4) which result in diverse reactivities 
that lead to various N-heterocyclic products.10  
 
Figure 1.4. Three different structures of 1-aza-2-azoniaallene salts. 
These salts were first reported as intermediates by Huisgen and Koch in 1955. They 
treated a diazonium salt (1.5) with a diazo species (1.6) to produce an azoniaallene 
intermediate (1.7), which was then trapped by the chloride counter ion (Scheme 1.1).11 
 4 
Many other methods, such as electrochemical oxidations of various hydrazones,10,12,13 
chemical oxidation of aryl hydrazones in the presence of lead tetraacetate,14,15 solvolysis 
of ,’-dichloroazoalkenes,17 and treating -chloroazos with Lewis acid,7, 8 have been 
reported to produce 1-aza-2-azoniaallene salt intermediates. 
 
Scheme 1.1. Trapping of azoniaallene intermediate starting from the reaction of 
diazonium salt with diazo compound. 
1.3 Jochims and coworkers’ contributions to the chemistry of heteroallene salts 
1-Aza-2-azoniaallene salts behave as cationic four-electron three-center components 
that can undergo cycloaddition to many different types of multiple bonds. Jochims and 
coworkers reported a variety of [3+2] cycloaddition reactions with multiple bonds. 
1.3.1 [3+2] Cycloaddition of 1-aza-2-azoniaallene salts with a variety of -systems 
Jochims and coworkers reported that an -chloroazo compound (e.g. 1.9, Scheme 
1.2) generated from the reaction of a hydrazone with t-butyl hypochlorite, reacted with a 
halophilic Lewis acid (SbCl5 or AlCl3) in the presence of nitriles to afford a substituted 
1,2,4-triazolium salt (e.g. 1.11) which may rearrange to give a thermodynamically stable 
product (e.g. 1.12, Scheme 2).6, 11 In many cases, they could not isolate the initial 
cyclization product 1.11 due to fast rearrangement to 1.12.  
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Scheme 1.2. Polar [3+2] cycloadditions between 1-aza-2-azoniaallene salts and nitriles. 
They further reported that [3+2] cycloadditions of 1-aza-2-azoniaallene cations occur 
with multiple  systems. For example, 1-aza-2-azoniaallene salt 1.13 (Scheme 1.3) reacts 
with 3-hexyne to give 1H-pyrazolium salt 1.16.8 In this reaction, the isopropyl group is 
solely migrated to the adjacent nitrogen atom due to the formation of more stable 
carbocation intermediate. However, when they replaced the isopropyl group by methyl 
group, the methyl group was solely migrated to the adjacent carbon atom to afford the 
product 1.19.8  
 
 
Scheme 1.3. Polar [3+2] cycloadditions between 1-aza-2-azoniaallene salts and 3-
hexyne. 
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To understand the stereoselectivity of [3+2] cycloadditions, they treated 1-aza-2-
azoniaallene salt 1.20 (Scheme 1.4) with trans 3-hexene which gave a trans form of a 
single stereoisomer (1.22).8 They did not observe any trace of a second stereoisomer. 
From this observation, they concluded that this cycloaddition reaction occurs via a 
concerted mechanism. 
 
Scheme 1.4. Polar [3+2] cycloadditions between 1-aza-2-azoniaallene salts and 3-hexene. 
In a competition experiment, they treated 1-aza-2-azoniaallene salt 1.24 with 
homoallylic nitrile 1.25 (Scheme 1.5).8 The nitrile group reacted exclusively in favor of 
the alkene with cation 1.24 to give triazole 1.26 as the only product. This result shows 
that a nitrile group undergoes [3+2] cycloaddition with a heteroallene salt more rapidly 
than an olefin. 
 
Scheme 1.5. Competitive experiment of allylic cyanide. 
To understand the mechanism of migratory aptitudes for [3+2] cycloadditions, they 
treated 1-aza-2-azoniaallene salt 1.27 containing methyl and cyclopropyl group with 
acetonitrile (Scheme 1.6).8 This salt gave an equimolecular mixture of the triazolium salt 
1.29 and 1.30 which shows that the migratory aptitudes of methyl and cyclopropyl are 
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comparable. However, when they took 1-aza-2-azoniaallene salt 1.31 (Scheme 1.7) 
containing two cyclopropyl groups, they isolated only 1.33 in 90% yield.8 They did not 
observe any trace of an allylic compound which could be obtained from ring opening of 
the cyclopropane. Based on this observation, the intermediate in which a cation was 
directly adjacent to the cyclopropane was ruled out. Thus, they concluded that the 
rearrangement occurs via a concerted [1,5]-sigmatropic migration of the cyclopropyl 
group.  
 
Scheme 1.6. [3+2] Cycloaddition reaction with cyclopropyl and methyl substituents. 
 
Scheme 1.7. [3+2] Cycloaddition reaction with dicyclopropyl substituents on 1-aza-2-
azoniaallene salt. 
To examine the migratory aptitudes with respect to electron withdrawing and electron 
releasing groups, they treated the heteroallene 1.34 (Scheme 1.8) with acetonitrile. The 
ethyl group preferentially migrated to the nitrogen atom to provide the 
thermodynamically stable product 1.36.17 
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Scheme 1.8. [3+2] Cycloaddition reaction of 1-aza-2-azoniaallene salt containing an 
electron-withdrawing and releasing groups. 
In a study of the scope of the reaction of 1-aza-2-azoniaallene cations with different 
-systems, they reported that carbodiimides and isocyanates react to give five-membered 
heterocycles (Scheme 1.9).9,18 Although there were a number of possibilities for the 
migration of the R1 group, they confirmed via X-ray structural analysis that migration 
occurs to the adjacent nitrogen to give product 1.41. To determine if the cycloaddition 
occurs via a concerted or a two-step process, they performed AM1 calculations. 
Reactions proceeding through a concerted cycloaddition, were higher energy than the 
two-step pathway (Figure 1.5).18  
 
Scheme 1.9. [3+2] cycloadditions of heteroallene salt with carboiimide and isocyanate. 
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Figure 1.5. Jochim’s mechanistic study of [3+2] cycloadditions of heteroallene cation 
with carboiimide. 
These authors also investigated the mechanism of the cycloaddition of acetylenes 
(Scheme 1.10) with 1-aza-2-azoniaallene cations using AM1 computational methods. The 
formation of intermediate XIII from the heteroallene X and 2-butyne (XI) was calculated 
to be exothermic by 92 kj/mol (Figure 1.6).19 This reaction does not give a low energy 
intermediate as compared to carbodiimides and isocyantes, and this reaction occurs via an 
asynchronous concerted mechanism. In this reaction, 1-aza-2-azoniaallene cation 1.42 
and the acetylene 1.43 are acting as the 1,3-dipole and dipolarophile respectively 
(Scheme 1.10). This cycloaddition is electronically similar to a 1,3-dipolar cycloaddition 
with inverse electron demand. The cycloaddition that forms the intermediate XIII is 
followed by a [1,2] alkyl shift via intermediate XIV to provide final product XV. The 
Tao group also reported a computational study on the heteroallene/acetylene 
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cycloaddition using a higher-level computation.20 This study agreed with the earlier AM1 
study. 
 
Scheme 1.10. [3+2] cycloadditions of 1-aza-2-azoniaallene salt with alkyne. 
 
Figure 1.6. Mechanistic study of [3+2] cycloadditions of 1-aza-2-azoniaallene salt with 
alkyne. 
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Jochim went on to study reactions of 1-aza-2-azoniaallene salt 1.46 with 
isothiocyanates (R-NCS) which gave a single heterocycle product in good yield (Scheme 
1.11).21 According to AM1 calculations, the cycloaddition of heteroallenes to 
isothiocyanates occurs via a two-step reaction pathway. To understand the migratory 
aptitude, they used a variety of substituents to carry out this reaction. When R1, R2 = i-Pr; 
R3 = 2,4,6-Cl3C6H2, and R4 = Ph, intermediate 1.48 follows path A (Scheme 1.11) to give 
product 1.49 in 82% yield, in which isopropyl group preferentially migrates. When R1, R4 
= Me; R2 = Bn; and R3 = 2,4,6-Cl3C6H2, intermediate 1.48 follows path B to give product 
1.50 in 56% yield followed by hydrolysis in the presence of aqueous sodium hydroxide to 
provide electrically neutral product 1.53 in 57% yield. In path B, instead of 1,2-shift, 
intermediate 1.48 loses the benzyl group to give product 1.50 because of the presence of 
traces of water in the reaction trap the free benzyl cation as benzyl alcohol. When R1, R2 
= Me; R3 = COPh; and R4 = i-Pr, intermediate 1.48 follows path C to give product 1.51 in 
59% yield followed by hydrolysis in the presence of aqueous base to give electrically 
neutral product 1.54 in 89% yield. In path C, intermediate 1.48 loses the benzoyl group, 
which is a good leaving group, to afford the moderately stable iminium salt 1.51. Again, 
the presence of traces of moisture in the reaction mixture is responsible for this result. 
When R1, R2 = Me; R3 = 2,4,6-Cl3C6H2; and R4 = i-Pr, intermediate 1.48 undergoes 
Dimroth rearrangement to give intermediate 1.52 followed by 1,2-shift to afford 
triazolium salt 1.55 in 66% yield. Therefore, the substituents on both the heteroallene and 
the isothiocyanate play a significant role in determining the reaction outcome. 
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Scheme 1.11. [3+2] Cycloadditions of 1-aza-2-azoniaallene salt with isothiocyanate. 
After conducting a systematic study of the reactions of 1-aza-2-azoniaaline salts with 
a variety of -systems, Jochims and coworkers concluded that the rate of the reaction of 
heteroallene salts with π systems follows the following decreasing order:22  
Nitriles carbodiimides  strained alkenes >> unstrained alkenes, alkynes, isocyanates, 
isothiocyanates.  
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1.3.2 [3+2] Cycloaddition of 1,3-diaza-2-azoniaallene salts with alkenes 
1,3-Diaza-2-azoniaallene salt23 1.57 is an another reactive heteroallene species. This 
salt is stable below -50 °C and can be prepared in situ by the reaction of N-
chlorotriazenes with Lewis acids. This species undergoes smooth cycloadditions with 
electron-rich and electron-deficient olefins to give dihydro-1,2,3-triazolium salts (1.58) 
with complete conservation of the configuration of the alkenes via a concerted process 
(Scheme 1.12). However, this reactive intermediate neither reacts with nitriles or with 
isocyanates.23 
 
Scheme 1.12. [3+2] Cycloaddition of 1,3-diaza-2-azoniaallene salts with alkenes. 
1.4 Applications of 1-aza-2-azoniaallene salts in synthesis 
1.4.1 Synthesis of electrically neutral heterocycles 
The major drawback of the cycloaddition of cationic heteroallene is that the reaction 
products end up as salts.8-18 Jochims and coworkers were interested in preparing 
electrically neutral heterocycles using the heteroallene salts, which are achieved by 
incorporating a cleavable group on nitrogen. In search for 1-aza-2-azoniaallene salts with 
an appropriate leaving group, they discovered ’-dichloroazo compound 1.59 (Scheme 
1.13).24 Treating 1.59 with SbCl5 in the presence of electron-rich alkenes gave 4,5-
dihydro-3H-pyrazolium salts (1.62) which could be hydrolyzed to give a charge neutral 
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product. They assumed that the intermediate 1-aza-2-azoniaallene salt (1.60) formed 
during the reaction underwent cycloaddition with alkene (1.61). The pyrazolium salts 
(1.64 – 1.68) were hydrolyzed with aqueous sodium hydrogen carbonate in the presence 
of a small amount of ammonia to give the corresponding 3H-4,5-dihydropyrazoles (1.69 
– 1.73).  
 
Scheme 1.13. Formation of electrically neutral heterocycles via [3+2] cycloaddition. 
1.4.2 Synthesis of Cinnolinium salt 
In the synthesis of cinnolinium salts,18 Jochims and coworkers employed 1-aza-2-
azoniaallene 1.74, which was derived from phenylacetone. In the presence of oxygen, the 
cinnolinium salt 1.75 was readily dehydrogenated to the cinnolium tetracloroantimonate 
1.76 (Scheme 1.14).  
 15 
Scheme 1.14. Synthesis of cinnolinium salts via [3+2] cycloaddition. 
1.4.3 Syntheses of C-nucleosides from 1-aza-2-azoniaallene and 1,3-diaza-2-
azoniaallene salts 
Nucleosides are the molecular building blocks of the nucleic acids, DNA and RNA. 
Jochims and coworkers applied 1,3-diaza-2-azoniaallene and 1-aza-2-azoniaallene salts 
in the synthesis of C-nucleosides.23 The reactive salts (1.78 and 1.81) underwent 
cycloaddition reactions with the triple bonds of glycosylalkyne 1.77 and glycosyl cyanide 
1.80 to afford the 4-glucosyl-1,2,3-triazolium salt 1.79 and glycosyl-1,2,4-triazole 1.83 
respectively (Scheme 1.15 and 1.16).  
 
Scheme 1.15. Synthesis of 4-glucosyl-1,2,3-triazolium salt via [3+2] cycloaddition. 
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Scheme 1.16. Synthesis of glycosyl-1,2,4-triazole via [3+2] cycloaddition. 
1.4.4 Reaction with azomethines and azirine to form iminium and azolium salts 
Azomethines (1.85) undergo nucleophilic addition to the heteroallene 1.84 to give 
the N-(azoalkyl)iminium salt 1.86 in 88% yield (Scheme 1.17).23 When two equivalents 
of isoamide (1.85) and two equivalents of SbCl5 are used, the product 1.87 can be 
isolated in 83% yield. 
 
Scheme 1.17. Formation of iminium salt via [3+2] cycloaddition. 
 The heteroallene 1.88 undergoes cycloaddition across the C=N of the azirine 1.89 to 
give the azirinium salt 1.90 which is electrophilic enough to close the ring by attack on an 
azo nitrogen atom to afford the azirenotriazolium salt 1.91 in 76% yield (Scheme 1.18).23  
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Scheme 1.18. Formation of azolium salt via [3+2] cycloaddition. 
1.4.5 Syntheses of coumarin derivatives  
 The heteroallene salt 1.92, containing a coumarin scaffold, reacts with acetonitrile to 
give intermediate 1.93, which then cyclizes to provide the 3H-triazolium salt 1.94 that 
undergoes Wagner-Meerwein type [1,2] shift of a methyl group to afford the 1H-trizolum 
salt 1.95 in 71% yield. In addition, a small amount (8% yield) of pyrazole 1.96 was 
isolated as by product (Scheme 1.19).22 Without acetonitrile, this reaction gives 
electrically neutral pyrazole 1.96 in 86% yield.  
 
Scheme 1.19. Synthesis of coumarin derivatives from 1-aza-2-azoniallene salt. 
1.4.6 Syntheses of 3’-azole derivatives 
 In the development of new 3’-azole derivatives26 that exhibit anti-AIDS activity,27,28 
Al-Soud and Al-Masoudi explored a new technique, in which 5’-acetyl-3’-dexoy-3’-
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isothiocyanatothymidine 1.98a (Scheme 1.20) and sugar nitrile 1.98b (Scheme 1.21) 
undergo cycloadditions with 1-aza-2-azoniaallene salts to afford 3’-azole derivatives. As 
shown in Scheme 1.20, the heteroallene 1.97a undergoes a nucleophilic addition reaction 
with the isothiocyanate 1.98a to give the nitrilium ion 1.99 as an intermediate followed 
by cyclization to afford the thiadiazoium salt 1.100, which loses the tert-butyl group as an 
isobutane to give the iminium salt 1.101. This salt is deprotonated with added sodium 
bicarbonate to afford the thiadiazole 1.102, which is subsequently deacylated by NaOMe 
in MeOH to give the product 1.103 in 79% yield.  
 
Scheme 1.20. Synthesis of thiadiazole derivative from 1-aza-2-azoniaallene salt. 
 As shown in Scheme 1.21, heteroallene 1.97a undergoes cycloaddition with the sugar 
nitrile 1.98b to give the unseparable 3’-(3H-1,2,4-triazolium5-yl)thymidine 1.104. 
Migration of an alkyl group via a 1,2-shift and elimination of the CClMe2 group at -30 °C 
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afforded the protonated 1,2,4-triazolium salt 1.105.23 This salt was deprotonated with 
sodium bicarbonate to afford the 3’-(1,5(1,5-disubstituted-1,2,4-triazole 1.106 in 78% 
yield, which was deacylated by NaOMe in MeOH to give the free nucleoside 1.107 in 
78% yield.  
 
Scheme 1.21. Synthesis of triazole derivative from 1-aza-2-azoniaallene salt. 
1.4.7 Synthesis of dienes and allylic ethers via [3,3] sigmatropic rearrangement of 1-
aza-2-azoniaallene intermediates from N-allylhydrazones 
Thomson and coworkers utilized 1-aza-2-azoniaallene salts (1.109, Scheme 1.22) to 
synthesize dienes (1.111) and homoallylic ethers (1.112).29,30 The reactive heteroallene 
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was generated by reacting N-allylhydrazones (1.108) with either N-bromosuccinimide 
(NBS) or a hypervalent iodine species. The heteroallene undergoes a subsequent [3,3] 
sigmatropic rearrangement and nucleophilic substitution or loss of proton to provide the 
desired products.  
 
Scheme 1.22. [3,3] Sigmatropic rearrangement of 1-aza-2-azoniaallene intermediates 
from N-allylhydrazones 
1.5 Theoretical studies on the mechanisms for cycloadditions between 1-aza-2-
azoniaallene cations and RNCO 
 Although Jochims and coworkers studied the mechanism of cycloaddition reaction 
between 1-aza-2-azoniaallene cations and isocyanate computationally,18 a high-level 
calculation for this study is still very significant. The Fang group reported these studies.31 
The Fang group used the reaction shown in Scheme 1.23 as a model. In this model 
reaction, when R1, R2, and R3 are hydrogen atoms, the bond length of the C1-N2 bond in 
structure 1.115 is 2.734 Å at the B3LYP/6-31 + + G** level. When the two reactants 
come more closely, 4,5-dihydro-5-oxo-3H-1,2,4-triazolum ion (1.116) is obtained via 
transition state TS1, in which the N2-C1-N4 angle becomes 140.0° from the original 
167.1°, and the N2-C1 and N5-C3 distances are 2.092 and 3.371 Å respectively. Therefore, 
this step (the formation of product 1.116) is an asynchronous but concerted pathway. This 
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differs from Jochims and coworkers’ AM1 results, which favored a two-step reaction 
proceeding via acylium ion intermediates. Although the Fang group was able to locate the 
two-step-process intermediate in model reaction (a, Figure 1.7) by the AM1 method, they 
failed to find a similar intermediate at the B3LYP/6-31 ++ G** level. Based on the 
B3LYP/6-31++G** results, they concluded that the cycloaddition reaction occurs by an 
asynchronous but concerted pathway. During the theoretical study of the 1,2-hydrogen 
shift, they observed some ring distortion in product 1.117, in which the N2-C1, N4-C1, and 
N5-C3 bond lengths are all shortened by about 0.1 Å, whereas N5-N4 and C3-N2 bond 
lengths are longer than their counterparts in the product 1.116 by 0.143 and 0.087 Å 
respectively. The bond distances of N2-C1 and N4-C1 in the product 1.117 are shorter than 
a normal carbon and nitrogen single bond, which shows that those bonds have some 
double bond characteristics. When they studied the effect of the solvent for the model of 
reaction, they found that cycloaddition products 1.116 and 1.117 are more stable in the 
solution phase than their in gas phase. 
 
Scheme 1.23. Model reaction for theoretical study. 
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Figure 1.7. Energy profile diagram for cycloadditions between 1-aza-2-azoniaallene 
cations and RNCO. 
 The Fang group also studied the effect a variety of substituents, such as electron-
withdrawing and electron-releasing groups have on the nitrogen atom of the isocyanates 
and on the carbon atom of the 1-aza-2-azoniaallene cation at the B3LYP/6-31 + + G** 
level.31 When R1, R2 = H and R3 = CH3 (Figure 1.7, b), they observed longer bond 
distances for C1-N2 and C3-N5 in TS1 than the transition state of an isocyanate without a 
methyl group because the methyl group on the nitrogen atom has a larger steric effect. 
The cycloaddition product 1.116b of this reaction is more stable than without methyl 
derivative by 9 kcal/mol. Therefore, the methyl substituent favors the rearrangement 
reaction to give the final product 1.117b. When the methyl group is replaced by an 
electron-withdrawing chlorine atom (Figure 1.7, c), the stabilization energy of 1.115c is 
lower by 0.15 kcal/mol than that of the isocyanate without a chlorine atom. The 
activation barrier for the cycloaddition reaction to form the product 1.116c is thus higher. 
In regard to the rearrangement reaction, the activation barrier and stabilization energy to 
 23 
form the product 1.117c from the intermediated 1.116c are very similar to that reaction, 
in which the isocyanate is without a chlorine atom. 
 When two methyl groups are present at the C1 of the 1-aza-2-azoniaallene cation 
(Figure 1.7, d), they make the C1-N2 bond distance of structure 1.115d longer than those 
in other complexes due to a larger steric effect. Therefore, methyl substituents on the 1-
aza-2-azoniaallene cation disfavors the cycloaddition reaction. The presence of an 
electron-withdrawing chlorine atom at C1 of the heteroallene cation (Figure 1.7, e), 
makes the bond distance of the C1-N4 bond of structure 1.115e larger than that of 
structure 1.115a, and smaller than that of structure 1.115d. The presence of chloride 
substituents on the heteroallene cation also lowers the activation energy for the [1,2]-shift 
reaction. 
1.6 Brewer group’s contributions to cycloadditions of 1-aza-2-azoniaallene salts 
 For the past several years, the Brewer group has studied the reactivity of 1-aza-2-
azoniaallene species in intramolecular reactions. When constrained to intramolecular 
reactions, cationic heteroallenes can react through a variety of mechanistically distinct 
pathways to give different classes of nitrogen heterocycles.  
1.6.1 [3+2] Cycloaddition reactions  
 In order to undergo various [3+2] cycloaddition reactions with a variety of -system, 
heteroallenes act as 1,3-dipoles to afford the corresponding five membered-ring 
heterocycles. Using this concept, in 2009, the Brewer group reported that heteroallene 
salts (e.g. 1.119, Scheme 1.24) obtained by the reaction of -chloroazo compounds (e.g. 
1.118) with halophilic Lewis acids, such as aluminum trichloride and antimony 
pentachloride, can also react with a pendant alkene to give structurally complex bicyclic 
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diazenium salts 1.120a and 1.120b via intramolecular 1,3-dipolar [3+2] cycloaddition 
reactions.32 No such type of intramolecular [3+2] cycloaddition reactions had been 
previously reported.  
 
Scheme 1.24. [3+2] cycloaddition to form bicyclic diazenium salts. 
 The reactivities of intramolecular [3+2] cycloaddition reactions depend on the length 
of the tether, substituents on alkene as well as on the electronics of the N-aryl 
substituent.32 The pendent alkenes of heteroallenes having electron-withdrawing or -
releasing substituents give only ring-fused diazenium salts as single diastereomers, 
whereas alkenes without any substituents provide a mixture of ring-fused and bridged 
diazenium salts. In the first case, the diastereoselectivity suggests that the reaction occurs 
via asynchronous concerted process.32 In latter case, the ratio of the mixture of diazenium 
salts depends on the length of the tether between the alkene and the 1-aza-2-azoniaallene 
group. As shown in Figure 1.8, the Brewer group proposed the possible transition states 
to form the ring-fused diazenium salt 1.121a and bridged diazenium salt 1.121b. 
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Figure 1.8. Proposed transition states to form ring-fused and bridged diazenium salts. 
 After a more systematic study of the intramolecular [3+2] cycloaddition, the Brewer 
group reported in 2010 that the partial positive charge develops on the carbon atom that 
forms a new C-N bond in the asynchronous cycloaddition mechanism.33 The proposed 
transition state 1.121b, in which a partial positive charge develops on a secondary carbon 
atom, gives the 6,5-bridged product 1.123b, whereas the proposed transition state 1.121a, 
in which a partial positive charge develops on a primary carbon atom, provides the 5,5-
fused product 1.123a (Figure 1.9). Although the energy of the ring-fused diazenium 
transition state is higher than that of the bridged diazenium transition state, the ring-fused 
transition state is entropically favored. Therefore, the fused diazenium salt is always 
dominant over the bridged diazenium salt.  
 
Figure 1.9. Location of partial positive charge in diazenium salts. 
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 To describe the effect of the length of the tether on the formation of fused and bridged 
bicyclic diazenium salts, the Brewer group reported that the seven-membered carbocyclic 
ring (diazenium salt 1.125b, Scheme 1.25) forms in preference to the six-membered 
bicyclic diazenium salt (1.125a).33 To identify the conformation leading to the 7,5-
bridged bicyclic product, the Brewer group described the reactive orbital alignments 
between the heteroallene and the alkene. When the reactive orbitals are in a chair-like 
conformation (1.126, Figure. 1.10), they do not effectively overlap to give a 6-membered 
ring. Although the orientation of the reactive orbitals in the boat structure (1.127) gives 
more effective overlap, the boat-like conformation is high in energy and thus the 6,5-
fused bicyclic diazenium salt is unfavorable. Conformation 1.128 leading to the 7,5-
bridged bicyclic product is favored because the longer tether length lends enough 
flexibility to provide a good orbital alignment. I have discussed a computational study 
about the effect of the tether length in the next section. 
 
Scheme 1.25. [3+2] cycloaddition to form seven-membered ring diazenium salts. 
 
Figure 1.10. Proposed conformations leading to diazenium salts. 
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 While studying the intramolecular [3+2] cycloaddition reaction of 1-aza-2-
azoniaallene salts with pendent alkenes, the Brewer group discovered a new method by 
which hydrazones can be directly converted into the corresponding diazenium salts (e.g. 
1.131a, 1.132b, Scheme 1.26) via oxidation with either Me2S(OTf)2 or a hypervalent 
iodine (III) reagent [PhI(OTf)2].
31 
 
Scheme 1.26. [3+2] Cycloaddition reaction via hypervalent iodine (III) reagent. 
1.6.2 [4+2] Cycloaddition reactions  
 While studying the scope of the intramolecular [3+2] cycloaddition reactions, the 
Brewer group became interested to see how the length of the tether connecting the 
reacting groups affected the outcome of the reaction. Brewer found that a heteroallene 
salt with a shortened tether (1.132, Scheme 1.27) reacted by an unprecedented 
intramolecular [4+2] cycloaddition to provide a tricyclic protonated azomethine imine 
containing a 1,2,3,4-tetrahydrocinnoline scaffold (e. g. 1.133) in high yield.35 
 
Scheme 1.27. Intramolecular [4+2] cycloaddition of 1-aza-2-azoniaallene salt. 
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 The derivatives of tetrahydrocinnoline show diverse biologically activity.36 An initial 
exploration of the scope of this reaction has shown the reaction is quite general and gives 
the corresponding protonated azomethine in high yield. 
 To determine if this [4+2] cycloaddition occurs by a concerted or stepwise pathway, 
the Brewer group prepared heteroallenes 1.134 and 1.136 (Scheme 1.28) containing cis 
and trans alkenes respectively. The subsequent [4+2] cycloadditions provided unique 
diastereomers of the corresponding product (1.135 and 1.137). This result suggests that 
the cycloaddition reaction occurs via a concerted pathway.35  
 
Scheme 1.28. Comparison of [4+2] cycloaddition reaction for cis and trans alkenes. 
1.6.3 Computational study on the role of tether for intramolecular [3+2] and [4+2] 
cycloadditions between heteroallene and pendent alkenes 
 In light of these surprising experimental results, the Brewer group was interested to 
study computationally how the length of the tether controls whether the heteroallene 
undergoes a [3+2] or a [4+2] cycloaddition reaction.32-,35 The Brewer group undertook 
these studies in collaboration with the Houk group from UCLA. 35 These studies showed 
 29 
that when the shortest tether (n = 0, in Figure 1.11) is present, it preferentially undergoes 
intramolecular [4+2] cycloaddition via TS 1.140, which was already demonstrated 
experimentally by the Brewer group.32 When n = 1 (in Figure 1.11), it gives two 
regioisomeric [3+2] (e.g. 1.141 and 1.142) and one [4+2] (e.g. 1.143) transition states. 
However, the [4+2] cycloaddition is energetically disfavorable. Therefore, these results 
correspond to the experimental finding that only [3+2] cycloaddition products 1.141 and 
1.142 were observed.32,33 When n = 2 (in Figure 1.11), the 1,5-substituted [3+2] 
cycloaddition product 1.145 is more favorable with less TSG which is also consistent 
with the experimental observation. The latter result is very similar to the intramolecular 
[3+2] cycloaddition reaction.32,33 In conclusion, the shortest tether (n = 0) preferentially 
gives the intramolecular [4+2] cycloaddition product, whereas the longest tether (n = 2) 
gives the [3+2] product and the tether effects are very low. 
 
Figure 1.11. The possible transition states and DFT-computed activation enthalpies and 
free energies (energy in kcal/mol) for the intramolecular [3+2] and [4+2] cycloadditions. 
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 To understand the regioselectivity of intermolecular [3+2] cycloadditions, these group 
also studied the intermolecular reaction between heteroallene 1.147 and propene (1.148) 
with three possible transition states that correspond to concerted pathway.37 In the 
transition state TS-1.149, the methyl group of propene is proximal to the nitrogen 
attached to the phenyl ring, whereas in the transition state TS-1.151, the methyl group is 
distal to this nitrogen (Figure 1.11). The free energy barriers for [3+2] cycloaddition via 
TS-1.149 is lower by 4.9 kcal/mol than that of cycloaddition via TS-1.151. Therefore, the 
TS-1.149 provides the more stable five-membered ring product 1.150. Importantly, the 
terminal carbon of the heteroallene 1.147 has much a larger LUMO+1 orbital coefficient 
than the terminal nitrogen, which makes it more electrophilic. Therefore, the terminal 
carbon of methyl propene (1.148) reacts via nucleophilic attack on the electrophilic 
carbon of the heteroallene 1.147 to provide the more stable product 1.150. The transition 
state TS-1.153, obtained via [4+2] cycloaddition, has a higher activation barrier than the 
transition states TS-1.149 and TS-1.151. 
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Figure 1.12. The possible transition states, products, and DFT-computed energies (in 
kcal/mol) for intramolecular [3+2] and [4+2] cycloadditions between heteroallene and 
propene. 
1.7 Scope of intramolecular [4+2] cycloaddition reaction  
 In prior work, the Brewer group showed that the intramolecular cycloaddition 
reaction proceeded in high yield. 32-,35 With a better understanding of the mechanism of 
this [4+2] cycloaddition in hand, we were interested to determine how changes to the 
electronics of the N-aryl ring or substituent of the alkene would affect the cycloaddition 
process.  
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1.7.1 Scope of the SbCl5 mediated intramolecular [4+2] cycloadditions from -
chloroazo precursors 
 To determine what affect substitution on the aromatic ring would have on the result of 
the cycloaddition process. I first prepared -chloroazo compounds (1.155) from toluene 
hydrazone derivatives. A dichloromethane solution of -chloroazo compounds were 
treated with 0.95 equiv of antimony pentachloride at -78 °C to form the protonated 
azomethine amine salts (1.157) in high yields (Scheme 1.29). 
 
Scheme 1.29. SbCl5 mediated intramolecular [4+2] cycloaddition reactions. 
 After these results, I carried out this reaction with a methoxy substituent at the para-
position. However, this substrate failed to provide a clean cycloaddition product (Scheme 
1.30) and due to the presence of SbCl6, all my attempts to purify the desired product 
failed.  
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Scheme 1.30. Limitation of SbCl5 mediated intramolecular [4+2] cycloaddition for 
methoxy substituent on N-aryl ring. 
 The Brewer group had previously reported that the intramolecular [4+2] 
cycloaddition reaction with mono-, di-, and tri-substituted alkenes proceeded in high 
yield.33 So, we were interested to see if a more highly hindered tetra-substituted alkene 
would also be a suitable reaction partner for [4+2] cycloaddition. With this in mind, I 
prepared -chloro-azo compound 1.161 (Scheme 1.31) from the phenyl hydrazone of 
dihydro--ionone. However, this substrate also did not give clean cycloaddition product 
under standard SbCl5 mediated cycloaddition conditions, and all efforts to purify the 
desired product 1.163 failed. 
 
Scheme 1.31. Limitation of SbCl5 mediated intramolecular [4+2] cycloaddition of -
chloroazo compound of dihydro--ionone derivative. 
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 To expand the scope of this cycloaddition, we were interested to see if a heteroallene 
salt with an alkene group attached via an N-aryl ring would react productively. So, I 
prepared the -chloroazo compound 1.164a and 1.164b (Scheme 1.32) from the 
corresponding hydrazone derivatives. However, these systems failed to give any of the 
expected cycloaddition products. We presume that the reaction failed because of poor 
orbital alignment between heteroallene and alkene in the transition state of the 
cycloaddition step. 
 
Scheme 1.32. Limitation of SbCl5 mediated [4+2] cycloadditions of -chloroazo 
compound, in which an alkene group is attached via an N-aryl ring. 
1.7.2 Scope of the TMSOTf mediated intramolecular [4+2] cycloadditions from -
chloroazo precursors 
The use of antimony pentachloride as Lewis acid was not ideal from a purification, 
environmental, and practical standpoint. With these limitations in mind, we sought to 
develop a greener, more general, and higher yielding alternative. Our initial goal was to 
find a Lewis acid that could give the desired cycloaddition products more cleanly and in 
higher yield from an -chloroazo starting material. Dr. Tsvetkov had established that 
TMSOTf could be used in place of SbCl5 to facilitate diazenium salt formation. 
Therefore, I reacted a hexane solution of -chloroazo 1.158 derived from the 4-methoxy 
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phenyl hydrazone of hex-5-en-2-one, with trimethylsilyltrifluoromethanesulfonate 
(TMSOTf) at room temperature for 12 hours. These conditions provided the desired 
product 1.168 in 85% yield (Scheme 1.33). Importantly, this reaction occurred very 
cleanly. Figure 1.13 shows the 1HNMR peaks of the protonated azomethine imine salt 
1.168, in which the chemical shift 4.53 represents the characteristic 1HNMR peak for 
the proton adjacent to the imine nitrogen. 
 
Scheme 1.33. TMSOTf mediated intramolecular [4+2] cycloaddition from -chloroazo 
compound containing methoxy substituent on N-aryl ring.  
 
Figure 1.13. 1HNMR spectrum showing the characteristic peak of the protonated 
azomethine imine salt. 
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With this result in hand, I treated a hexane solution of -chloro-azo 1.161 under the 
same reaction conditions, which gave the desired product 1.170 in 45% yield after 
purification by recrystallization from methanol and diethyl ether (Scheme 1.34). When I 
increased the equivalents of TMSOTf from 1.05 to 1.5, the yield increased to 60%. 
Crystals of this salt suitable for X-ray diffraction were prepared from a mixture of 
methanol and diethyl ether. X-ray crystallography provided the crystal structure shown in 
Fig.1.12, which confirmed the structure of this sterically congested product. 
 
Scheme 1.34. TMSOTf mediated intramolecular [4+2] cycloaddition of -chloroazo 
compound of dihydro--ionone derivative. 
 
Figure 1.14. Crystal structure of protonated azomethine imine 1.170. 
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 When the new reaction conditions were also applied to the toluene derived 
hydrazones (Scheme 1.35), the yield of the desired products were almost identical to the 
SbCl5 mediated reactions. However, the TMSOTf mediated reactions provided cleaner 
cycloaddition products than the SbCl5 mediated reactions.  
 
Scheme 1.35. TMSOTf mediated intramolecular [4+2] cycloaddition of -chloroazo 
precursors. 
1.7.3 TMSOTf mediated intramolecular [4+2] cycloadditions from -
trifluoroacetoxyazo precursors 
 We were interested to see how a nitro substituted aryl group would affect the 
cycloadditions. However, I was not able to form the requisite -chloroazo compound 
(1.174) under Swern conditions (Scheme 1.36a). To overcome this limitation, I sought to 
identify an alternate technique to form a different -substituted azo species that could 
serve as a heteroallene precursor. To achieve this, I replaced the oxalyl chloride with 
trifluoroacetic anhydride (TFAA) in Swern reaction, which gave the corresponding-
trifluoroacetoxyazo compound 1.175 in 82% yield (Scheme1.36b). More details about 
this method for the preparation of -trifluoroacetoxyazo derivatives have been discussed 
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in Chapter 3. However, it is worth noting at this point that this method has proven to be 
quite general. 
 
Scheme 1.36a. A method to form -chloroazo compound from a hydrazone derivative. 
 
Scheme 1.36b. A new method to prepare -substituted azo compound. 
 With a new and general route to prepare -substituted azo compounds in hand, I 
needed to establish if these could serve as heteroallene precursors. I began these studies 
by reacting BF3·Et2O with a hexane solution of -trifluoroacetoxy 1.176 (Entry 1, Table 
1.1) at room temperature for 12 hours. However, this did not give clean cycloaddition 
product (1.170). Therefore, I replaced the BF3·Et2O with TMSOTf. Under identical 
reaction conditions, this latter Lewis acid gave the protonated azomethine imine salt 
1.170 in 55% yield (Entry 2, Table 1.1) which is a slight improvement over the result 
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obtained from the corresponding -chloroazo precursor (Scheme 1.32). When I changed 
the solvent to dichloromethane (Entry 3, Table 1.1), it gave comparable yield, whereas 
THF polymerized under the reaction conditions (Entry 4, Table 1.1) giving no desired 
product. When I raised the temperature to 40 °C with 1.5 equivalent of TMSOTf (Entry 
5, Table 1.1), the desired product was formed in 47% yield in shorter time (45 mins). 
Increasing the time to 4 hours with 1.04 equivalent of TMSOTf (Entry 6, Table 1.1) gave 
substantially improved product yield (67%). Finally, increasing the equivalent of 
TMSOTf to 1.5 at 40 °C for 4 hours (Entry 7, Table 1.1) provided high product yield 
(72%) which became the conditions of choice to carry out the reaction scope studies. 
Table 1.1. Optimization of intramolecular [4+2] cycloaddition reaction using 
trifluroacetoxy azo derivative of dihydro--ionone 
 
entry solvent reagent (equiv) time temperature yield 
1  hexane BF3. Et2O (1.05) 12 hrs rt - 
2  hexane TMSOTf (1.05) 12 hrs rt 55% 
3  CH2Cl2 TMSOTf (1.04) 12 hrs rt 58% 
4  THF TMSOTf (1.05) 3 hrs rt - 
5  hexane TMSOTf (1.5) 45 mins 40 °C 47% 
6  hexane TMSOTf (1.04) 4 hrs 40 °C 67% 
7  hexane TMSOTf (1.5) 4 hrs 40 °C 72% 
 We began these scope studies by evaluating the effect of N-aryl substituents on the 
cycloaddition with a sterically hindered alkene. The methyl substituent either on ortho- or 
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para-position on the N-aryl group of 1.177 gave good yield, whereas the methoxy and 
chloride substituents at the para-position gave low yields (Scheme 1.37). The latter 
reactions were repeated several times, but the yields were consistently low each time. 
Interestingly, compound 1.182, containing a methoxy substituent, gave very nice golden 
crystals, which were not observed for any other substituents. 
 
Scheme 1.37. Scope of TMSOTf mediated [4+2] cycloaddition of -trifluoroacetoxyazo 
derivatives containing sterically hindered alkene. 
 When the nitro substituted -trifluoroacetoxy 1.184 was treated with optimized 
condition, it did not give a cycloaddition product, but it gave a very small amount of the 
triflate salt of hydrazone 1.187 (Scheme 1.38). To confirm this product, I treated nitro-
substituted hydrazone derivative 1.185 with TMSOTf at room temperature and it gave 
identical material. Therefore, an electron-withdrawing nitro group seems to prevent the 
intramolecular [4+2] cycloaddition reaction with a sterically hindered alkene. 
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Scheme 1.38. Formation of the salt of hydrazone derivative of nitro substituent on N-aryl 
ring from-trifluoroacetoxyazo compound and hydrazone derivative of dihydro--
ionone. 
 Although the chloride substitution product 1.183 (Scheme 1.37) was formed in low 
yield, I was still interested to try the cycloaddition reaction with a dichloro-substituted 
aryl ring. -Trifluoroacetoxyazo 1.187 was treated with the optimized conditions, it also 
failed to undergo the cycloaddition reaction, but it gave a very small amount of the 
hydrazone salt (Scheme 1.39). Therefore, I have concluded that the presence of nitro or 
dichloride electron-withdrawing groups on the N-aryl ring, generally prevents the 
cycloaddition from occurring with sterically hindered alkenes.  
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Scheme 1.39. Formation of the salt of hydrazone derivative of dichloro substituents on 
N-aryl ring from-trifluoroacetoxyazo compound and hydrazone derivative of dihydro-
-ionone. 
 With a better understanding of the substrate scope, we continued to study the 
cycloaddition reaction with simple alkenes. The toluene hydrazone gave very good yields 
(Scheme 1.40), as did an anisol derivative (product 1.168; 81% yield). This latter result is 
better than the result obtained from the -trifluoroacetoxyazo precursor of sterically 
hindered alkene. Interestingly, an electron withdrawing nitro aryl derivative underwent 
cycloaddition in excellent yield. (1.193 in 96% yield). As might be expected, the meta-
substituted nitro group gave a mixture of regioisomeric cycloaddition products in a 3:2 
ratio based on 1HNMR, but the total yield for both regioisomeric products (1.194 and 
1.195) was quantitative. These regioisomers were separated based on the solubility. The 
isomer 1.194 was sparingly soluble in chloroform, whereas the isomer 1.195 was 
completely soluble in chloroform. Both were soluble in acetonitrile. A chloride 
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substituent at the para-position (1.196) also gave good yield, but dichloride substituents 
at ortho- and para-positions (1.197) gave comparatively lower yield than the mono-
substitution. Without any substitution on the aryl group, the cycloaddition reaction 
occurred very smoothly under the standard condition to afford the desired product 1.198 
in 96% yield. 
 
Scheme 1.40. Scope of TMSOTf mediated [4+2] cycloaddition reaction using simple 
alkene.  
 I also attempted a one pot synthesis of protonated azomethine imine salts starting 
directly from hydrazone derivatives.  In this case, hydrazone 1.199 (Scheme 1.41) was 
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treated with trifluoroacetic anhydride in the presence of DMSO and triethyl amine at -78 
°C for 30 minutes to form the -trifluoroacetoxy azo compound. After 30 minutes, 
without any work-up, TMSOTf was added into the reaction mixture which was then left 
overnight at room temperature to form the desired product 1.200. I was only able to 
recover 1.200 in 19% yield. The actual yield was slightly higher, but the 
triethylammonium salt generated during the oxidation step, made it impossible to isolate 
all the product from the mixture. 
 
Scheme 1.41. One pot reaction to form a protonated azomethine imine salt starting from 
a hydrazone derivative. 
1.7.4 Formation of dearomatized non-protonated azomethine imine salt 
 The Brewer group has already reported that the intramolecular [4+2] cycloaddition 
reactions occur via concerted pathway, in which the N-aryl group is first dearomatized 
reaction and subsequently aromatized via 1,3-hydride shift to give the protonated 
azomethine imine salts.32 To further verify this mechanism, we were interested to isolate 
the dearomatized product. This could be achieved by starting with a substrate that has 
both ortho positions of the N-aryl ring blocked. Several attempts to prepare the desired 
dearomatized product from -chloroazo compound of 1.201 failed. Therefore, I prepared 
-trifluoroacetoxyazo compound 1.201 from the corresponding hydrazone derivative. 
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The azo compound 1.201 was then treated with a dichloromethane solution of 0.95 equiv 
of SbCl5 to afford the dearomatized non-protonated azomethine imine salt 1.203 in 61% 
yield (Scheme 1.42). The methyl group at the quaternary carbon of the ring prevents the 
product (1.203) from aromatizing. This study confirms that the intramolecular 
cycloaddition reaction occurs via a concerted cycloaddition pathway. 
 
Scheme 1.42. SbCl5 mediated intramolecular [4+2] cycloaddition reaction from -
trifluoroacetoxyazo compound to form non-protonated azomethine imine salt. 
1.8 Conclusions 
 Jochims and coworkers explored polar [3+2] cycloadditions of 1-aza-2-azoniaallene 
salts with a wide variety of π systems to synthesize a variety of different classes of N-
heterocycles. Taking advantages from these preliminary investigations, the Brewer group 
developed a polar [3+2] cycloaddition of 1-aza-2-azoniaallene salts to prepare 
structurally complex bicyclic diazenium salts. During these studies, we discovered that 
aryl-1-aza-2-azoniaallene salt could undergo an unprecedented intramolecular [4+2] 
cycloaddition to provide a tricyclic pronated azomethine imine salt containing a 1,2,3,4-
tetrahydrocinnoline scaffold in high yield. To understand the mechanism of these polar 
cycloadditions, the Brewer group, in collaboration with the Houk group, studied the role 
of the tether computationally for intramolecular [3+2] and [4+2] cycloadditions.  
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 With a better understanding of the mechanism of the intramolecular [4+2] 
cycloaddition in hand, we used a variety of substituents on the N-aryl ring and a more 
highly hindered tetra-substituted alkene to give structurally complex protonated 
azomethine imine salts. The metal mediated reaction did not facilitate the cycloadditions 
very well, so we replaced the antimony pentachloride with TMSOTf. Although the non-
metallic Lewis acid provided very clean products with -chloroazo compounds, the novel 
-trifluoroacetoxyazo compounds prepared from the corresponding hydrazone 
derivatives and trifluoroacetic anhydride, underwent [4+2] cycloadditions more cleanly 
and in higher yield with TMSOTf as the Lewis acid. 
 Finally, to further verify the proposed mechanism of the [4+2] cycloaddition, I was 
also able to synthesize a dearomatized non-protonated azomethine imine salt. 
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CHAPTER 2: INTRAMOLECULAR C-H AND ALKENE AMINATION OF 1-
AZA-2-AZONIAALLENE SALTS 
2.1 Introduction 
 Selective and direct functionalization of unactivated carbon-hydrogen bonds is a 
powerful tool in synthetic organic chemistry. This approach has a broader potential in the 
synthesis of complex molecules compared to the traditional approaches of conducting 
transformation on pre-existing functional groups because C–H bonds are ubiquitous in 
organic substances.1-10 In recent years, metal nitrenoid complexes have been extensively 
used for C-H functionalization, which is referred to as C-H amination. Highlighting the 
power of C-H amination, DuBois and colleagues have reported a number of syntheses of 
complex natural products, such as manzacidin,12 (+)-saxitoxin,13 and (-)-tetrodotoxin14 
(2.3, Scheme 2.1) via C-H amination.  
 
Scheme 2.1. Synthesis of (-)-tetrodotoxin (2.3) via nitrenoid C-H insertion reaction.  
2.2 Intramolecular C-H amination of 1-aza-2-azoniaallene salts 
 The Brewer group discovered that 1-aza-2-azoniaallene salts (e.g. 2.5, Scheme 2.2) 
without a pendent alkene, undergo unprecedented C-H amination at benzylic and tertiary 
aliphatic centers to afford pyrazoline products (e. g. 2.6) without the formation of a metal 
nitrenoid intermediate.14  
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Scheme 2.2. Intramolecular C-H insertion reaction to prepare pyrazoline. 
Table 2.1. Examples of substrate scope for C-H amination with above conditions 
entry -chloroazo      product                                 yield 
1  
 
 
2  
 
 
3  
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 To understand how this reactivity is affected by electronic environment of the 
benzylic position, the Brewer group carried out a competition experiment in which the 
reactive heteroallene intermediate 2.14 has equal chance to react at a benzylic position of 
4-methoxybenzene or 4-nitrobenzene.14 The experimental result showed that the benzylic 
position of 4-methoxybenzene reacted exclusively, giving the pyrazoline product 2.15 in 
92% yield (Scheme 2.3). This was interpreted to indicate that the electron donating 
methoxy group stabilizes a benzylic cation that is generated during the reaction, which 
allows this C-N bond to form more quickly. 
 
Scheme 2.3. Competition experiment at benzylic positions. 
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 To compare the reactivity between benzylic and tertiary positions, the Brewer group 
performed another competition reaction, in which the reactive heteroallene 2.17 derived 
from the -chloroazo compound 2.16, has equal chance to undergo C-H insertion at a 
benzylic or a tertiary position. In this case, the insertion reaction occurred preferentially 
at the benzylic position (Scheme 2.4).15 
 
Scheme 2.4. Competition experiment between benzylic and tertiary positions. 
 To study the stereochemistry, the Brewer group performed the insertion shown in 
Scheme 2.5 at a tertiary benzylic position. This reaction occurred without loss of 
enantiomeric excess.14 Although this result supports the notion that the amination 
reaction occurs via a concerted process, later computational studies did not support that 
assertion. I have discussed the theoretical study for this mechanism in the next section. 
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Scheme 2.5. To study stereochemistry for C-H insertion reaction. 
2.3 Theoretical study of intramolecular C-H amination of 1-aza-2-azoniallene salt 
 We in collaboration with the Houk group (UCLA) reported computational results that 
describe the mechanism of intramolecular C-H insertion reactions of 1-aza-2-
azoniaallene salts.14 First, the structures of transition states and the free energy changes of 
single and triplet C-H amination pathways of aryl-1-aza-2-azoniaallene were calculated. 
In the singlet pathway (Figure 2.1), the heteroallene cation 2.22 gives the singlet 
transition state 2.23 in which the HOMO of the benzylic C-H bond interacts with the 
LUMO of the 1,3-monoplar heterocumulene fragment. This interaction suggests that a 
hydride migration occurs initially to form the N-H bond and a benzyl carbocation. 
Finally, the benzyl carbocation forms a C-N bond with the lone pair of electrons on 
nitrogen to provide the amination product. In the case of a triplet pathway (Figure 2.1), 
the triplet diradical heterocumulene species 2.25 could be generated from spin transition 
of the heteroallene cation 2.22. This species could then undergo C-H amination via a 
radical pathway to give diradical species 2.27. However, the triplet state aryl-1-aza-2-
azoniaallene 2.25 is less stable than the singlet 2.22 by 23.9 kcal/mol. Therefore, the 
singlet C-H amination pathway is more favorable than the triplet C-H pathway. It is also 
worth noting that literature data,16,17,18 indicates that C-H insertion of singlet nitrenes 
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proceeds with retention of configuration while triplet nitrenes react via H-
abstraction/radical recombination resulting in stereochemical erosion, which again 
support a singlet pathway.  
 
Figure 2.1. Gibbs free energy changes in kcal/mol of singlet and triplet C-H amination 
pathways of aryl-1-aza-2-azoniaallene. 
 Based on intrinsic reaction coordinate (IRC),14 the Houk and the Brewer groups also 
reported that the benzylic hydride gradually migrates to the electron-deficient terminal 
nitrogen to form a N-H bond and a benzyl carbocation. The benzyl carbocation 
subsequently undergoes C-N bond formation to give the heterocyclic product. To support 
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these facts, these groups report the quasi-classical molecular dynamic trajectories (Figure 
2.2) for the singlet C-H amination of an ary-1-aza-2-azoniaallene. This study showed that 
N-H bond formation takes place much faster than C-N bond formation and that C-C bond 
rotation occurs much slower than the C-N bond formation, which accounts for the 
stereospecificity observed for the C-H insertion reaction (Scheme 2.4). 
 
Figure 2.2. Probability vs. timing of N-H and C-N bond formation at 298 K (Figure 
courtesy of J. Am. Chem. Soc. 2015, 137, 9100-9107).  
2.4 Effect of tether length on intramolecular reactions of 1-aza-2-azoniaallenes 
 To understand the effect of the tether length on intramolecular C-H aminations, the 
Brewer group prepared a heteroallene salt (e.g. 2.30, Scheme 2.6a), in which the tether is 
one methylene unit longer than 2.5 (Scheme 2.2). This heteroallene unexpectedly 
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underwent an electrophilic aromatic substitution reaction to give azotetralin 2.31 in 76% 
yield instead of a C-H insertion product.14 This result showed that the tether length plays 
a vital role in determining the result of these reactions. To investigate the reactivity of 
this Friedel-Crafts type reaction, the Brewer group also prepared the heteroallene salt 
2.33 from the -chloroazo compound 2.32 and treated it with toluene (2.34) to give the 
azo-cymene 2.35 in 30% yield (Scheme 2.6b).14 Therefore, this type of reaction is not 
limited to intramolecular reactions. When the Brewer group, in collaboration with the 
Houk group, studied the tether effect on the competition between C-H amination and 
electrophilic aromatic substitution, they found that the longer tether made the transition 
state leading to electrophilic aromatic substitution more stable than the transition state for 
C-H amination.14 
 
Scheme 2.6a. Effect of tether length on intramolecular reactions of 1-aza-2-
azoniaallenes. 
 
Scheme 2.6b. Test reaction of 1-aza-2-azoniaallene for Friedel-Crafts type reactivity. 
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2.5 Kinetic isotope effects for intramolecular C-H amination of 1-aza-2-azoniaallene 
Kinetic isotope effects (KIEs) give useful information about relative rates which can 
be used to determine the mechanism of reactions. In this method, a hydrogen atom is 
replaced by a deuterium atom, and the relative rates of reaction are compared. The zero-
point energy of deuterium is lower than the zero-point energy of hydrogen because 
deuterium is heavier than hydrogen (Figure 2.3). Due to this, the bond dissociation 
energy for a C-D is greater than the bond dissociation energy for a C-H. Therefore, the 
reaction rate for the conversion of C-D is typically slower than the reaction rate for the 
conversion of C-H. However, the degree to which the different in rate is observed 
depends on how fully the bond is broken at the transition state. Reactions that have highly 
developed bond cleavage at the transition state show large KIEs (more than 3). A 
minimal bond cleavage at the transition state shows the KIEs in between 1 and 2. A KIEs 
of 1 shows that there is no difference between C-H and C-D bonds and the isotope effect 
is too small to be detected.19,20,21  
Figure 2.3. A Morse potential diagram showing zeropoint energy for C-H and C-D. 
The determination of the KIEs for C-H amination could provide crusial information 
to better understand the mechanism of heteroallene insertion. To complete these 
experimental studies, I prepared -chloroazo compound 2.36 (Scheme 2.7) from the 
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corresponding hydrazone derivative. After subjecting this compound to the insertion 
reaction under the standard conditions, we observed an average 4.3:1 ratio of deuterated 
to nondeuterated amination product. This ratio was calculated by integration of the 
1HNMR spectrum of the crude reaction mixture. Based on the literature, KIEs between 3 
and 6 generally indicates a rapid radical rebound mechanism,24,25 or a highly 
asynchronous concerted insertion.17,22,23 The observed KIEs (4.3) and the computational 
results are both consistent with the latter mechanism. Therefore, we finally concluded 
that the mechanism of the C-H amination of 1-aza-2-azoniaallene salts occurs through an 
asynchronous concerted pathway. 
 
Scheme 2.7. Experimental kinetic isotope effect. 
2.6 Exploration of the scope of 1-aza-2-azoniaallene salts  
After discovering that 1-aza-2-azoniaallene salts can participate in the intramolecular 
C-H amination reactions,14,15 we were intetrested to explore the scope of this insertion 
reaction. The results of these studies are described in the sections that follow. 
2.6.1 Limitation of C-H insertion on seconary aliphatic center 
 As described in section 2.2, table 2.1, 1-aza-2-azoniaallene salt easily undergo 
intramolecular C-H insertion reaction at tertiary aliphatic and benzylic centers.14,15 We 
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were interested in exploring the C-H amination reaction at a secondary aliphatic center. 
Therefore, I prepared the -chloroazo compounds 2.39a and 2.39b (Scheme 2.8) from 
the corresponding hydrazone derivatives. The reactive heteroallene intermediate 2.40a 
and 2.40b, generated by treating the-chloroazo compounds with AlCl3 under the 
standard conditions, did not undergo C-H amination reaction to provide the expected 
products (2.41a and 2.41b), but instead were hydrolized giving the starting ketones 2.42a 
and 2.42b. After several attempts, we concluded that the C-H insertion reaction does not 
occur at a secondary aliphatic center.15 
 
Scheme 2.8. Limitation of C-H insertion reactions at secondary aliphatic centers. 
2.6.2 Limitation of C-H insertion to synthesize indoline and indole products 
The C-H insertion reaction might not be limited to just pendent groups that are 
attached to the heteroallene. To extend the scope of the C-H insertion reaction, we 
proposed that insertion at a position tethered through the N-aryl ring could yield indole 
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and indoline products (Scheme 2.9). To test this, I prepared hydrazine derivatives 2.44a 
and 2.44b by treating the corresponding aniline derivatives (2.43a and 2.43b) with 
sodium nitrite, tin (II) chloride, and hydrochloric acid at 0 °C.26 The hydrazones were 
then reacted with acetone to provide hydrazones 2.45a and 2.45b. This reaction did not 
provide very pure hydrazone derivatives; due to the instability, I was unable to fully 
purify these derivatives. I took these impure materials to prepare the corresponding α-
chloroazo compounds 2.46a and 2.46b, but they were impure as well. Previously, I had 
prepared an o-tolylhydrazone and its corresponding α-chloroazo compound without issue. 
However, in these more functionalized cases, purity was always an issue and I was not 
able to generate expected products 2.47a and 2.47b. 
 
Scheme 2.9. Synthetic approach to form indoles via C-H amination. 
We were also interested to synthesize hemiaminal 2.53 (Scheme 2.10 and 2.11) via 
C-H amination. In this case, we expected the oxygen atom to activate the benzylic 
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position toward C-H insertion. To test this, I prepared hydrazine 2.49 (Scheme 2.10) by 
reacting 2-(benzyloxy)aniline (2.48) with aqueous sodium nitrate, tin chloride, and 
hydrochloric acid at 0 °C.27 The hydrazine 2.49 was then treated with acetone to give 
hydrazone 2.50, which was then oxidized under Swern conditions to give -chloroazo 
compound 2.51 in 60% yield. When this -chloroazo compound was treated with 
anhydrous AlCl3 in the presence of triethylamine at -60 °C, it did not undergo a C-H 
amination reaction. Replacing the Lewis acid with TMSOTf, did not help the situation, 
and after aqueous work-up, the starting hydrazone 2.50 was isolated. 
 
Scheme 2.10. Limitation of C-H amination from -chloroazo compound. 
s described in Chapter 1, -trifluoroacetoxyazo compounds also give heteroallene 
salts upon treatment with TMSOTf. So, we were interested to try the C-H amination 
reaction starting from the -trifluoroacetoxyazo compound.  I prepared -
trifluoroacetoxyazo 2.54 (Scheme 2.10) from the hydrazone 2.50, and treated it with 
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TMSOTf at room temperature for 12 hours. This reaction also failed to give the desired 
product, and after aqueous work-up, the starting hydrazone 2.50 was isolated. 
 
Scheme 2.11. Limitation of C-H amination from -trifluoroacetoxyazo compound. 
2.7 C-H Amination and chloro-amination of allylic heteroallene salts 
 The Brewer group had reported that heteroallenes having pendent alkenes undergo 
either [3+2]28,29 or [4+2]30 cycloaddition reactions depending on the length of the 
connecting the reacting partners.31 While studying the substrate scope for the C-H 
amination, Dr. Al-Batainech prepared heteroallene salt of cyclopentene derivative, which 
underwent a C-H insertion reaction to give pyrazole 2.58 (Scheme 2.12). In this case, the 
cycloaddition reaction is unfavorable because of conformational constraints.15  
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Scheme 2.12. C-H amination for allylic heteroallene salt. 
 However, we were surprised to find the seemingly analogous heteroallene 2.60 
underwent an alkene addition reaction instead of allylic C-H amination to provide the 
chloro-substituted tetrahydropyridazine 2.61 in 84% yield (Scheme 2.13).32  
 
Scheme 2.13. Intramolecular chloro-amination reaction of heteroallene. 
 In collaboration with Prof. Houk (UCLA) and Dr. Hong (Zhejiang University, 
China), the Brewer group modeled the reaction of allylic heteroallene salts using DFT 
calculations.32 These studies compared possible C-H amination and nitrenium [2+1] 
cycloaddition addition pathways (Figure 2.4). The heteroallene of cyclopentene 
derivative 2.62 undergoes a C-H amination reaction via transition state TS-2.63 with an 
energy barrier of 15.3 kcal/mol. The competing [2+1] cycloaddition pathway proceeds by 
transition state TS-2.65, which has an energy barrier of 16.2 kcal/mol that is 0.9 kcal/mol 
higher than the C-H amination. Therefore, the C-H amination pathway is more favorable 
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than the nitrenium (2+1) addition pathway, which is consistent with the experimental 
result (Scheme 2.12).  
 
Figure 2.4. Gibbs free energy barrier in kcal/mol for C-H amination and aziridinium 
pathways for 5-membered ring. 
 On the other hand, the cyclohexene derivative (2.67) undergoes C-H amination via 
transition state TS-2.68 with an energy barrier of 20.4 kcal/mol and nitrenium (2+1) 
addition via transition state TS-2.70 with an energy barrier of 16.4 kcal/mol. In this case, 
the cycloaddition pathway is 4.0 kcal/mol lower in energy. Therefore, the nitrenium 
(2+1) addition pathway is more favorable than C-H amination pathway, which is also 
consistent with the experimental result (Scheme 2.12) because of the formation of 
pyrazole 2.58.  
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Figure 3.5. Gibbs free energy barrier in kcal/mol for C-H amination and aziridinium 
pathways for 6-membered ring. 
2.8 Limitation of intramolecular alkene aminations 
As described in section 2.7, the chloroamination path proceeds through an 
aziridinium ion intermediate. We hypothesized that it might be possible to trap this 
intermediate ion by a variety of external nucleophiles. To examine this, I prepared -
substituted azo compounds 2.73 and 2.74 from hydrazone 2.72 (Scheme 2.14). After 
treating Lewis acid such as, TMSOTf and AgOTf, with a hexane solution of these azo 
compounds at -78 °C, the reaction mixture was stirred for 10 minutes. Then, an external 
nucleophile, such as MeOH, was added and stirred for additional 20 minutes at -78 °C 
and warmed up to room temperature. After aqueous work-up, I was unable to get the 
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expected product 2.78. When I used -chloroazo compound 2.73 as a starting material, I 
observed a small amount of chloro-substituted product (2.77). The aqueous work-up of 
the TMSOTf mediated product was oxidized to give starting ketone 2.79. 
 
Scheme 2.14. Limitation of alkene amination. 
We also thought it might be possible to trap aziridinium ion by migraton of a methyl 
group. For example, as shown in Scheme 2.15,  heteroallene 2.83 would be expected to 
react with the attached alkene to give aziridinium ion 2.84.  In this case, pinicol-type 
migration of an adjacent methyl group would provide the diazabicyclo ketone 2.85.  
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Scheme 2.15. Purposed reaction path to form diazabicyclo ketone (2.85) via alkene 
amination. 
 The required ketone 2.80 (Scheme 2.15) was not commercially available and our 
first goal was to synthesize this ketone. To achieve this, perillaldehyde (2.86) was reacted 
with hydroxyl amine to give the hydroxyl imine 2.87,33 which was then converted into 
the nitrile group34 (2.88) by reaction with MsCl and pyridine (Scheme 2.16). The alkene 
group of 2.88 underwent selective ozonolysis of the uncojugated alkene to form ketone 
2.89, which was then treated with ethanol and acetyl chloride to afford the ester 2.90. The 
ketone group of 2.90 was protected as the acetal (2.91), which was then treated with 
methyl lithium to form 3° alcohol 2.92.35 All that is required is hydrolysis of the acetal to 
afford ketone. To achieve this, acetal 2.91 was treated under different conditions, 
including 1M of HCl, THF, 0 to 25 °C, 13h; 6N of HCl, EtOH (95%), 4h, rt; AcOH 
(20%), EtOH, reflux, 2h; and CAN, CH3CN, H2O, 70 °C. Under all of these conditions, 
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the desired deprotection occurred, but so did elimination of the tertiary alcohol to give the 
undesired diene 2.93. 
 
Scheme 2.16. First attempt to prepare the desired ketone 2.84. 
 As an alternative strategy to prepare ketone 2.80 (Scheme 2.15), I treated 
perillaldehyde (2.96) with MeLi to form the 2° alcohol (2.94, Scheme 2.17), and 
subsequent Swern oxidation gave the ketone 2.95, and this ketone was converted into the 
3° alcohol with MeLi.35 But, I was not able to selectively oxidize the less substituted 
alkene to give ketone 2.80. 
 69 
 
Scheme 2.17. Second attempt to prepare the desired ketone 2.80. 
 In view of the difficulties, we faced in preparing 2.80, we determined that this 
methodology would not be generally useful, and we set this project aside.  
2.9 New type of C-H amination via nitrenium cation 
The Brewer group has discovered many different reactivities of 1-aza-2-azoniaallene 
salts,14,15,29-32 and we recognized that this reactivity can be ascribed to the aza-substituted 
nitrenium cation 1.4 (Figure 2.6). We recognized that if we replaced the nitrogen atom of 
the aza group in structure 1.2 by an oxygen atom, it would give the oxonium cation 2.97 
(Figure 2.6). This oxonium cation is a resonance form of nitrenium cation 2.98, which is 
analogous to the aza-nitrenium cation 1.4. Therefore, we hypothesized that the reactivity 
of 2.98 should be similar to the reactivity of 1-aza-2-azoniaallene cations.  
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Figure 2.6. Comparison of traditional approach with new approach to undergo new type 
of C-H amination. 
Our major goal was to develop a new synthetic strategy, in which structures, such as 
2.98 (Figure 2.6), react via C-H insertion to give a heterocycle containing an O-N bond. 
This would be useful because O-N bonds are easy to cleave. We thought it might be 
possible to generate 2.98 from a hydroxyl amine precursor with a good leaving group on 
nitrogen (Scheme 2.18). After releasing the leaving group, we expected to form the 
intermediate oxonium cation 2.98 or nitrenium cation 2.97, which could undergo C-H 
insertion in the presence of a suitable base to provide the desired product 2.101.  
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Scheme 2.18. A synthetic strategy to form O-N bond in a ring system via C-H amination. 
To this end, I first prepared 1-hydroxy-1,3-diphenylurea36 (2.103, Scheme 2.19) 
from the reaction of isocyanatobenzene (2.102) and N-phenylhydroxyl amine. This urea 
derivative underwent nucleophilic substitution with 3-bromopropyl benzene (2.104) to 
give the desired product 2.10536,37 in 98% yield. The nitrogen of the structure 2.105 was 
deprotected in the presence of hydrazine and hydroquinone to require hydroxyl amine 
2.106 in 57% yield.36,37 
 
Scheme 2.19. Formation of a starting material for new type of C-H amination reaction. 
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 Treating 2.106 (Scheme 2.20) with trifluoroacetoxydimethylsulfonium 
trifluoroacetate generated from trifluoroacetic anhydride (TFAA) and DMSO in the 
presence of triethyl amine at 0 °C for 20 minutes did not give the desired product 2.107, 
but instead gave 2.108, in which the nitrogen atom is protected by a trifluoroacetyl group. 
To confirm this result, I treated a small amount of starting material with TFAA in a NMR 
tube, and it also provided 2.108.  
 
Scheme 2.20. Reaction for C-H amination. 
Other potential oxidants, including triflic anhydride, PhI(OTf)2, and PITFA, also 
failed to give desired insertion product 2.107. In all cases, the starting materials were 
consumed, and in some cases, I isolated N-phenylhydroxyl amine which must have 
forced by breaking the C-O bond of the starting material, but insertion never occurred. 
2.10 New type of alkene amination via nitrenium cation 
Although the C-H amination of an oxygen stabilized a nitrenium cation failed to 
provide the desired product, we thought it might be possible to take advantages of that 
species in an alkene amination reaction32 (Scheme 2.21). Our hypothesis was that the 
nitrenium cation 2.109 (Scheme 2.20) could form a reactive aziridinium intermediate 
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(2.110) by engaging a pendent alkene. Aziridinium opening by a subsequent nucleophilic 
attack would provide heterocycle 2.111. 
 
Scheme 2.21. A synthetic strategy to form O-N bond in a ring system via alkene 
amination. 
To obtain the starting material 2.114 (Scheme 2.22), I treated 1-hydroxyl-1,3-
diphenylurea (2.105) with 4-bromobut-1-ene (2.112) which gave the O-alkylated product 
2.113 in 74% yield. Subsequent deprotection of nitrogen gave the desired N-aryl-O-alkyl 
hydroxyl amine 2.114 in 67% yield.36,37 
 
Scheme 2.22. Formation of starting material for alkene amination via nitrenium cation. 
To test the alkene amination reaction, hydroxyl amine 2.114 (Scheme 2.22) was 
treated with triflic dimethylsulfonium triflate and DTBMP at -78 °C. After few minutes, a 
few drops of methanol were added into the reaction mixture to open the aziridinium ring. 
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However, this reaction did not provide the desired product. After changing the oxidant 
PITFA, I still did not obtain the expected product. These preliminary studies led us to 
conclude that neither C-H amination nor alkene addition of oxygen-stabilized nitrenium 
cation would occur under the applied conditions. 
2.11 Conclusions 
 C-H amination has proven to be an important tool to construct C-N bonds as 
highlighted by its appliction in natural product synthesis, such as manzacidin,12 (+)-
saxitoxin,13 and (-)-tetrodotoxin14. Developing new methods to effect C-H amination 
could further increase the scope and utility of this useful reactivity. With this in mind, the 
Brewer group has developed unprecedented intramolecular C-H amination of 
heteroallene salts. We have also studied the mechanism of this insertion computationally 
and experimentally. These studies showed that benzylic position of 4-methoxybenzene 
are more favorable for C-H amination reaction than benzylic position of 4-nitrobenzene. 
In the competition reaction between benzylic and aliphatic tertiary positions, the benzylic 
position preferentially underwent insertion. Computational studies show that heteroallene 
salts energetically favor the singlet state, and that C-H insertion proceeds via an 
asynchronous concerted pathway. However, insertion is not always the most favorable 
process, and a longer tether follows a Friedel-Craft type electrophilic aromatic 
substitution reaction to provide an azotetralin derivative. Insertion does not occur at 
secondary aliphatic center. Finally, our efforts to develop a synthesis of indoles and 
indolines via C-H amination failed. 
 The intramolecular alkene amination of heteroallene salts provides a new way to 
synthesize a variety of bicyclic compounds. The Brewer group’s studies show that the 
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heteroallene salt of a cyclohexene derivative (2.75, Scheme 2.13) preferentially 
undergoes alkene amination. Computational studies indicate that this intramolecular 
reaction occurs via the formation of an aziridinium ion, which is trapped by the chloride 
counter ion. However, my all attempts to trap the aziridinium ion by an external 
nucleophile failed. 
 We purposed a new strategy to affect C-H amination and alkene addition reactions 
via a nitrenium cation intermediate, but these effors did not lead to a productive reaction.  
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CHAPTER 3: NEW SYNTHETIC ROUTES TO SYNTHESIZE -
SUBSTITITUED AZO COMPOUNDS 
3.1 Introduction 
 -Chloroazo compounds (e.g. 3.1, Figure 3.1) are useful synthetic precursors to a 
variety of cyclic and acyclic compounds. Jochims and coworkers used these precursors to 
synthesize 1,2,4-triazolium salts,1-3 4,5-dihydro-1,2,3-triazolium salts,4,5 1,3,4-
thiadiazolium salts,2 4,5-dihydro-3H-pyrazolium salts,5-7 3H-4-,5-dihydropyrazoles,8 and 
1H, or 4H-pyrazolium salts9 via 1-aza-2-azoniaallene salt intermediates. Al-Soud also 
synthesized pyrazole, 1,2,4-thiadiazole, 1,2,4-triazole, and 1,3,4-
thiadiazoliminothymidine derivatives using chloroazo precursors.10 Finally, Rai and 
coworkers employed these precursors to prepare azoalkenes, which were used to 
synthesize tetrahydropyridazine derivatives.11 
 
Figure 3.1. Structure of -chloroazo compound. 
 The Brewer group also utilized the -chloroazo compounds to synthesize structurally 
complex bicyclic diazonium salts,12-14 pyrazoline products,15,16 protonated azomethine 
imines salts,17,18 azotetralin derivatives,16 tetrahydropyridazine derivatives,16 and 
bicyclo[2.2.2]oct-2-ene via [3+2] and [4+2] cycloadditions,19 C-H insertions, and alkene 
aminations of 1-aza-2-azoniaallene salts. These reactions were discussed in detail in 
Chapters 1 and 2. 
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3.2 Preparation of -chloroazo compounds and their stability 
 The first synthesis of -chloroazo compounds was reported by Moon in 1972. In this 
procedure, hydrazone derivatives were treated with either chlorine or tert-butyl 
hypochlorite.20-22 He reported that the stability of these azo compounds depended on the 
substituents attached to the -position. Several azo compounds were prepared by 
chlorination of ketone phenylhydrazone derivatives, and these were not very stable; 
chromatography on silica gel led to decomposition. Although these azo compounds were 
not stable at room temperature for prolonged periods, some of the azo compounds were 
stable in ethanolic solutions of hydrochloric acid or sodium hydroxide at ambient 
temperature.20 Hydrazone derivatives containing electron-withdrawing groups on the 
carbon of the C-N double bond gave more stable -chloroazo products that could be 
purified using silica gel chromatography. For an example, compound 3.3 (Scheme 3.1) 
was thermally stable up to 250 °C, at which point it decomposed to release nitrogen gas.20 
 
Scheme 3.1. Formation of -chloroazo compound from hydrazone and chlorine. 
 When Moon used electron rich aromatic substituents on the hydrazone derivatives, 
the aryl ring underwent chlorination before the carbon-nitrogen double bond. To solve 
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this problem, he replaced chlorine with the less powerful chlorinating agent tert-butyl 
hypochlorite (Scheme 3.2).21 
 
Scheme 3.2. Formation of -chloroazo compound from hydrazone and tert-butyl 
hypochlorite.  
 Jochims and coworkers used Moon’s methods to synthesize a variety of -chloroazo 
compounds (3.1, Scheme 3.3).1-9 Table 3.1 shows examples of -chloroazo compounds 
(3.1) synthesized by Jochims and coworkers starting from the corresponding hydrazone 
derivatives (3.6).  
 
Scheme 3.3. Formation of -chloroazo compounds from the corresponding hydrazone 
derivatives. 
Table 3.1. Examples of-chloroazo compounds prepared by Jochims and coworkers 
entry R1 R2 R3 reagent conditions yield 
1  Me Me 2,4,6-Cl3C6H2 t-BuOCl CH2Cl2, -50 to 0 °C, 3h 99% 
2  H Me t-Bu t-BuOCl CH2Cl2, -50 to 0 °C, 3h 80% 
3  (CH2)5 - 2,4,6-Cl3C6H2 t-BuOCl CH2Cl2, -50 to 0 °C, 3h 78% 
4  Et H 2,4,6-Cl3C6H2 t-BuOCl CH2Cl2, -50 to 0 °C, 3h 92% 
5  Me Me t-Bu t-BuOCl CH2Cl2, -50 to 0 °C, 3h 94% 
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6  H Me 2,4,6-Cl3C6H2 t-BuOCl CH2Cl2, -30 to 0 °C, 
1.5h 
96% 
7  H Et t-Bu t-BuOCl CH2Cl2, -30 to 0 °C, 
1.5h 
96% 
8  Ph Et 2,4,6-Cl3C6H2 t-BuOCl -50 to -60 to 0 to 23 °C, 
CH2Cl2 
91% 
9  iPr iPr 4-O2NC6H4 t-BuOCl -50 to -60 to 0 to 23 °C, 
CH2Cl2 
98% 
10  Me Et CO2Et t-BuOCl -50 to -60 to 0 to 23 °C, 
CH2Cl2 
85% 
11  CF3 Me 2,4,6-Cl3C6H2 t-BuOCl CH2Cl2, rt, 2h 96% 
 Rai and coworkers developed a new technique to prepare -chloroazo compounds 
(3.8) from the corresponding hydrazone derivatives using chloromine-T (3.9) as the 
chlorine source (Scheme 3.4).11 Chloramine-T is also called tosylchloramide or N-chloro 
tosylamide sodium salt. 
 
Scheme 3.4. Formation of -chloroazo from hydrazone using chloroamine-T. 
3.3 Brewer group’s contribution for the formation of -chloroazo compounds 
 The methods developed by Moon20-22 and Rai11 are not ideal for the formation of -
chloroazo compounds because the chlorinating reagents used, are highly reactive, which 
can result in complex product mixtures. Therefore, the Brewer group was interested to 
develop a more mild way to affect this conversion that would be compatible with a 
variety of functional groups.12-17 
 In 2006, Prof. Brewer reported that unsubstituted hydrazones (3.10) are converted 
into alkyl chlorides (3.11) under Swern oxidation conditions (Scheme 3.5).23 In this 
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reaction, hydrazone 3.10 reacts with the dimethylchlorosulfonium ion (3.12, Scheme 3.6) 
generated from DMSO and oxalyl chloride to provide diazosulfonium ion 3.13. Loss of 
dimethyl sulfide gives N-protonated diazonium ion 3.14, which tautomerizes to give the 
diazonium ion 3.15.  Loss of nitrogen and attack by chloride give the final product (3.11).  
 
Scheme 3.5. Formation alkyl chloride from unsubstituted hydrazone. 
 
Scheme 3.6. Proposed mechanism for the formation of alkyl chlorides from hydrazones 
and dimethylchlorosulfonium ion. 
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 With these results in hand, the Brewer group was interested to carry out this reaction 
with hydrazones bearing a substituent on the terminal nitrogen. In doing so, the Brewer 
group surprisingly obtained phenyl--chloroazo compounds (3.17) in good yield without 
chlorination of the phenyl ring (Scheme 3.7).24 In exploring of the scope of this reaction, 
they discovered that hydrazones containing pendent alkenes underwent this reaction very 
smoothly to give the desired products without chlorination of the alkene (e.g. entries 5 
and 6, Table 3.2). However, this method failed to provide the desired -chloroazo 
products of allylic and benzylic hydrazones (e.g. entries 7 and 8, Table 3.2). 
 
Scheme 3.7. Formation of phenyl--chloroazo compound from phenyl hydrazones. 
Table 3.2. A variety of examples of phenyl--chloroazo compounds that form from the 
corresponding phenyl hydrazones under Swern oxidation condition 
entry substrate (hydrazone) product (-chloroazo) yield 
1  
 
 
81% 
2  
 
 
78% 
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3  
 
 
54% 
4  
 
 
59% 
5  
 
 
83% 
6  
 
 
94% 
7  
 
 
0 
8  
 
 
0 
 The Brewer group also purposed a mechanism for this reaction, which is shown in 
Scheme 3.8. The lone pair of electrons on the aryl amine is thought to attack the 
sulfonium ion (3.12) to give aza sulfonium salt 3.18. Elimination of dimethyl sulfide 
would give the phenyl-1-aza-2-azoniaallene salt 3.19, which would then react with a 
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chloride counter ion at the heteroallene carbon to form phenyl--chloroazo compound 
3.17. 
 
Scheme 3.8. Proposed mechanism for formation of -chloroazo compounds under Swern 
oxidation conditions. 
3.4 Discovery of a new method with acetyl chloride 
It is known that acetyl chloride can also activate DMSO for Swern-type oxidations,26 
and we were interested to know how this reagent combination would affect hydrazone 
oxidation. So, I treated acetyl chloride with DMSO at -55 ºC to generate the DMSO 
activated species, and then added a dichloromethane solution of hydrazone and Et3N at -
78 ºC, which gave the expected -chloroazo product in yields similar to the original 
procedure that used oxalyl chloride as activating agent. Using acetyl chloride, hydrazones 
3.20 and 3.22 gave the desired products 3.21 and 3.23 in 70% and 84% yields 
respectively (Scheme 3.9), while using oxalyl chloride17 gave the same products in 84% 
and 97% yields. We concluded that while acetyl chloride is effective for this conversion, 
it is not optimal. 
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Scheme 3.9. Test reactions to form -chloroazo compounds using acetyl chloride as 
activating agent. 
3.5 Effect of aryl ring substitution on -chloroazo formation 
 In order to assess the effect of aryl ring substitution on the [4+2] cycloaddition, I had 
to prepare a variety of -chloroazo compounds. To do this, I first prepared the 
corresponding hydrazone derivatives shown in Table 3.3 from N-aryl hydrazines and 5-
hexen-2-one. These hydrazone derivatives were then treated with 
chlorodimethylsulfonium chloride (generated in situ by reacting oxalyl chloride, DMSO, 
and triethylamine at -55 ºC) at -78 ºC to give the corresponding -chloroazo 
compounds.23,24 Methyl (Entries 1 and 2, Table 3.3), dimethyl (Entry 6), and methoxy 
(Entry 3), substituents provided excellent product yields, whereas nitro aryl substituents 
(Entries 4 and 5) provided intractable mixtures. Due to the instability of the azo products, 
we were unable to purify these nitro derivatives.  
 
 87 
Table 3.3. Formation of hydrazones and -chloroazo compounds 
entry hydrazine ketone hydrazone yielda -chloroazo yieldb 
1  
 
 
 
75% 
 
94% 
2  
 
 
 
83% 
 
95% 
3  
 
 
 
64% 
 
95% 
4  
 
 
 
65% 
 
Not 
pure 
5  
 
 
 
78% 
 
Not 
pure 
6  
 
 
 
92% 
 
93% 
a = yield of hydrazones, b = yield of -chloroazo compounds 
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 The phenyl hydrazone of dihydro--ionone (3.26) (Scheme 3.10) also reacted cleanly 
with chlorodimethylsulfonium chloride to give the desired -chloroazo compound 3.27 in 
an excellent yield. 
 
Scheme 3.10. Formation of an -chloroazo compound of sterically hindered alkene. 
3.6 New methods to form -substituted azo compounds 
 With unsuccessful attempts to form -chloroazo derivatives from nitro aryl 
compounds in mind, we were interested to develop new methods to form -substituted 
azo products. Our first goal was to replace chlorodimethylsufonium chloride by a suitable 
reagent. I first attempted to prepare -acetoxyazo compounds (3.30) by treating the 
phenyl hydrazone and acetoxydimethylsulfonium acetate, but this reaction failed 
(Scheme 3.11). In this reaction, I recovered all the starting material 3.28.  
 
Scheme 3.11. Unsuccessful attempt to prepare -acetoxyazo compound. 
 In a second attempt, I used trifluoroacetic anhydride (TFAA) as DMSO activating 
agent, which surprisingly provided the desired product with high purity. With this result 
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in hand, I optimized this method by changing a variety of conditions (Table 3.4). When I 
used 2.2 equivalents of TFAA, 2.5 equivalents of DMSO, and 2.5 equivalents of triethyl 
amine in DCM at -78 ºC, the product 3.31 was isolated in 89% yield (Entry 1, Table 3.4). 
However, this material contained some triethyl ammonium salt. Changing to 1.1 
equivalents of TFAA, 1.2 equivalents of DMSO, and 1.5 equivalents of Et3N in DCM 
provided the desired product in 89% yield (Entry 2). Changing the solvent to THF gave 
the product in 84% yield (Entry 3). Therefore, the conditions described in entry 2 were 
determined to be the best choice. 
Table 3.4. Optimization to -trifluoroacetoxyazo compounds 
 
entry solvent TFAA DMSO Et3N yield note 
1  CH2Cl2 2.0 equiv 2.5 equiv 2.5 equiv 89% 
Observed peaks 
of Et3NH
+ 
2  CH2Cl2 1.1 equiv 1.2 equiv 1.15 equiv 87% Pure (best) 
3  THF 1.1 equiv 1.2 equiv 1.15 equiv 84% 
Pure  
(lower) yield) 
 I next carried out this reaction with substrates that contain a sterically hindered 
pendent alkene. We were pleased to observe that the reaction was successful for all 
substituted N-aryl hydrazones. Methyl (Entries 1 and 2, Table 3.5), methoxy (Entry 3), 
chloride (Entry 4), dichloride (Entry 5), and nitro (Entries 6 and 7) substituted aryl 
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hydrazones underwent this reaction very smoothly to provide the desired products in 
good yields.  
Table 3.5. Formation of a variety of hydrazones and -chloroazo compounds using 
trifluoroacetoxy dimethylsulfonium trifluoroacetate as an oxidant 
entry hydrazine ketone hydrazone yielda zo-product yieldb 
1  
 
 
 
76% 
 
76% 
2  
 
 
 
85% 
 
83% 
3  
 
 
 
57% 
 
76% 
4  
 
 
 
55% 
 
86% 
5  
 
 
 
53% 
 
90% 
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6  
 
 
 
79% 
 
81% 
7  
 
 
 
73% 
 
95% 
a = yield of hydrazones, b = yield of azo compounds 
 We were also interested to see if hydrazones with poly-substituted N-aryl rings would 
react productively. We were pleased to see that hydrazone 3.32 (Scheme 3.12a) provided 
the desired azo product 3.33 in 98% yield. In additions, the dimethyl substituted 
compound 3.34 (Scheme 3.12b) also gave the desired product 3.35 in very good yield. 
 
Scheme 3.12a. Formation of azo product from trichloro-substituted compound. 
 
Scheme 3.12b. Formation of azo product from dimethyl-substituted compound. 
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 Predictably, hydrazones derived from 5-hexene-2-one also gave the desired azo 
products in very good yields (Table 3.6).  
Table 3.6. Scope of reaction with a simple pendent alkene 
entry hydrazone azo-compound yield 
1  
  
69% 
2  
  
65% 
3  
  
74% 
4  
  
82% 
5  
  
88% 
6  
  
80% 
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 To understand the electronic effects of the N-aryl ring, I carried out this reaction with 
hydrazones containing two or three electron withdrawing groups. Tri- and di-
chlorosubstituted compounds (3.30a and 3.36b, Scheme 3.13) provided the desired 
products (3.30b and 3.36b) in very good yields, while di-nitrosubstituted compound 
(3.37a) gave the desired product 3.37b in low yield. 
 
 Scheme 3.13. Formation of azo product with dimethyl-substituted N-aryl ring. 
 With further experimentation, we discovered that a hexane solution of hydrazone, 
DMSO, and Et3N can be treated with TFAA at 0 ºC to provide the desired product in 
good yield. Although hydrazones that contain the unhindered pendent alkene (entries 1, 
2, and 3; table 3.7) and sterically hindered pendent alkenes (entry 5) gave the desired 
product in very good yields, a methoxy substituent on the aryl ring (entry 4) resulted in 
comparatively low yield. Although this reaction afforded the desired product in good 
yield at room temperature (entry 6, table 3.7), this condition was not practically feasible 
because of the exothermic nature of the reaction. The 0 °C procedure, which is effectively 
7  
  
80% 
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simpler than low-temperature conditions, is remarkable because the trifluoroacetoxy 
dimethylsulfonium trifluoroacetate generated by the activation of DMSO with TFAA is 
known to decompose above -30 ºC.23-25 In this case, the low polarity of the solvent likely 
slows the decomposition of the activated DMSO species, allowing the hydrazone to react 
with the in situ generated oxidant. 
Table 3.7. Further experimentation to form -trifluoroacetoxyazo compound 
entry hydrazone condition zo-product yield 
1  
 
TFAA (1.1 equiv), DMSO 
(1.1 equiv), Et3N (1.15 
equiv), hexane, 0 °C to rt 
 
87% 
2  
  
62% 
3  
  
79% 
4  
 
 
57% 
5  
 
 
82% 
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6  
 
TFAA (1.1 equiv), DMSO 
(1.1 equiv), Et3N (1.15 
equiv), hexane, rt 
 
80% 
 In continuing to explore the scope of this reaction, we were interested to see if allylic 
hydrazones could react productively because previously24 these hydrazones did not give 
the corresponding -chloroazo compounds when treated with chlorodimethylsulfonium 
chloride. Treating hydrazone 3.39 with trifluoroacetoxy dimethylsulfonium 
trifluoroacetate at -78 ºC, surprisingly gave pyrazole product 3.40 in 93% yield instead of 
an - or -substituted azo product (3.41 or 3.42, Scheme 3.14).  
 
Scheme 3.14. Unexpected result during the attempted formation of an azo product from 
an allylic hydrazone. 
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3.7 Proposed mechanism for formation of -trifluoroacetoxyazo compound  
 We propose that mechanism of -trifluoroacetoxyazo formation is analogous to that 
of -chloroazo formation. In this case, DMSO is activated by TFAA to give 
trifluoroacetoxysulfonium trifluoroacetate (3.46, Scheme 3.15, A), which reacts with the 
aryl hydrazone to give aza sulfonium 3.47 (Scheme 3.15, B). Loss of dimethylsulfide 
gives aryl-1-aza-2-azoniaallene salt 3.48, which reacts with trifluoroacetate to provide the 
desired product 3.49. 
 
Scheme 3.15. Proposed mechanism for the formation of -trifluoroacetoxyazo products. 
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3.8 Conclusions 
 -Chloroazo compounds serve as precursors to 1-aza-2-azaniaallene salts, which can 
lead to monocyclic, bicyclic, tricyclic, and tetracyclic compounds via cycloaddition 
reactions, C-H aminations, or alkene additions. The Brewer group developed a new 
strategy to prepare this precursor based on the Swern oxidation of hydrazones. The 
strategy developed by the Brewer group was not compatible with aryl hydrazones bearing 
electron withdrawing functional groups. For example, nitro aryl compounds did not 
undergo this reaction very smoothly. So, I developed a new method to prepare -
substituted azo compounds, in which trifluoroacetic anhydride activates the DMSO to 
give trifluoroacetoxy dimethylsulfonium trifluoroacetate, which further reacts with 
arylhydrazones to give-trifluoroacetoxyazo compounds. This technique is compatible 
with all types of functional groups. Notably, aryl-nitro hydrazones are easily converted 
into the corresponding azo products. For reasons that are not clear, this method converts 
allylic hydrazones into the corresponding pyrazole derivatives. 
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CHAPTER 4: 1,3-DIPOLAR CYCLOADDITION OF PROTONATED 
AZOMETHINE IMINE SALTS 
4.1 Introduction 
 Azomethine imines (e.g. 4.1, Figure 4.1), are synthetically useful 1,3-dipoles, that 
have been used to synthesize a variety of heterocyclic compounds, including tetrazepine 
derivatives,1 spiro[pyrazolidine-3,3’-oxindoles],2 2-acryloyl-3-pyrazolidinone,3 five-
membered nitrogen heterocycles,4,5,6 and (+)-manzacidin C.7 They react with a variety of 
π-systems via [3+2],8-10 [3+3],2,11,12 [4+3],1,13,14 [3+2+3],14, [5+1],15 and [5+3]16 
cycloadditions to form pharmaceuticals, and biologically active compounds. These 
reactive intermediates can be classified into three groups based on their structure: acyclic, 
C,N-cyclic, and N,N’-cyclic azomethine imines (Figure 4.1).16-23 These three types of 
azomethine imines have difference reactivities, which will be described in the following 
sections. 
 
Figure 4.1. Classification of azomethine imines. 
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4.2 Reactivities of azomethine imines 
4.2.1 Acyclic azomethine imines 
 Acyclic azomethine imines are often generated under harsh reaction conditions, and 
have been used to prepare five-membered heterocycles through intra- and intermolecular 
cycloadditions.19 Nájera, Sansano, and Yus described a more mild procedure to facilitate 
an intramolecular cycloaddition that gives androstenoarylpyrazoline 4.12 (Scheme 4.1). 
This cycloaddition involves acyclic azomethine imine 40.11 which is formed in the 
presence of BF3 and react via an intramolecular [3+2] cycloaddition with a pendent 
olefin.19 

Scheme 4.1. An intramolecular [3+2] a cycloaddition of acyclic azomethine imine. 
 The Iley group reported that azomethine imine 4.15 (Scheme 4.2), generated in situ 
from benzaldehyde (4.13) and N-alkyl-N-acyl hydrazine (4.14), undergoes intermolecular 
cycloaddition reactions with electron-deficient dipolarophiles to give the corresponding 
3,4-disubstituted pyrazolidenes as mixtures of cis/trans diastereomers in low yields.24 
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Scheme 4.2. Intermolecular [3+2] cycloaddition of acyclic azomethine imine. 
4.2.2 C,N-Cyclic azomethine imines 
 Heterocyclic compounds in which C-N double bond is incorporated into a ring are 
another class of azomethine imines. These types of compounds have been widely applied 
to synthesize a variety of ring-fused pyrazolines, pyrazoles, and pyrazolines.19 For 
example, azomethine imine 4.24 reacts with methyl acetylenedicarboxylate (4.25) to give 
fused pyrazoline 4.26 in 45% yield (Scheme 4.3).25 

Scheme 4.3. Reaction of C,N-cyclic azomethine imine with acetylenedicarboxylate.
 The Xiao group reported the synthesis of biologically important and highly 
functionalized 1,2,4,5-tetrazepine derivatives (4.29) via a [4+3] cycloaddition between a 
C,N-cyclic azomethine imine (4.28) and an azoalkene (4.27, Scheme 4.4).1 
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Scheme 4.4. Formation of 1,2,4,5-tetrazepine derivatives using C,N-cyclic azomethine 
imines with azoalkene via [4+3] cycloaddition.  
 A direct catalytic asymmetric alkynylation of C,N-cyclic azomethine imines (4.30) to 
provide chiral tetrahydroisoquinoline derivatives (4.32, Scheme 4.5) was described by 
Maruoka and coworkers.26 This was the first catalytic asymmetric reaction wherein 
alkynes directly add to the carbon nitrogen double bond to give a chiral tetra-substituted 
carbon center with high enantioselectivity.  
 
Scheme 4.5. Catalytic asymmetric alkynylation of C,N-cyclic azomethine imines. 
 The Tang group developed a highly enantioselective asymmetric [3+3] cycloaddition 
of cyclopropane diesters (4.36) with aromatic azomethine imines (4.35) catalyzed by 
Ni(ClO4)2 complex with trisoxazoline derivative (4.38) as a chiral ligand to afford a 
variety of 6,6,6-tricyclic dihydroisoquinoline derivatives (4.37) in high yields with 
excellent diastereo- and enantioselectivities (Scheme 4.6).27  
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Scheme 4.6. Enantioselective [3+3] cycloaddition of azomethine imine and cyclopropane 
diesters.  
4.2.3 N,N’-Cyclic azomethine imines 
 Azomethine imines, in which the N-N bond is incorporated in a ring are called N,N’-
cyclic azomethine imines. They are more stable and more readily accessible than other 
types of azomethine imines. These heterocycles have been increasingly applied in 
preparing pyrazolones and related dinitrogen fused compounds, such as 
tetrahydropyrazolo-pyrazolones,28 -pyridazinones,14 -diazepinones,14 and -diazocinones,14 
which are important products or intermediates to synthesize a variety of biological active 
molecules.  
 Over the past years, a number of 1,3-dipolar cycloaddition reactions of N,N’-cyclic 
azomethine imines have been reported. For example, Svete and coworker described the 
[3+2] cycloaddition of azomethine imines (4.39) with dimethyl acetylenedicarboxylates 
4.40 to provide 2,3-dihydro-1H-,5H-pyrazolo[1,2-a]-pyrazol-1-ones 4.41 (Scheme 4.7).29   
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Scheme 4.7. [3+2] Cycloaddition of azomethine imines with alkyne. 
 In an investigation of the catalytic and enantioselective cycloaddition of 1,3-dipoles 
with olefins, the Sibi group explored the first general strategy for copper (II)-catalyzed 
diastereoselective and enantioselective cycloadditions of azomethine imines (4.43) with 
pyrazolidinone acrylates (4.42) to give the cycloadduct 4.45 in good to high yields 
(Scheme 4.8).30  
 
Scheme 4.8. Copper-catalyzed diastereoselective and enantioselective cycloadditions of 
azomethine imines. 
 The Wang group reported that an isatin N,N’-cyclic azomethine imine 4.46 undergoes 
an uncommon Michael reaction with -nitrostyrenes (4.47) catalyzed by tributylamine to 
afford 3-aminooxindoles 4.48 and 4.49 in good yields with moderate to good 
diastereoselectivities (Scheme 4.9).31 The 3-aminooxindole scaffold is found in variety of 
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biologically active species, such as AG-041R, SSR-149415, HIV protease inhibitors, and 
anticancer agents.31 
 
Scheme 4.9. Michael addition with isatin N,N’-cyclic azomethine imine.  
 The Ready group reported the synthesis of bicyclic pyrazolidinones (4.51) in high 
yields with good diastereoselectivities via a [3+2] cycloaddition of azomethine imines 
(4.50) with lithium ynolates (Scheme 4.10).8  
 
Scheme 4.10. [3+2] Cycloaddition of azomethine imines with ynolates to form bicyclic 
pyrazolidinones.  
 The Wang group explored base-catalyzed [3+3] cycloadditions between azomethine 
imine 4.52 and 3-isothiocyanatooxindoles 4.53 to afford 3,3’-triazinyl spirooxindoles 
4.54 in high yields and high diastereoselectivities (Scheme 4.11).32 
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Scheme 4.11. Based-catalyzed [3+3] cycloaddition of azomethine imines. 
4.3 Cycloaddition of protonated azomethine imine salts (C,N and N,N’-cyclic 
azomethine imines) 
We derived a number of protonated azomethine imine salts (4.0) via the [4+2] 
cycloaddition of -substituted azo compounds.33,34 This type of azomethine falls into 
both the C,N, and N,N’-cyclic azomethine imine classes (e.g. 4.0, Figure 4.2) because the 
C-N-N bonds are incorporated in two different rings. These compounds are much more 
stable than cyclic azomethine imines. Although 1,3-dipolar cycloadditions of azomethine 
imines are very common, cycloadditions of protonated azomethine imine salts that have a 
C-N double bond and a N-N bond incorporated in two different rings is not common. 
Therefore, we were interested to see how the C,N, and N,N’-cyclic azomethine imines 
will react with a variety of π system.  
 
Figure 4.2. C,N or N,N’-Cyclic azomethine amine. 
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4.3.1 Optimization of intermolecular 1,3-dipolar cycloaddition of protonated 
azomethine imine salts 
In order to establish that the protonated azomethine imine salt could serve as 
azomethine imine precursors for 1,3-dipolar cycloadditions, I selected diethyl maleate as 
cycloaddition partner because this is a doubly activated symmetrical dipolarophiles, 
which reacts stereospecifically with a variety of dienes in the Diels-Alder reaction,43,44 
and triethylamine was taken as a base to form azomethine imine (Table 4.1). When the 
reaction was run at low temperature (-78 ºC) in CH2Cl2 solvent, the desired cycloaddition 
occurred in 23% yield and returned two distereoisomers in a 1:22 diastereomeric ratio 
(Entry 1, Table 4.1). When the reaction temperature was raised to room temperature and 
the reaction time was extended to two hours, yield increased to 75% with 1:2.8 
diastereoisomeric ratio (Entry 3). Changing the solvent to acetonitrile caused the yield to 
decrease slightly (70%) and gave 1:6.0 diastereoisomeric ratio (Entry 3). Extending the 
time to 16 hours under the same condition did not improve in yield (Entry 4). Changing 
the solvent to THF resulted in lower yields (Entries 5 and 6). Increasing the reaction 
temperature to 30 ºC with dichloromethane as a solvent gave similar yield as the room 
temperature result (1:2.4 diastereoisomeric ratio; Entry 7). When the temperature was 
increased to 55 ºC in acetonitrile for 1 hour, the reaction yield increased to 76% (1:4.8 
diastereoisomer ratio; Entry 8), and extending the reaction time to 2 hours gave 
comparable yield with the same diastereoisomeric ratio (Entry 9). Ultimately, we 
discovered that lowering the equivalents of triethylamine to 1.3 significantly increased 
the yield while giving the same diastereoisomeric ratio (Entry 10), and these became the 
conditions of choice. 
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Table 4.1. Optimization of 1,3-dipolar cycloaddition of protonated azomethine imine 
 
entry reagent 
(equiv) 
Et3N 
(equiv) 
solvent time 
(hrs.) 
temp. yield dr. ratio 
4.57a: 5.57b 
1  1.2 2.0 DCM 1 -78 °C 23% 1:22 
2  1.2 2.0 DCM 2 rt 75%  1:2.8 
3  1.2 2.0 CH3CN 2 rt 70%  1:6.0 
4  1.2 2.0 CH3CN 16 rt 70%  1:5.3 
5  1.2 2.0 THF 2 rt 65%  1:3.3 
6  1.2 2.0 THF 16 rt 66%  1:3.4 
7  1.2 2.0 DCM 2 30 °C 72%  1:2.4 
8  1.2 2.0 CH3CN 1 55 °C 76%  1:4.8 
9  1.2 2.0 CH3CN 2 55 °C 80%  1:5.1 
10  1.2 1.3 CH3CN 2 55 °C 90%  1:4.6 
dr = diastereomeric 
4.3.2 Reactions with dipolarophiles having activated alkenes  
 Both dialkyl maleate and fumarate are doubly activated symmetrical dipolarophiles, 
which generally react via a stereospecific intermolecular reaction in the Diels-Alder 
reaction.43,44 Our goal was to understand how the azomethine imines react with these 
reagents via 1,3-dipolar cycloadditions. These cis and trans reagents might also provide 
noteworthy information about the 1,3-dipolar reactions.  
4.3.2.1 With diethyl and dimethyl maleates as dipolarophiles 
Using the optimized conditions, 1,3-dipolar cycloaddition between diethyl maleate 
and protonated azomethine imines (Scheme 4.12, 4.58 and 4.60) that contain a methyl or 
chloride substituent at the para-position of the N-aryl ring provided the desired 
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tetracyclic products (4.61 and 4.63) in good yields (83% and 84%) and moderate 
diastereoselectivities (1:3.9 and 1:5.0). Changing the N-aryl methyl group to the ortho-
position gave the cycloadduct 4.63 in lower yield (64%), but comparable 
diastereoselectivity (4.8:1). 
 
Scheme 4.12. 1,3-Dipolar cycloaddition between protonated azomethine imines and 
diethyl maleate. 
 Replacing the diethyl maleate with dimethyl maleate, gave the corresponding 
products in comparable yields, but these reactions were somewhat more 
diastereoselective (Scheme 4.13).  
 
Scheme 4.13. 1,3-Dipolar cycloaddition between azomethine imines and dimethyl 
maleate. 
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4.3.2.2 With dimethyl fumarate as dipolarophile 
 Changing the dipolarophile to dimethyl fumarate (4.69, Scheme 4.14), which is a 
trans form of dimethyl maleate (4.64, Scheme 4.13), provided the cycloadducts in good 
to excellent yields. However, the stereochemical outcome of these reactions were 
different than the cycloadducts formed from dimethyl maleate. Cis and trans alkenes 
provided unique diastereomers, so the 1,3-dipolar cycloaddition of azomethine imine 
occurs via concerted mechanism. In general, reactions involving dimethyl fumarate were 
less diastereoselective than those involving the maleate reagents. However, azomethine 
imines that had a methyl or chloride substituent at the ortho-position gave only one 
product diastereomer (4.72 and 4.74, Scheme 4.14) in 73% and 99% yield respectively. 
All other azomethine imines assessed the desired cycloadducts (4.70, 4.71 and 4.73) in 
moderate to good yields with no diastereoselectivity.  
 
Scheme 4.14. 1,3-Dipolar cycloaddition between protonated azomethine imines and 
dimethyl fumarate. 
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4.3.3 Reactions with dimethyl acetylene dicarboxylate as dipholarophile 
 To extend the scope of this cycloaddition reaction, we were interested to carry out 
this reaction with alkyne dipolarophiles. For example, dimethyl acetylene dicarboxylate 
(4.75, Scheme 4.15) is also a doubly activated symmetrical dipolarophile, which could 
also give important information for this 1,3-dipolar cycloaddition. After reacting this 
reagent with azomethine imines shown in Scheme 4.5 under optimized conditions, in 
each cases, the desired cycloaddition products were formed in excellent yields (86-99%). 
In most cases, diastereoselectivities were low, but the substitution at the ortho-position of 
the azomethine imine (4.78) increased the diastereomeric ratio to 1:6.2. 
 
Scheme 4.15. 1,3-Dipolar cycloaddition between protonated azomethine imines and 
dimethyl acetylene dicarboxylate. 
4.3.4 Reactions with maleic anhydride and N-methylmaleimide as dipolarophiles 
 To increase the structural complexity of the products formed by this cycloaddition 
reaction, we used conjugated cyclic esters as dipolarophiles. Maleic anhydride reacted 
with protonated azomethine imine salts shown in Scheme 16, very smoothly to provide 
the corresponding cycloadducts in excellent yields. Interestingly, incorporating a methyl 
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substituent at the ortho-position gave only low yields of the desired product. It is 
noteworthy that all of the reactions were diastereospecific. Due to the instability of the 
products, this reaction had to be run at room temperature, and these products were not 
stable in solution for prolong time. Interestingly, compound 4.81 was soluble in several 
organic solvents, whereas compounds 4.82 and 4.83 were insoluble in chloroform, 
slightly soluble in acetonitrile, and completely soluble in dichloromethane, methanol and 
DMSO. Compound 4.84 was insoluble in acetonitrile and chloroform, and soluble in 
dichloromethane, methanol, and DMSO. 
 
Scheme 4.16. 1,3-Dipolar cycloaddition between protonated azomethine imines and 
maleic anhydride. 
 N-methylmaleimide was also a productive electrophile, giving the cycloaddition 
products shown in Scheme 4.17 in good yields. Again, diastereoselectivity was low (4.55, 
4.58 and 4.60) unless a substituent was present at the ortho position of the N-aryl ring 
(4.59). Based on the 1HNMR, compound 4.55 gave an equimolar mixture of two 
diastereomers, but these had identical Rf values with many different solvents system and 
thus were inseparably by chromatography. The diastereomers derived from compound 
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4.58 and 4.60, on the other hand, were separated based on solubility as one of the 
diastereomers was insoluble in almost all organic solvent except dichloromethane.  
 
Scheme 4.17. 1,3-Dipolar cycloaddition between protonated azomethine imines and 
dimethyl acetylene dicarboxylate. 
4.3.5 Reactions involving unsymmetrical π-systems as dipolarophiles 
 In the previous sections, we used a variety of symmetrical acyclic and cyclic reagents 
as dipolarophiles for the 1,3-dipolar cycloaddition of azomethine amines. These reagents 
provided diastereoselective, non-diastereoselective as well as diastereospecific products. 
We were also interested with a variety of unsymmetrical conjugated π-systems as 
dipolarophiles, which could provide regioisomers including diastereomers. When I 
treated the azomethine imines shown in Scheme 4.18 with methyl vinyl ketone (MVK), I 
was able to isolate two different regioisomeric cycloaddition products. Interestingly, 
these reactions were diastereospecific as only one diastereomer of each product was 
isolated. All substituents provided the desired cycloadducts in good to excellent yields.  
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Scheme 4.18. 1,3-Dipolar cycloaddition between protonated azomethine imines and 
MVK. 
 Changing the dipolarophile to 2-cyclohexen-1-one gave a single diastereomer in 
moderate yield. No other regio- or diastereomers were isolated from this reaction. 
  
Scheme 4.19. 1,3-dipolar cycloaddition between protonated azomethine imines and 
cyclohex-2-enone. 
 Our interest was not limited to conjugated carbonyl systems, and acrylonitrile was 
treated with azomethine imines to provide the cycloaddition products in good to excellent 
yields as mixtures of diastereomers (Scheme 4.20). But, these diastereomers could not be 
separated by chromatography.  In the case of a chloride substituent (4.103), I was able to 
isolate one diastereomer in very low yield (4%).  
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Scheme 4.20. 1,3-Dipolar cycloaddition between protonated azomethine imines and 
acrylonitrile. 
4.4 Summary of 1,3-dipolar cycloaddition of azomethine imines 
 Azomethine imines underwent 1,3-dipolar cycloaddition reactions with doubly 
activated symmetrical alkenes as dipolarophiles to provide the corresponding 
cycloadducts in high yields with moderate to high diasteroselctivities. Although both 
dimethyl maleate and diethyl maleate gave the corresponding cycloadducts in comparable 
yields, the cycloadditions with dimethyl maleate were somewhat more diastereoslective 
than diethyl maleate. Dimehtyl fumarate which is a trans form of dimethyl maleate, also 
provided good to excelletn yields. However, the stereochemical outcome of these 
reactions were different than the cycloadducts formed from diemthyl maleate. So, Cis and 
trans alkenes provided uniqe diastereomers. These results indicate that the 1,3-dipolar 
cycloaddition reactions of azomethine occurs via concerted mechanism. Also, the the 
reactions involving dimethyl fumarate was less diastereoslective than those involving the 
maleate reagents. Cycloaddition of dimethyl acetylene dicarboxylate provided excellent 
yield, but in most cases, the diastereoslectivities were very low.  
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  Activated symmetrical cyclic alkenes, such as maleic anhydride and N-
methylmaleimide as dipolarophiles, activley involved in the 1,3-dipolar cycloadditions of 
azomethine imines to provide the corresponding cycloadducts in good to excellent yields. 
Although the cycloaddition reactions  involving maleic anhydride were diastereospecific, 
the diastereoselectivities of the reactions involving N-mehtylmaleimide were very low. 
 The 1,3-dipolar cycloaddition reactions of azomethine imines with unsymmetrical 
alkenes, such as MVK,  gave the corresponding two different regioisomeric cycloaddition 
pruducts in comparable yields. Interesingly, these reactions were diastereospecific. The 
cycloaddition reactions with 2-cyclohexen-1-one gave a single diastereomers in low 
yield.  In the case of acrylonitrile, it provided the desired cycloadducts in good yields as 
mixtures of regio- or diastereomers.  
 In term of substituents on N-aryl ring of the azomethine imine salt, an electorn 
withdrawing chloride substituent generlly underwent 1,3-dipolar cycloaddition with a 
varity of π-system to give the corresponding cycloadducts in higher yields than an 
electron donating methyl substituent.   
 In several cases, we observed more than one diastereomers and regioisomers. Due to 
the lower energy gap between HOMO and LUMO of dipoles and dipolarophiles, the 
interaction of frontier molecular orbitals became very stronger, which affects the 
diastereoselectivity and regioselectivity.  
4.5 Oxidation of protonated azomethine imine salt  
 The cycloaddition reactions described above, were run under a nitrogen atmosphere. 
When I ran this reaction in open air, I isolated ketones 4.104 and 4.105 in addition to the 
expected cycloadducts. These ketone products are the result of an oxidation reaction, and 
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when I reacted an acetonitrile solution of azomethine imine salt 4.55 with triethyl amine 
at room temperature in open air for two hours, I was able to isolate ketones 4.104 in 34 % 
yield and 4.104 in 17% yield (Scheme 4.21). Base on this result, protonated azomethine 
imine salts in the presence of base are air sensitive. Therefore, to carry out the 
cycloaddition reaction of these salts, an inert atmosphere is required. 
 
Scheme 4.21. Oxidation of protonated azomethine imines. 
4.6 Computational study for 1,3-dipolar cycloadditions of azomethine imine salts 
 Although there were a number of possibilities of diastereomers, in most of the cases, I 
isolated two diastereomers from the cycloaddition of azomethine imine salts with a 
variety of π-system. To understand why certain diastereomers were more favorable than 
others, I calculated the energy barrier for these cycloadditions using computational 
methods. 
4.6.1 Computational methods 
 All density functional theory (DFT) calculations were performed with Gaussian 09.35 
Geometry optimizations were carried out at the B3LYP level36,37,38 with the 6-31G(d) 
basis set.39 The vibrational frequencies were computed at the same level to check whether 
each optimized structure is an energy minimum or a transition state and to evaluate its 
zero-point vibrational energy (ZPVE) and thermal energies at 298 K. The single-point 
energies and solvation effects in acetonitrile were computed at the M06-2X/6- 311+(d,p) 
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level,40,41 based on B3LYP/6-31G(d)-optimized geometries. Solvation energy corrections 
for acetonitrile were evaluated by a self-consistent reaction field (SCRF) using the 
SMD42 model under the same level of theory as the single-point energy calculation (M06-
2X/6- 311+(d,p)).  
4.6.2 Calculation of energy barriers of 1,3-dipolar cycloaddition of azomethine 
imine and MVK 
 The cycloaddition reaction of azomethine imine 4.106 with MVK could provide eight 
different products including regio-and diastereomers (Scheme 4.22). These, of course, 
would be formed via eight different transition states. Compounds 4.107, 4.108, 4.109, 
and 4.110 are diastereomers of one regioisomer, while compounds 4.111, 4.112, 4.113, 
and 4.114 are diastereomers of another regioisomer.  
 
Scheme 4.22. Possible regio- and diastereomers generated by the cycloaddition of 
azomethine imine 4.106 with MVK. (Enantiomers are not shown.) 
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 In reality, these reactions are fairly diastereoselective, and to understand this 
selectivity, I calculated the energy barriers for each transition states leading to the 
products shown above. TS-4.107, TS-4.108, TS-4.109, and TS-4.110 (Entries 1-4, Table 
4.2) are the transition states leading to products 4.107, 4.108, 4.109, and 4.110, while TS-
4.111, TS-4.112, TS-4.113, and TS-4.114 (Entries 5-8) are the transition states leading to 
the regioisomeric products 4.111, 4.112, 4.113, and 4.114. 
Table 4.2. Calculated energy barriers for all possible transition states generated by the 
cycloaddition of azomethine imine 4.106 and MVK 
entry transition 
state (TS) 
ΔG‡ for R = H 
(kcal/mol) 
ΔG‡ for R = CH3 
(kcal/mol) 
ΔG‡ for R = Cl 
(kcal/mol) 
1  TS-4.107 22.61 21.91 23.72 
2  TS-4.108 19.15 18.99 20.26 
3  TS-4.109 23.38 22.72 24.67 
4  TS-4.110 19.18 18.53 19.82 
5  TS-4.111 19.87 18.92 20.15 
6  TS-4.112 21.47 20.74 22.31 
7  TS-4.113 20.61 20.07 21.45 
8  TS-4.114 21.30 20.20 21.92 
 In all cases, the azomethine imine with an electron withdrawing chloride substituent 
had comparatively higher energy barriers than the azomethine imine containing an 
electron donating methyl substituent. Experimentally (Scheme 4.18), an electron donating 
methyl substituent (4.58) provided the cycloadduct 4.93 in higher yield than the 
azomethine imine containing an electron withdrawing chloride substituent (4.60). 
Therefore, the computational results in term of substituents are consistent with the 
experimental results. When considering the two sets of regioisomers separately, the 
energy barriers of transition states TS-4.108 and TS-4.110 (entries 2 and 4, table 4.2) are 
similar to each other and lower than those of transition states TS-4.107 and TS-4.109 
(Entries 1 and 3, Table 4.2). In the case of another regioisomer, transition state TS-4.111 
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(Entry 5, Table 4.2) has the lowest energy barrier. In all cases, the activation barriers of 
the transition states leading to the diastereomers, in which the methyl group and hydrogen 
atom adjacent to the central nitrogen are in the opposite faces, have lower than those of 
the transition states leading to the diastereomers, in which both methyl group and 
hydrogen atom are on the same face. In this cycloaddition reaction, the regioselectivity 
might be affected by the equal interactions of frontier molecular orbitals. Therefore, these 
reactions gave the regioisomeric product in 1:1 ratio.  
4.6.3 Calculation of energy barriers of 1,3-dipolar cycloaddition of azomethine 
imine and maleic anhydride 
 The cycloaddition of azomethine imine 4.106 with maleic anhydride (4.80) could 
provide four different diastereomeric products (4.115 – 4.118, Scheme 4.23). 
Experimentally, this reaction was diastereospecific.  
 
Scheme 4.23. Possible diastereomers generated by the cycloaddition of azomethine 4.106 
imine with maleic anhydride. (Enantiomers are not shown.) 
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 Computational studies show that an electron withdrawing chloride substituent has 
higher energy barrier than an electron donating methyl substituent (Table 4.3). In term of 
diastereomers, transition state TS-4.117 (Entry 3, Table 4.3) leading to exo-convex 
diastereomeric product (4.117), gave the lowest energy barrier for all substituents, 
whereas the transition state TS-4.116 leading to exo-concave diastereomeric product 
(4.116) gave than highest energy barrier for all substituents. Again, the transition state 
leading to the diastereomeric product, in which the methyl group and hydrogen atom 
adjacent to the central nitrogen, are on opposite faces, have lowest activation barrier.  
Table 4.3. Calculated energy barriers for all possible transition states generated by the 
cycloaddition of azomethine imine 4.106 and maleic anhydride 
entry transition 
state (TS) 
ΔG‡ for R = H 
(kcal/mol) 
ΔG‡ for R = CH3 
(kcal/mol) 
ΔG‡ for R = Cl 
(kcal/mol) 
1  TS-4.115 13.54 12.11 14.45 
2  TS-4.116 15.23 14.20 16.15 
3  TS-4.117 12.26 11.51 13.36 
4  TS-4.118 13.00 11.75 13.82 
4.6.4 Calculation of energy barriers of 1,3-dipolar cycloaddition of azomethine 
imine and dimethyl maleate and fumarate 
 The cycloaddition of an azomethine imine salt with dimethyl maleate could lead to 
four diastereomeric products (4.119, 4.120, 4.121, and 4.122, Scheme 4.24). 
Experimentally, I isolated only two diastereomers from these reactions, and these 
products differed from those isolated from the reaction with dimethyl fumarate, so alkene 
was not isomerized over the course of the reaction. The computational studies (Table 4.4) 
show that an electron withdrawing chloride substituent has higher activation barrier than 
an electron donating methyl substituent. Transition states TS-4.120 and TS-4.122 
 122 
(Entries 2 and 4, Table 4.4) have lower energy barriers than transition states TS-4.119 
and TS-4.121 (entries 1 and 3, table 4.4). The energy barriers of transition states TS-
4.120 and TS-4.122 are comparable.  
 
Scheme 4.24. Possible diastereomers generated by the cycloaddition of azomethine imine 
4.106 with dimethyl maleate. (Enantiomers are not shown.) 
Table 4.4. Calculated energy barriers for all possible transition states generated by the 
cycloaddition of azomethine imine 4.106 and dimethyl maleate 
entry transition 
State (TS) 
ΔG‡ for R = H 
(kcal/mol) 
ΔG‡ for R = CH3 
(kcal/mol) 
ΔG‡ for R = Cl 
(kcal/mol) 
1  TS-4.119 21.92 20.97 22.68 
2  TS-4.120 19.82 19.54 21.00 
3  TS-4.121 21.64 20.95 22.46 
4  TS-4.122 19.31 19.65 19.94 
 Dimethyl fumarate (E-alkene) could also provide four different cycloaddition 
diastereomers (Scheme 4.25). Experimentally, only two of these diastereomers were 
isolated. Once again, the isolated products did not correspond to the product that were 
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isolated from the Z-alkene, products showing that the alkene was not isomerized during 
the reaction. In term of substituents, the computational results (Table 4.5) have the same 
trend as those of the Z-alkene (Table 4.4). In term of diastereomers, transition states TS-
4.124 and TS-4.126 (Entries 2 and 4, Table 4.5) have lower activation barriers than 
transition states TS-4.123 and TS-4.125 (Entries 1 and 3, Table 4.5). The energy barriers 
of transition states TS-4.124 and TS-4.126 are comparable, which is consistent with the 
experimental results (Scheme 4.14) because the yields of both diastereomeric products 
are were similar. 
 
Scheme 4.25. Possible diastereomers generated by the cycloaddition of azomethine imine 
4.106 with dimethyl fumarate. (Enantiomers are not shown.) 
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Table 4.5. Calculated energy barriers for all possible transition states generated by the 
cycloaddition of azomethine imine 4.106 and dimethyl fumarate 
entry transition 
state (TS) 
ΔG‡ for R = H 
(kcal/mol) 
ΔG‡ for R = CH3 
(kcal/mol) 
ΔG‡ for R = Cl 
(kcal/mol) 
1  TS-4.123 17.75 17.12 18.73 
2  TS-4.124 16.73 16.11 17.62 
3  TS-4.125 19.25 18.46 20.13 
4  TS-4.126 16.76 15.82 17.50 
 In both cases (diemthyl maleate and fumarate), the methyl group and hydrogen atom 
adjacent to the central nitrogen that are either on opposite faces or on same face, is also 
following the previous tends regarding the activation barriers. 
4.6.5 Calculation of energy barriers of 1,3-dipolar cycloaddition of azomethine 
imine and dimethyl acetylene dicarboxylate 
 Both theoretically and experimentally, the cycloaddition reaction of azomethine imine 
4.106 with dimethyl acetylene dicarboxylate provides two diastereomers 4.127 and 4.128 
(Scheme 4.26).  Computational results in term of substituent, show that an electron 
withdrawing chloride substituent again has a higher activation barrier than an electron 
donating methyl substituent (Table 4.6). In term of diastereomers, the energy barriers of 
transition states TS-127 and TS-128 (Entries 1 and 2, Table 4.6) are similar, which is 
consistent with the experimental results (Scheme 4.15) because experimental results also 
provided two diastereomeric products. In regard to the methyl and hydrogen atom 
adjacent to the central nitrogen, the trend of the activation barriers of this cycloaddition 
are also similar to the previous cycloaddition reactions. 
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Scheme 4.26. Two diastereomers generated by the cycloaddition of azomethine imine 
4.106 with dimethyl acetylene dicarboxylate. (Enantiomers are not shown.) 
Table 4.6. Calculated energy barriers for all possible transition states generated by the 
cycloaddition of azomethine imine 4.106 and dimethyl acetylene dicarboxylate 
entry transition 
State (TS) 
ΔG‡ for R = H 
(kcal/mol) 
ΔG‡ for R = CH3 
(kcal/mol) 
ΔG‡ for R = Cl 
(kcal/mol) 
1  TS-4.127 13.93 13.44 15.08 
2  TS-4.128 12.97 12.54 14.01 
4.7 Issues with determining the stereochemistry of the cycloaddition products 
 Many of the cycloadditions described above provided two diastereomeric products 
and were attempted to determine the relative configuration of these materials. However, 
2D NOSYs of the diastereomers 4.76a and 4.76b (Scheme 4.15), did not show significant 
differences of the spectra, and could not be used to establish configuration. I made many 
attempts to grow X-ray quality crystals of these compounds without success. I had hoped 
that the computational studies described above might shed light on this issue, but the 
energy barriers of the corresponding diastereomers were not different enough to make a 
reasonable prediction. Therefore, we were unable to determine the configuration of the 
diastereomeric products.  
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4.8 Conclusions 
 Azomethine imines have been used to synthesize a variety of heterocycle compounds 
via 1,3-dipolar cycloadditions. Although these reactions are common, the cycloadditions 
described here that have a C-N double bond and a N-N bond incorporated in two 
different rings have little procedure. We were pleased to find that the azomethine imines 
generated under basic conditions from the protonated azomethine imines, react smoothly 
with a variety of π-system to give the corresponding cycloadducts. Cis and trans alkenes 
provided unique diastereomers, so 1,3-dipolar cycloaddition reaction of azomethine 
occurs via concerted mechanism. These 1,3-dipolar cycloadditions typically gave the 
products as a mixture of two diastereomers. But, efforts to determine the diastereomeric 
configuration of these products have not been successful.   
 I also determined the energy barriers of transition states of the corresponding 
diastereomers. An electron withdrawing chloride substituent on the aryl ring consistently 
raised energy barrier compared to an electron donating methyl substituent. In all 1,3-
dipolar cycloaddition reactions, the transition states leading to the diastereomeric 
products in which the methyl group and hydrogen atom adjacent to the central nitrogen 
are on the difference faces have the lowest activation barriers than others. The energy 
barriers of the transition states leading to the corresponding diastereomers were not very 
different. Therefore, based on these results, we were unable to determine the 
stereochemistry of the corresponding diastereomers.  
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SUMMARY OF THESIS AND FUTURE GOAL 
Summary of thesis 
The Brewer group has studied the reactivity of 1-aza-2-azoniaallene salt intermediates 
in intramolecular reaction, and we have discovered that these cationic heteroallenes can 
react through a variety of mechanistically distinct pathways to give different classes of 
nitrogen heterocycles. Throughout Chapter 1 and 2, I have discussed in several of these 
reactivities including intramolecular [4+2] cycloaddition reactions, intramolecular C-H 
amination, and alkene amination. My initial studies focused on evaluating the scope of 
the intramolecular [4+2] cycloaddition reaction, which gives protonated azomethine 
imine salts containing 1,2,3,4-tetrahydrocinnoline scaffold. I first evaluated what affect 
substituents on the N-aryl ring had on the reaction and whether highly hindered tetra-
substituted alkene could give structurally complex protonated azomethine imine salts. 
The metal mediated reaction did not facilitate the cycloadditions very well, so I replaced 
the antimony pentachloride with TMSOTf. Although the non-metallic Lewis acid 
provided very clean products from -chloroazo starting materials, the novel -
trifluoroacetoxyazo compounds prepared from the corresponding hydrazone derivatives 
and trifluoroacetic anhydride, underwent [4+2] cycloadditions even more cleanly and in 
higher yield with TMSOTf as the Lewis acid. To further verify the proposed mechanism 
of the [4+2] cycloaddition, I synthesized a dearomatized non-protonated azomethine 
imine salt. 
 In the case of C-H amination, the Brewer group has explored the unprecedented 
intramolecular C-H insertion of heteroallene salts. We have also studied the mechanism 
of this insertion computationally and experimentally. As part of these mechanistic 
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studies, I carried out kinetic isotope effect experiments. My results were consistent with 
an asynchronous concerted mechanism. Although the insertion reaction occurs readily at 
benzylic and tertiary centers, secondary centers do not undergo C-H amination. My 
attempts to synthesize indoles and indolines via C-H insertion also failed.  
The intramolecular alkene amination of heteroallene salts provides a new way to 
synthesize a variety of bicyclic compounds. The Brewer group studies show that the 
heteroallene salt of a cyclohexene derivative preferentially undergoes alkene amination 
via an aziridinium ion intermediate that is trapped by the chloride counter ion. However, 
my efforts to trap the aziridinium ion by an external nucleophile failed. 
I also attempted to develop a new strategy to affect C-H amination and alkene 
addition reactions via a nitrenium cation intermediate. But, these effors did not lead to a 
productive reaction. 
 In Chapter 3, I discussed the -chloroazo compounds as precursors to 1-aza-2-
azaniaallene salts, which can lead to monocyclic, bicyclic, tricyclic, and tetracyclic 
compounds via cycloaddition reactions, C-H aminations, or alkene additions. The method 
developed by the Brewer group to prepare -chloroazo compounds was not compatible 
with aryl hydrazones bearing electron withdrawing functional groups. For example, nitro 
aryl compounds did not undergo this reaction very smoothly. So, I developed a new 
method to prepare -substituted azo compounds, in which trifluoroacetic anhydride 
activates DMSO to give trifluoroacetoxy dimethylsulfonium trifluoroacetate, which 
further reacts with arylhydrazones to give-trifluoroacetoxyazo compounds. This 
technique is more general than the original Swern procedure and is compatible with all 
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types of functional groups. Notably, aryl-nitro hydrazones are easily converted into the 
corresponding azo products. 
In Chapter 4, I described the work I have done to develop an intermolecular 1,3-
dipolar cycloaddition reaction of azomethine imines with a variety of doubly or singly 
activated π-systems to give structurally complex tetra- or pentacyclic products. These 
1,3-dipolar cycloadditions typically gave the products as a mixture of two diastereomers. 
Cis and trans alkenes provided unique diastereomers, so 1,3-dipolar cycloaddition of 
azomethine imine occurs via concerted mechanism. Unsymmetrical alkenes (singly 
activated) provided two different regioisomeric cycloaddition products. But, efforts to 
determine the diastereomeric configuration of these products have not been successful. 
And I have determined the energy barriers of transition states for the corresponding 
diastereomers. Interestingly, an electron withdrawing chloride substituent on the aryl ring 
consistently raised the energy barrier compared to an electron donating methyl 
substituent. However, the energy barriers of the transition states leading to diastereomers 
were not very different. Therefore, we were unable to determine the stereochemistry of 
the corresponding diastereomers based on these computational results.  
Future goal 
 Intramolecular C-H amination of heteroallene salts is a good strategy to form five-
membered N-heterocycles. However, this metal mediated and low temperature reaction is 
not very practical, environmentally friendly, or green. It would be beneficial to developed 
a new greener strategy to affect the insertion. A good starting point would be to replace 
the metallic Lewis acid with a suitable alternative. At one point, I used the non-metallic 
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Lewis acid TMSOTf for the C-H amination reaction. I observed a small amount of the 
desired product, but I did not optimize the conditions.  
   
 I have shown that the base mediated 1,3-dipolar cycloaddition of protonated 
azomethine imines with π-systems is a good strategy to form structurally complex 
polycyclic heterocycles. However, this reaction is not very regio- or diastereoselective. 
To make this reaction more regio- and diastereoselective, polar dipolarophiles, such as 
lithium ynolates, should be assessed as reaction partners. In addition, allenoate reagents 
(e.g. 2, Scheme 1) might be interesting dipolarophiles for this reaction as they would 
provide an exo double bond. In any events, the configuration of the diastereomers formed 
in the cycloaddition reaction achieve to date need to be assigned, at which point, 
meaningful trends may become apparent. 
 
Scheme 1. 1,3-Dipolar cycloaddition of azomethine imine with allenoate. 
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CHAPTER 5: EXPERIMENTAL INFORMATION 
5.1 General experimental information  
All reactions were performed under an atmosphere of nitrogen in flame-dried 
glassware. All solvents were removed in vacuo using a rotary evaporator attached to a 
self-cleaning dry vacuum pump, and further dried under reduced pressure on a high 
vacuum line. Tetrahydrofuran (THF), acetonitrile (CH2CN), and dichloromethane 
(CH2Cl2) were dried via a solvent dispensing system. Triethylamine was freshly distilled 
from CaH2 before use. Oxalyl chloride, trimethylsilyl trifluoromethanesulfonate and 
antimony(V)chloride, purchased from Acros Organics, were freshly distilled before use. 
Anhydrous aluminum(III)chloride (98.5%), purchased from Acros Organics, was used as 
received and stored in a dry glovebox under an atmosphere of nitrogen. Extra dry DMSO 
stored over molecular sieves was purchased from Acros Organics and was used as 
received. All hydrazones were freshly prepared before use as these materials could not be 
stored and underwent facile auto oxidation on standing in air. Molecular sieves (4 Å) 
were activated by heating overnight at 120 °C in a vacuum oven. 
Reactions were cooled to –78 °C by immersion in dry-ice acetone baths and were 
maintained at -60 °C with the aid of an immersion cooler. Silica gel flash column 
chromatography was performed using silica gel (230-400 mesh) and TLC analysis was 
carried out using silica on glass plates. Visualization of TLC plates was achieved using 
ultraviolet light, polyphosphomolybdic acid and cerium sulfate in EtOH with H2SO4, 
ceric ammonium molybdate, or iodine.  
1H and 13C NMR data was collected at room temperature on a 500 MHz 
spectrometer in CDCl3 or CD3CN. 
1H NMR chemical shifts are reported in ppm ( units) 
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downfield from tetramethylsilane. Solvent peaks were used as internal references for all 
13C NMR. Accurate mass data was acquired in ESI mode using an orbitrap mass 
analyzer. X-Ray diffraction data were collected on a Bruker APEX 2 CCD platform 
(MoK, λ= 0.71073 Å) at set temperature of 135 K. A suitable crystal was mounted in a 
nylon loop under Paratone-N cryoprotectant oil. Direct methods and standard difference 
map techniques were used for solution structure followed by refinement using full-matrix 
least squares procedures on F2 via SHELXTL (version 6.14; Sheldrick, G. M., Acta 
Cryst. 2008, A64, 112-122). Non-hydrogen atoms were refined anisotropically. The 
hydrogen atom on N(2), H(1), was located in the Fourier difference map and refined 
semi-freely using a distance restraint.  
5.2 Experimental information for [4+2] cycloaddition (Chapter 1) 
5.2.1  Representative procedure for SbCl5 mediated [4+2]-cycloaddition 
SbCl5 (0.95 equiv) was added in a dropwise manner to a solution of an -chloroazo 
compound (1 equiv) in CH2Cl2 under a nitrogen atmosphere at -78 °C. The mixture was 
stirred for 30 min at -78 °C and then warmed to room temperature. The solvent was 
removed in vacuo to give a thick foam that was triturated with petroleum ether 3 times 
and dried under high vacuum to give the cycloaddition product as a powder. To 
determine yields, the solid material was fully dissolved in CD3CN, 1,3,5-
trimethoxybenzene (0.95 equiv) was added as an internal standard, and an aliquot of this 
homogeneous mixture was analyzed by 1H NMR.  
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5.2.2 Preparation and characterization data of protonated azomethine imine SbCl6 
salts 
3,8-dimethyl-2,5,10,10a-tetrahydro-1H-pyrrolo[1,2-b]cinnolin-4-ium 
hexachlorostibate(V) (1.157a): The title [4+2] cycloaddition product 1.157a was 
prepared in 86% yield as determined by 1HNMR (crude product 95%, 444 
mg) as described in representative experimental procedure 5.2.1 by reacting 
-chloroazo 1.155a (206 mg, 0.87 mmol), SbCl5 (2 M in CH2Cl2, 0.42 mL, 
0.83 mmol), and CH2Cl2 (15 mL). Mp 92.6 
°C. 1H NMR (500 MHz, Acetone-d6) δ = 7.05 
(d, J = 7.1, 1H), 7.05 (s, 1H), 7.01 (d, J = 8.9, 1H), 4.81 – 4.59 (m, 1H), 3.42 – 3.25 (m, 
3H), 3.05 (dt, J = 17.2, 8.6, 1H), 2.86 – 2.73 (m, 1H), 2.63 (s, 3H), 2.27 (s, 3H), 2.16 
(ddd, J = 18.9, 12.9, 9.2, 1H). 13C NMR (126 MHz, Acetone-d6) δ 168.9, 135.9, 132.7, 
130.2, 129.5, 119.4, 114.9, 67.6, 36.4, 33.4, 25.9, 20.6, 16.3; IR (film) max: 3200, 3003, 
2970, 2947, 1738, 1724, 1504, 1423, 1366, 1275, 1227, 1217, 1157, 1032, 816 cm-1. MS 
(ESI) calcd for [C13H17N2]
+:  201.1392, found: 201.1387. 
3,6-dimethyl-2,5,10,10a-tetrahydro-1H-pyrrolo[1,2-b]cinnolin-4-ium 
hexachlorostibate(V) (1.157b): The title [4+2] cycloaddition product 1.157b was  
prepared in 80% yield as determined by 1HNMR   (crude product 89%, 341 
mg) as described in representative experimental procedure 5.2.1 by reacting 
-chloroazo 1.155b  (170 mg, 0.72 mmol), SbCl5 (2 M in CH2Cl2, 0.34 mL, 
0.68 mmol), and CH2Cl2 (15 mL). Mp 96.8 
°C. 1H NMR (500 MHz, Acetone-d6) δ = 7.11 
(dd, J = 17.7, 7.5, 2H), 6.97 (t, J = 7.5, 1H), 4.72 (d, J = 6.1, 1H), 3.50 – 3.31 (m, 3H), 
3.11 (dd, J = 15.6, 12.6, 1H), 2.90 – 2.77 (m, 1H), 2.73 (s, 3H), 2.32 (s, 3H). 13C NMR 
(126 MHz, Acetone-d6) δ 176.6, 136.5, 130.4, 127.8, 125.0, 123.6, 120.1, 66.6, 36.6, 
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34.0, 25.4, 17.3, 17.0; IR (film) max: 3200, 3014, 2970, 2941, 1738, 1724, 1474, 1435, 
1366, 1269, 1229, 1217, 1206, 1090, 1032 cm-1. MS (ESI) calcd for [C13H17N2]
+: 
201.1392, found: 201.1386. 
5.2.3 Representative experimental procedure for TMSOTf mediated [4+ 2] 
cycloaddition  
 Freshly distilled trimethylsilyl trifluoromethanesulfonate (1.05 equiv or 1.5 equiv) 
was added dropwise via syringe to a stirred solution of -chloroazo or -
trifluoroacetoxyazo compound (1.0 equiv) in hexane or CH2Cl2 under a nitrogen 
atmosphere at room temperature. The resulting mixture was stirred at room temperature 
for 12h or at 40 °C for 4h at which point a light-brown precipitate was collected by 
filtration, and washed with diethyl ether to give a solid product. In some cases, the 
product was recrystallized using a very small amount of methanol with diethyl ether to 
provide very fine crystals. 
5.2.4 Preparation and characterization data of protonated azomethine imine triflate 
salts 
8-methoxy-3-methyl-2,5,10,10a-tetrahydro-1H-pyrrolo[1,2-b]cinnolin-4-ium 
trifluoromethanesulfonate (1.168): The title [4+2] cycloaddition product 
1.168 was prepared in 85% yield (137 mg) as described in representative 
experimental procedure 5.2.3 by reacting -chloroazo 1.158 (1 equiv, 111 
mg, 0.44 mmol), TMSOTf (1.05 equiv, 0.08 mL, 0.46 mmol), and hexane 
(5 mL) for 12h at room temperature. Alternatively, the title [4+2] cycloaddition product 
was prepared in 81% yield (267 mg) as described in representative experimental 
procedure 5.2.3 by reacting the corresponding -trifluoroacetoxyazo 1.190 (1 equiv, 300 
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mg, 0.9 mmol), TMSOTf (1.05 equiv, 0.17 mL, 0.95 mmol), and hexane (20 mL) for 12h 
at room temperature. Mp 146.2 °C (recrystallized from MeOH/Et2O). 
1H NMR (500 
MHz, CD3CN) δ = 8.95 (s, 1H), 6.94 (d, J = 8.8, 1H), 6.88 – 6.82 (m, 1H), 6.79 (d, J = 
2.5, 1H), 4.53 – 4.44 (m, 1H), 3.76 (s, 3H), 3.25 (dd, J = 16.1, 4.3, 1H), 3.17 – 2.99 (m, 
2H), 2.93 (dd, J = 16.0, 12.5, 1H), 2.63 (dtd, J = 12.2, 8.1, 3.9, 1H), 2.37 (s, 3H), 2.02 – 
1.95 (m, 1H). 13C NMR (126 MHz, CD3CN) δ 168.3, 156.4, 131.7, 121.1, 116.1, 115.1, 
114.9, 67.5, 56.2, 36.2, 33.3, 25.6, 15.8; IR (film) max: 3229, 3015, 2970, 1740, 1503, 
1435, 1369, 1277, 1227, 1217, 1155, 1029 cm-1. MS (ESI) calcd for [C13H17N2O]
+: -
217.1341, found: 217.1337. 
(4aR,13bR)-4,4,7,13b-tetramethyl-1,2,3,4,5,6,9,13b-octahydrobenzo[c]pyrrolo[1,2-
b]cinnolin-8-ium trifluoromethanesulfonate (170): The title [4+2] cycloaddition 
product 170 was prepared in 45% yield (519 mg) as described in 
representative experimental procedure 5.2.3 by reacting -chloroazo 1.161 
(1 equiv, 851 mg, 2.66 mmol), TMSOTf (1.05 equiv, 0.51 mL, 2.8 mmol), 
and hexane (20 mL) for 12h at room temperature. Alternatively, treating -
trifluoroacetoxyazo compound 1.176 (1 equiv, 595 mg, 1.5 mmol) with TMSOTF (1.5 
equiv, 0.41 mL, 2.25 mmol) in hexane (12 mL) for 4h at 40 °C provided 467 mg of 1.170 
(72% yield). Mp 189.4 °C (recrystallized from MeOH/Et2O).
 1H NMR (500 MHz, 
CD3CN) δ = 9.30 (s, 1H), 7.34 (d, J = 7.8, 1H), 7.26 (t, J = 7.1, 1H), 7.10 (t, J = 7.1, 1H), 
6.89 (d, J = 8.1, 1H), 3.21 – 3.01 (m, 1H), 2.54 (s, 3H), 2.53 – 2.43 (m, 3H), 1.72 – 1.43 
(m, 4H), 1.35 – 1.27 (m, 1H), 1.06 (s, 3H), 0.95 (s, 3H), 0.62 (s, 3H). 13C NMR (126 
MHz, CD3CN) δ 171.6, 137.6, 128.7, 128.2, 124.8, 124.3, 114.4, 85.4, 42.3, 41.5, 39.4, 
36.4, 32.2, 29.8, 27.2, 25.6, 24.9, 18.6, 16.6; IR (film) max: 3188, 3003, 1591, 1497, 
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1445, 1344, 1285, 1242, 1225, 1151, 1028 cm-1. MS (ESI) calcd for [C19H27N2]
+: 
283.2174, found: 283.2173. 
3,8-dimethyl-2,5,10,10a-tetrahydro-1H-pyrrolo[1,2-b]cinnolin-4-ium 
trifluoromethanesulfonate (1.172a): The title [4+2] cycloaddition product 1.172a was 
prepared in 85% yield (113 mg) as described in representative experimental 
procedure 5.2.3 by reacting -chloroazo 1.155a (1 equiv,  89 mg, 0.38 mmol), 
TMSOTf (1.05 equiv, 0.07 mL, 0.39 mmol), and hexane (10 mL) for 12h at 
room temperature. Alternatively, this product was prepared in 86% yield (325 
mg) as described in representative experimental procedure 5.2.3 by reacting the 
corresponding -trifluoroacetoxyazo 1.190 (1 equiv, 340 mg, 1.1 mmol), TMSOTf (1.05 
equiv, 0.21 mL, 1.15 mmol), and hexane (7 mL) for 4h at 40 °C. Mp 152.7 °C 
(recrystallized from MeOH/Et2O).
 1H NMR (500 MHz, CD3CN) δ = 9.08 (s, 1H), 7.08 (d, 
J = 8.2, 1H), 7.03 (s, 1H), 6.90 (d, J = 8.2, 1H), 4.48 (qd, J = 12.3, 10.4, 1H), 3.24 (dd, J 
= 16.0, 4.3, 1H), 3.16 – 3.00 (m, 2H), 2.92 (dd, J = 15.8, 12.6, 1H), 2.63 (dtd, J = 12.1, 
8.1, 3.9, 1H), 2.38 (s, 3H), 2.28 (s, 3H), 2.01 – 1.95 (m, 1H). 13C NMR (126 MHz, 
CD3CN) δ 168.4, 135.7, 133.4, 130.4, 129.8, 119.5, 114.7, 67.6, 36.2, 33.2, 25.7, 20.6, 
15.9; IR (film) max: 3198, 3024, 2970, 1740, 1728, 1501, 1427, 1366, 1294, 1233, 1217, 
1148, 1030, 833 cm-1. MS (ESI) calcd for [C13H17N2]
+:  201.1392, found: 201.1387. 
3,6-dimethyl-2,5,10,10a-tetrahydro-1H-pyrrolo[1,2-b]cinnolin-4-ium 
trifluoromethanesulfonate (1.172b): The title [4+2] cycloaddition product 
1.172b was prepared in 83% yield (40 mg) as described in representative 
experimental procedure 5.2.3 by reacting -chloroazo 1.155b (1 equiv,  33 
mg, 0.14 mmol), TMSOTf (1.05 equiv, 0.03 mL, 0.15 mmol), and 6 mL hexane (6 mL) 
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for 12h at room temperature. Alternatively, this product was also prepared in 90% yield 
(181 mg) as described in representative experimental procedure 5.2.3 by reacting the 
corresponding -trifluoroacetoxyazo 1.190 (1 equiv, 180 mg, 0.57 mmol), TMSOTf (1.5 
equiv, 0.16 mL, 0.86 mmol), and hexane (12 mL) for 4h at 40 °C. Mp 149.1°C 
(recrystallized from MeOH/Et2O).
  1H MR (500 MHz, CD3CN) δ = 8.22 (s, 1H), 7.13 (d, 
J = 7.4, 1H), 7.06 (d, J = 7.6, 1H), 6.97 (t, J = 7.5, 1H), 4.54 – 4.36 (m, 1H), 3.30 (dd, J = 
16.0, 4.4, 1H), 3.23 – 3.05 (m, 2H), 2.97 (dd, J = 15.9, 12.5, 1H), 2.72 – 2.62 (m, 1H), 
2.50 (s, 3H), 2.27 (s, 3H), 1.98 (ddd, J = 9.7, 8.9, 4.9, 1H). 13C NMR (126 MHz, CD3CN) 
δ 176.1, 136.4, 130.6, 128.0, 124.9, 123.8, 120.0, 66.6, 36.4, 33.8, 25.3, 16.9, 16.6; IR 
(film) max: 3219, 2995, 1713, 1668, 1601, 1479, 1425, 1391, 1362, 1281, 1254, 1234, 
1223, 1148, 1030 cm-1. MS (ESI) calcd for [C13H17N2]
+: 201.1392, found: 201.1386. 
(4aR,13bR)-4,4,7,12,13b-pentamethyl-1,2,3,4,5,6,9,13b-
octahydrobenzo[c]pyrrolo[1,2-b]cinnolin-8-ium 
trifluoromethanesulfonate (1.180): The title [4+2] cycloaddition 
product 1.180 was prepared in 25% yield (46 mg) as described in 
representative experimental procedure 5.2.3 by reacting the corresponding 
-trifluoroacetoxyazo 1.177 (1 equiv, 173 mg, 0.42 mmol), TMSOTf (1.05 equiv, 0.08 
mL, 0.44 mmol), and hexane (10 mL) for 12h at room temperature. Alternatively, this 
product was prepared in 70% yield (531 mg) as described in representative experimental 
procedure 5.2.3 by reacting the corresponding -trifluoroacetoxyazo 1.177 (1 equiv, 697 
mg, 1.7 mmol), TMSOTf (1.5 equiv, 0.46 mL, 2.54 mmol), and hexane (15 mL) for 4h at 
40 °C. Mp 211.5 °C (recrystallized from MeOH/Et2O).
 1H NMR (500 MHz, Acetone-d6) δ 
= 10.36 (s, 1H), 7.24 (s, 1H), 7.07 (dd, J = 8.1, 1.0, 1H), 6.89 (d, J = 8.2, 1H), 3.49 – 3.20 
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(m, 2H), 2.72 (s, 3H), 2.70 – 2.57 (m, 3H), 2.33 (s, 3H), 1.76 (td, J = 13.1, 4.1, 1H), 1.69 
– 1.54 (m, 2H), 1.50 (ddd, J = 10.9, 6.5, 3.4, 1H), 1.40 – 1.31 (m, 1H), 1.13 (s, 3H), 1.04 
(s, 3H), 0.72 (s, 3H). 13C NMR (126 MHz, CD3CN) δ 171.0, 135.3, 134.0, 129.2, 128.1, 
125.2, 114.5, 85.4, 42.3, 41.5, 39.4, 36.43, 32.2, 29.9, 27.2, 25.6, 24.9, 20.9, 18.6, 16.5; 
IR (film) max: 3204, 2978, 2870, 1713, 1645, 1614, 1506, 1279, 1242, 1223, 1155, 1028, 
827 cm-1. MS (ESI) calcd for [C20H29N2]
+: 297.2331, found: 2297.2332. 
(4aR,13bR)-4,4,7,10,13b-pentamethyl-1,2,3,4,5,6,9,13b-
octahydrobenzo[c]pyrrolo[1,2-b]cinnolin-8-ium trifluoromethanesulfonate (1.181): 
The title [4+2] cycloaddition product 1.181 was prepared in 33% yield 
(111 mg) as described in representative experimental procedure 5.2.3 by 
reacting the corresponding -trifluoroacetoxyazo 1.177 (1 equiv, 307 mg, 
0.75 mmol), TMSOTf (1.05 equiv, 0.14 mL, 0.79 mmol), and hexane (12mL) for 12h at 
room temperature. Alternatively, this product was prepared in 70% yield (262 mg) as 
described in representative experimental procedure 6 by reacting the corresponding -
trifluoroacetoxyazo 1.177 (1 equiv, 343 mg, 0.84 mmol), TMSOTf (1.5 equiv, 0.23 mL, 
1.3 mmol), and hexane (12 mL) for 4 h at 40 °C. Mp 216.4 °C (recrystallized from 
MeOH/Et2O).
  1H NMR (500 MHz, Acetone-d6) δ = 9.38 (s, 1H), 7.28 (d, J = 7.8, 1H), 
7.14 (dd, J = 7.4, 0.4, 1H), 7.05 (t, J = 7.6, 1H), 3.43 – 3.33 (m, 2H), 2.82 (s, 3H), 2.76 – 
2.54 (m, 3H), 2.31 (s, 3H), 1.80 – 1.45 (m, 4H), 1.35 (ddd, J = 13.6, 4.9, 3.1, 1H), 1.12 (s, 
3H), 1.07 (s, 3H). 13C NMR (126 MHz, CD3CN) δ 177.3, 135.8, 130.1, 128.4, 124.3, 
123.9, 122.5, 84.1, 42.2, 41.6, 39.5, 36.4, 32.3, 30.0, 26.9, 25.5, 24.7, 18.6, 17.2, 17.1; IR 
(film) max: 3208, 3015, 2970, 2941, 2870, 1740, 1728, 1464, 1423, 1369, 1283, 1254, 
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1225, 1217, 1150, 1032 cm-1. MS (ESI) calcd for [C20H29N2]
+: 297.2331, found: 
2297.2328. 
(4aR,13bR)-12-methoxy-4,4,7,13b-tetramethyl-1,2,3,4,5,6,9,13b-
octahydrobenzo[c]pyrrolo[1,2-b]cinnolin-8-ium trifluoromethanesulfonate (1.182): 
The title [4+2] cycloaddition product 1.182 was prepared in 53% yield (330 
mg) as described in representative experimental procedure 5.2.3 by reacting 
the corresponding -trifluoroacetoxyazo 1.177 (1 equiv, 578 mg, 1.35 
mmol), TMSOTf (1.05 equiv, 0.26 mL, 1.42 mmol), and hexane (20 mL)  
for 12h at room temperature. Alternatively, this product was prepared in 40% yield (143 
mg) as described in representative experimental procedure 5.2.3 by reacting the 
corresponding -trifluoroacetoxyazo 1.177 (1 equiv, 326 mg, 0.76 mmol), TMSOTf (1.5 
equiv, 0.21 mL, 1.15 mmol), and hexane (15 mL) for 4h at 40 °C. The final product was 
recrystallized using the smallest amount of methanol with diethyl ether to provide golden 
crystals. Mp 191.5 °C (recrystallized from MeOH/Et2O).
 1H NMR (500 MHz, CD3CN) δ 
= 9.24 (s, 1H), 6.87 (s, 1H), 6.84 (d, J = 2.1, 2H), 3.78 (s, 3H), 3.20 – 2.98 (m, 2H), 2.52 
(s, 3H), 2.51 – 2.42 (m, 3H), 1.70 – 1.42 (m, 4H), 1.35 – 1.28 (m, 1H), 1.12 (t, J = 7.0, 
1H), 1.06 (s, 3H), 0.95 (s, 3H), 0.64 (s, 3H).13C NMR (126 MHz, CD3CN) δ 170.6, 
157.2, 131.3, 129.7, 115.8, 114.1, 110.3, 85.3, 56.3, 42.4, 41.7, 39.3, 36.4, 32.2, 29.6, 
27.1, 25.6, 25.0, 18.7, 16.5; IR (film) max: 3196, 3005, 2874, 1713, 1645, 1592, 1501, 
1423, 1362, 1277, 1246, 1223, 1155, 1030, 872, 816 cm-1. MS (ESI) calcd for 
[C20H29N2O]
+: 313.228, found: 313.2277. 
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(4aR,13bR)-12-chloro-4,4,7,13b-tetramethyl-1,2,3,4,5,6,9,13b-
octahydrobenzo[c]pyrrolo[1,2-b]cinnolin-8-ium trifluoromethanesulfonate (1.183): 
The title [4+2] cycloaddition product 1.183 was prepared in 35% yield 
(160 mg) as described in representative experimental procedure 5.2.3 by 
reacting the corresponding -trifluoroacetoxyazo 1.177 (1 equiv, 422 mg, 
0.98 mmol), TMSOTf (1.05 equiv, 0.19 mL, 1.03 mmol), and hexane (20 
mL) for 12h at room temperature. Alternatively, this product was prepared in 42% yield 
(71 mg) as described in representative experimental procedure 5.2.3 by reacting the 
corresponding -trifluoroacetoxyazo 1.177 (1 equiv, 157 mg, 0.36 mmol), TMSOTf (1.5 
equiv, 0.10 mL, 0.55 mmol), and hexane (15 mL) for 4 h at 40 °C. Mp 230.0 °C 
(recrystallized from MeOH/Et2O).
 1H NMR (500 MHz, CD3CN) δ = 9.73 (s, 1H), 7.28 
(dd, J = 26.5, 24.9, 2H), 6.91 (d, J = 8.6, 1H), 3.26 – 2.93 (m, 2H), 2.56 (s, 3H), 2.53 – 
2.37 (m, 3H), 1.72 – 1.23 (m, 5H), 1.06 (s, 3H), 0.96 (s, 3H), 0.66 (s, 3H). 13C NMR (126 
MHz, CD3CN) δ 172.7, 136.5, 130.1, 128.7, 128.6, 124.8, 116.0, 84.9, 42.3, 41.7, 39.2, 
36.5, 32.0, 29.6, 27.0, 25.5, 24.8, 18.5, 16.7; IR (film) max: 3177, 3015, 2970, 2947, 
1740, 1728, 1493, 1435, 1366, 1279, 1225, 1217, 1161, 1028, 824 cm-1. MS (ESI) calcd 
for [C19H26ClN2]
+: 317.1785, found: 317.1781. 
3-methyl-8-nitro-2,5,10,10a-tetrahydro-1H-pyrrolo[1,2-b]cinnolin-4-ium 
trifluoromethanesulfonate (1.193): The title [4+2] cycloaddition product 
1.193 was prepared in 86% yield (324 mg) as described in representative 
experimental procedure 5.2.3 by reacting -trifluoroacetoxyazo 1.175 (1 
equiv, 298 mg, 0.99 mmol), TMSOTf (1.05 equiv, 0.19 mL, 1.04 mmol), and 
hexane (20 mL) for 12h at room temperature. Alternatively, this product was prepared in 
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96% yield (268 mg) as described in representative experimental procedure 5.2.3 by 
reacting -trifluoroacetoxyazo 1.175 (1 equiv, 253 mg, 0.732 mmol), TMSOTf (1.5 
equiv, 0.20 mL, 1.1 mmol), and hexane (15 mL) for 4h at 40 °C. Mp 209.6 °C 
(recrystallized from MeOH/Et2O). 
1H NMR (500 MHz, CD3CN) δ = 10.05 (s, 1H), 8.27 – 
7.83 (m, 2H), 7.16 (d, J = 8.7, 1H), 4.64 – 4.33 (m, 1H), 3.45 (dd, J = 16.2, 4.3, 1H), 3.23 
– 3.07 (m, 2H), 3.03 (dd, J = 16.2, 12.5, 1H), 2.73 – 2.62 (m, 1H), 2.45 (s, 3H), 2.05 – 
1.96 (m, 1H). 13C NMR (126 MHz, Acetone-d6) δ 172.1, 143.4, 143.0, 125.8, 124.9, 
119.9, 114.6, 67.0, 36.7, 33.2, 25.7, 16.0; IR (film) max: 3186, 3003, 1618, 1593, 1504, 
1344, 1287, 1240, 1223, 1153, 1030, 937, 826 cm-1. MS (ESI) calcd for [C12H14N3O2]
+: 
232.1086, found: 232.1084. 
3-methyl-7-nitro-2,5,10,10a-tetrahydro-1H-pyrrolo[1,2-b]cinnolin-4-ium 
trifluoromethanesulfonate and 3-methyl-9-nitro-2,5,10,10a-tetrahydro-1H-
pyrrolo[1,2-b]cinnolin-4-ium trifluoromethanesulfonate (1.194 & 1.195): The title 
[4+2] cycloaddition products was prepared as a 6:4 mixture in 87% yield (200 mg) as 
described in representative experimental procedure 5.2.3 by reacting the corresponding 
-trifluoroacetoxyazo 1.190 (1 equiv, 209 mg, 0.61 mmol), TMSOTf (1.5 equiv, 0.16 
mL, 0.91 mmol), and hexane (15 mL) for 12h at room temperature. Alternatively, this 
mixture was prepared in quantitative yield (467 mg) as described in representative 
experimental procedure 5.2.3 by reacting the corresponding -trifluoroacetoxyazo 1.190 
(1 equiv, 468 mg, 1.23 mmol), TMSOTf (1.5 equiv, 0.33 mL, 1.85 mmol), and hexane 
(15 mL) for 4h at 40 °C. The minor isomer (1.195) was less soluble in chloroform than 
the major isomer (1.194) and filtration of a chloroform solution provided pure minor 
isomer in 20% yield (15 mg from 75 mg of the mixture).  
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3-methyl-7-nitro-2,5,10,10a-tetrahydro-1H-pyrrolo[1,2-b]cinnolin-4-ium 
trifluoromethanesulfonate (1.194): 1H NMR (500 MHz, CD3CN) δ = 
9.74 (s, 1H), 7.85 (s, 1H), 7.86 – 7.81 (m, 1H), 7.43 (d, J = 8.3, 1H), 
4.58 – 4.47 (m, 1H), 3.45 (dd, J = 16.6, 4.3, 1H), 3.18 – 2.99 (m, 3H), 
2.73 – 2.61 (m, 1H), 2.45 (s, 3H), 2.08 – 1.95 (m, 1H). 13C NMR (126 MHz, CD3CN) δ 
171.4, 148.8, 138.8, 131.4, 126.6, 117.8, 109.5, 66.7, 36.5, 33.2, 25.5, 16.1. 
3-methyl-9-nitro-2,5,10,10a-tetrahydro-1H-pyrrolo[1,2-b]cinnolin-4-ium 
trifluoromethanesulfonate (1.195): Mp 191.7 °C  (recrystallized from MeOH/Et2O).
 
1H NMR (500 MHz, CD3CN) δ = z (d, J = 21.2, 1H), 7.66 (d, J = 8.1, 1H), 
7.47 (t, J = 8.2, 1H), 7.34 (d, J = 8.2, 1H), 4.47 – 4.36 (m, 1H), 3.66 (dd, J = 
17.2, 4.3, 1H), 3.21 – 3.00 (m, 3H), 2.66 (dtd, J = 12.5, 8.3, 4.0, 1H), 2.43 (s, 
3H), 2.04 (ddd, J = 18.4, 13.2, 9.1, 1H). 13C NMR (126 MHz, CD3CN) δ 
171.2, 150.2, 139.8, 129.7, 119.7, 119.3, 114.7, 65.7, 36.4, 30.5, 25.4, 16.0; IR (film) 
max: 3144, 2994, 2947, 1713, 1678, 1618, 1584, 1533, 1358, 1277, 1238, 1225, 1177, 
1153, 1177, 1153, 1030, 853, 804 cm-1. MS (ESI) calcd for [C12H14N3O2]
+ : 232.1086, 
found: 232.1082.  
8-chloro-3-methyl-2,5,10,10a-tetrahydro-1H-pyrrolo[1,2-b]cinnolin-4-ium 
trifluoromethanesulfonate (1.196): The title [4+2] cycloaddition product 1.196 was 
prepared in 72% yield (106 mg) as described in representative experimental 
procedure 5.2.3 by reacting the corresponding -trifluoroacetoxyazo 1.190 (1 
equiv, 134 mg, 0.4 mmol), TMSOTf (1.05 equiv, 0.07 mL, 0.42 mmol), and 
hexane (12 mL) for 12h at room temperature. Alternatively, this product was 
prepared in 84% yield (361 mg) as described in representative experimental procedure 
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5.2.3 by reacting the corresponding -trifluoroacetoxyazo 1.190 (1 equiv, 427 mg, 1.16 
mmol), TMSOTf (1.5 equiv, 0.31 mL, 1.73 mmol), and hexane (15 mL) for 4h at 40 °C. 
Mp 142.0 °C (recrystallized from MeOH/Et2O).
 1H NMR (500 MHz, CD3CN) δ = 9.35 (s, 
1H), 7.26 (d, J = 8.1, 2H), 7.00 (d, J = 8.4, 1H), 4.48 (dd, J = 4.5, 2.0, 1H), 3.29 (dd, J = 
16.1, 4.2, 1H), 3.18 – 3.03 (m, 2H), 2.94 (dd, J = 15.9, 12.6, 1H), 2.69 – 2.57 (m, 1H), 
2.40 (s, 3H), 2.05 – 1.95 (m, 1H).13C NMR (126 MHz, CD3CN) δ 169.8, 136.9, 129.7, 
129.0, 127.8, 121.5, 116.2, 67.0, 36.3, 32.9, 25.5, 15.9; IR (film) max: 3204, 3003, 1713, 
1678, 1610, 1491, 1433, 1420, 1283, 1237, 1223, 1152, 1026, 864, 804 cm-1. MS (ESI) 
calcd for [C12H14ClN2]
+: 221.0846, found: 221.0842. 
6,8-dichloro-3-methyl-2,5,10,10a-tetrahydro-1H-pyrrolo[1,2-b]cinnolin-4-ium 
trifluoromethanesulfonate (1.197): The title [4+2] cycloaddition product 
1.197 was prepared in 59% yield (120 mg) as described in representative 
experimental procedure 5.2.3 by reacting the corresponding -
trifluoroacetoxyazo 1.190 (1 equiv, 186 mg, 0.5 mmol), TMSOTf (1.05 
equiv, 0.10 mL, 0.53 mmol), and hexane (15 mL) for 12h at room temperature. 
Alternatively, this product was prepared in 73% yield (178 mg) as described in 
representative experimental procedure 5.2.3 by reacting the corresponding -
trifluoroacetoxyazo 1.190 (1 equiv, 233 mg, 0.6 mmol), TMSOTf (1.5 equiv, 0.16 mL, 
0.86 mmol), and hexane (15 mL) for 4h at 40 °C. Mp 169.9 °C (recrystallized from 
MeOH/Et2O). 
1H NMR (500 MHz, CD3CN) δ = 8.60 (s, 1H), 7.46 (dd, J = 2.2, 0.9, 1H), 
7.26 (s, 1H), 4.46 (ddd, J = 8.1, 3.8, 1.9, 1H), 3.34 (dd, J = 16.3, 4.4, 1H), 3.29 – 3.09 (m, 
2H), 2.99 (dd, J = 16.3, 12.4, 1H), 2.69 (dddd, J = 13.3, 9.9, 8.3, 3.5, 1H), 2.51 (s, 3H), 
2.06 – 1.96 (m, 1H). 13C NMR (126 MHz, CD3CN) δ 178.9, 133.9, 129.0, 128.9, 128.3, 
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123.8, 121.0, 66.0, 36.7, 33.4, 24.9, 17.0; IR (film) max: 3208, 2974, 1713, 1678, 1576, 
1479, 1414, 1277, 1244, 1223, 1148, 1028, 856 cm-1. MS (ESI) calcd for [C12H13Cl2N2]
+: 
255.0456, found: 255.0453. 
3-methyl-2,5,10,10a-tetrahydro-1H-pyrrolo[1,2-b]cinnolin-4-ium 
trifluoromethanesulfonate (1.198): The title [4+2] product 1.198 was prepared in 96% 
yield (258 mg) as described in representative experimental procedure 5.2.3 
by reacting the corresponding -trifluoroacetoxyazo 1.190 (1 equiv, 240 
mg, 0.8 mmol), TMSOTf (1.5 equiv, 0.22 mL, 1.2 mmol), and hexane (15 
mL) for 4h at 40 °C. Mp 136.0 °C (recrystallized from MeOH/Et2O).
 1H 
NMR (500 MHz, CDCl3) δ = 9.83 (s, 1H), 7.19 (t, J = 7.7, 1H), 7.08 (d, J = 7.6, 1H), 
7.02 (d, J = 7.9, 1H), 6.97 (td, J = 7.5, 0.9, 1H), 4.47 (dd, J = 5.0, 2.2, 1H), 3.28 – 3.14 
(m, 2H), 3.08 (dd, J = 19.5, 9.7, 1H), 2.94 (dd, J = 15.8, 12.6, 1H), 2.75 – 2.64 (m, 1H), 
2.50 (s, 3H), 1.98 (dq, J = 13.1, 9.4, 1H). 13C NMR (126 MHz, CDCl3) δ 169.3, 137.0, 
129.0, 128.7, 123.0, 117.3, 114.8, 66.1, 35.4, 33.3, 25.2, 16.0. MS (ESI) calcd for 
[C19H27N2]
+: 187.1235, found: 187.1231. 
5.3 Experimental information for dearomatized non-protonated azomethine imine 
salt (Chapter 1) 
3,6,9a-trimethyl-2,9a,10,10a-tetrahydro-1H-pyrrolo[1,2-b]cinnolin-4-ium 
pentachloro(2,2,2-trifluoroacetoxy)stibate(V) (1.203): The title 
[4+2] cycloaddition product 1.203 was prepared in 66% yield as 
determined by 1HNMR as described in representative experimental 
procedure 5.2.1 by reacting -trifluoroacetoxyazo compound 1.201 (114 mg, 0.35 
mmol), SbCl5 (2 M in CH2Cl2, 0.17 mL, 0.33 mmol), and CH2Cl2 (5 mL). 
1H NMR (500 
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MHz, CD3CN) δ 6.82 (d, J = 1.9 Hz, 1H), 6.33 – 6.18 (m, 2H), 4.09 (dd, J = 11.3, 4.9 Hz, 
1H), 3.19 (d, J = 7.3 Hz, 2H), 2.78 – 2.66 (m, 1H), 2.54 (d, J = 1.3 Hz, 3H), 2.47 (dd, J = 
13.6, 9.8 Hz, 1H), 2.24 (dd, J = 13.7, 6.5 Hz, 1H), 2.08 (s, 3H), 2.04 – 1.96 (m, 1H), 1.14 
(s, 3H). 13C NMR (126 MHz, CD3CN) δ 182.3, 143.2, 137.8, 130.3, 120.7, 61.8, 37.6, 
37.0, 29.2, 26.8, 16.9, 16.5. 
5.4 Experimental information for Chapter 2 
5.4.1 Preparation of aryl hydrazones 
A ketone (1.0 equiv, 1.0 mmol) was added to a room temperature solution of aryl 
hydrazine (1.2 equiv, 1.2 mmol) in CH2Cl2 (8 mL) containing 4Å molecular sieves under 
a nitrogen atmosphere. After stirring at room temperature for three hours, the solution 
was filtered and the filtrate was concentrated. The residue was dissolved in hexane (12 
mL), was passed through a plug of basic alumina and was concentrated in vacuo to 
provide a diastereomeric mixture of the hydrazone as a yellow oil.  
5.4.2 Characterization data of aryl hydrazones 
(E)-1-(pentan-2-ylidene)-2-phenylhydrazine: Yield = 100%; E/Z 1:0.18; major 
diastereomer: 1H NMR (500 MHz, CDCl3) δ 7.24 – 7.19 (m, 2H), 7.04 
(dd, J = 8.6, 1.0 Hz, 2H), 6.86 – 6.78 (m, 2H), 2.30 – 2.25 (m, 2H), 1.85 
(s, 3H), 1.61 (dd, J = 15.0, 7.5 Hz, 2H), 0.96 (t, J = 7.4 Hz, 3H). 13C NMR (126 MHz, 
CDCl3) δ 147.1, 146.1, 129.3, 119.6, 113.1, 113.0, 41.1, 20.1, 14.4, 13.9. Observable 
resonances for minor diastereomer: 1H NMR (500 MHz, CDCl3) δ 2.25 – 2.20 (m, 2H), 
2.02 (s, 3H), 1.02 (t, J = 7.4 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 31.5, 23.4, 18.7. 
(E)-1-(hexan-2-ylidene)-2-phenylhydrazine: Yield = 90%; E/Z 1:0.19; major 
diastereomer: 1H NMR (500 MHz, CDCl3) δ 7.25 – 7.19 (m, 2H), 7.08 – 6.98 (m, 2H), 
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6.82 (tt, J = 7.4, 1.1 Hz, 1H), 2.40 – 2.28 (m, 2H), 1.86 (s, 3H), 1.63 – 
1.52 (m, 2H), 1.42 – 1.25 (m, 5H), 0.92 (dt, J = 11.2, 7.0 Hz, 3H). 13C 
NMR (126 MHz, CDCl3) δ 146.1, 129.3, 119.6, 113.1, 39.0, 31.6, 26.5, 22.6, 14.4, 14.1. 
Observable resonances for minor diastereomer: 1H NMR (500 MHz, CDCl3) δ 2.27 – 
2.22 (m, 2H), 2.02 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 129.3, 77.4, 77.1, 76.9, 32.1, 
25.0, 23.4, 22.6. 
1-(2-(benzyloxy)phenyl)-2-(propan-2-ylidene)hydrazine (2.50): Yield = 70%.1H NMR 
(500 MHz, CDCl3) δ 7.46 – 7.28 (m, 8H), 6.97 – 6.91 (m, 1H), 6.88 (dd, J 
= 8.0, 1.1 Hz, 1H), 6.75 (td, J = 7.7, 1.6 Hz, 1H), 5.11 (s, 3H), 2.05 (s, 
3H), 1.83 (s, 3H). 
(E)-1-(1-(cyclohex-3-en-1-yl)ethylidene)-2-phenylhydrazine (2.72): Yield = 78%. 1H 
NMR (500 MHz, CDCl3) δ 7.26 – 7.18 (m, 2H), 7.05 (dd, J = 8.5, 0.9 Hz, 
2H), 6.89 (s, 1H), 6.84 – 6.75 (m, 1H), 5.76 – 5.61 (m, 2H), 2.53 – 2.42 (m, 
1H), 2.25 – 2.09 (m, 4H), 1.98 – 1.89 (m, 1H), 1.86 (s, 3H), 1.66 – 1.51 (m, 
1H). 13C NMR (126 MHz, CDCl3) δ 149.4, 146.1, 129.3, 126.8, 126.4, 119.6, 113.1, 
53.5, 42.9, 28.9, 26.6, 25.6, 13.0. 
5.4.3  Preparation of aryl -chloroazo compounds 
A solution of DMSO (2.5 equiv) in THF (10 mL) was stirred and cooled to -55 °C in 
a flame-dried flask under a nitrogen atmosphere at which point oxalyl chloride (2.0 
equiv) was added in a dropwise manner. The reaction was maintained at -55 °C until gas 
evolution ceased (~20 min) at which point the reaction was cooled further to -78 °C. A 
mixture of Et3N (2.5 equiv) and hydrazone (1 equiv) in THF (3 mL) was added in a 
dropwise manner via cannula to give a white precipitate. The reaction mixture was 
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maintained at -78 °C for 30 min and was then allowed to warm to room temperature at 
which point the solid was removed by filtration through a medium porosity sintered-glass 
funnel. The filtrate was concentrated by rotary evaporation and the residue was dissolved 
in pentane (15 mL). The pentane solution was filtered through a plug of cotton in a 
pasteur pipette to remove insoluble solids. The pentane was removed in vacuo to provide 
the clean α-chloroazo product as a yellow oil. 
5.4.4 Characterization data of -chloroazo compounds 
(E)-1-(2-chloropentan-2-yl)-2-phenyldiazene (2.39a): Yield = 81%. 1H NMR (500 
MHz, CDCl3) δ 7.83 – 7.65 (m, 2H), 7.47 (d, J = 1.8 Hz, 3H), 2.27 (ddd, 
J = 14.0, 11.7, 4.7 Hz, 1H), 2.16 (ddd, J = 14.0, 11.8, 4.7 Hz, 1H), 1.90 
(s, 3H), 1.57 (dddd, J = 10.9, 9.3, 7.0, 3.2 Hz, 1H), 1.49 – 1.38 (m, 1H), 
0.95 (t, J = 7.4 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 151.2, 131.3, 129.2, 123.0, 96.8, 
45.1, 28.8, 17.7, 14.1. 
(E)-1-(2-chloroheptan-2-yl)-2-phenyldiazene (2.39b): Yield = 91%. 1H NMR (500 
MHz, CDCl3) δ 7.86 – 7.66 (m, 2H), 7.57 – 7.40 (m, 3H), 2.24 (dddd, 
J = 54.8, 14.0, 11.7, 4.5 Hz, 2H), 1.93 (s, 3H), 1.68 – 1.51 (m, 1H), 
1.48 – 1.20 (m, 5H), 0.90 (dd, J = 8.9, 5.1 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 151.2, 
131.3, 129.2, 123.0, 97.0, 43.0, 31.8, 28.8, 24.0, 22.5, 14.1. 
(E)-1-(2-(benzyloxy)phenyl)-2-(2-chloropropan-2-yl)diazene (2.51): Yield = 60%. 1H 
NMR (500 MHz, CDCl3) δ 7.50 – 7.47 (m, 2H), 7.45 (dt, J = 3.5, 1.8 Hz, 
1H), 7.41 – 7.33 (m, 3H), 7.30 (ddd, J = 8.6, 4.4, 1.2 Hz, 1H), 7.10 (dd, J 
= 8.3, 1.1 Hz, 1H), 7.00 (ddd, J = 8.0, 7.4, 1.2 Hz, 1H), 5.29 (s, 2H), 1.95 
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(s, 6H). 13C NMR (126 MHz, CDCl3) δ 155.6, 141.4, 137.0, 132.4, 128.4, 127.7, 126.9, 
121.4, 118.0, 115.9, 93.5, 71.8, 30.3. 
(E)-1-(1-chloro-1-(cyclohex-3-en-1-yl)ethyl)-2-phenyldiazene (2.73): Yield = 92%. 1H 
NMR (500 MHz, CDCl3) δ 7.83 – 7.69 (m, 2H), 7.48 (ddd, J = 7.5, 4.4, 2.3 
Hz, 3H), 5.75 – 5.58 (m, 2H), 2.52 (dddd, J = 20.4, 12.8, 5.0, 2.3 Hz, 1H), 
2.24 – 2.04 (m, 4H), 1.98 (s, 3H), 1.58 – 1.44 (m, 2H). 13C NMR (126 MHz, 
CDCl3) δ 131.2, 129.0, 126.9, 126.7, 125.8, 125.7, 122.9, 45.3, 44.8, 26.7, 26.5, 25.6, 
23.8. 
5.4.5 Preparation of -trifluoroacetoxyazo compounds 
A solution of DMSO (1.2 equiv) in CH2Cl2 (1 mL) was added in a dropwise manner 
to a -78 °C solution of trifluoroacetic anhydride (TFAA) (1.1 or 1.2 equiv) in 10 mL of 
CH2Cl2 under a nitrogen atmosphere. The mixture was stirred for 10 min at -78 
°C at 
which point a solution of hydrazone (1 equiv) in CH2Cl2 (5 mL) was added dropwise to 
the mixture via cannula. After 1 min, TEA (1.15 equiv) was added in a dropwise manner. 
The mixture was stirred for 10 min at -78 °C and was then allowed to warm to room 
temperature (20 min) at which point the mixture was concentrated. The residue was 
dissolved in hexane (15 mL), filtered through a plug of basic alumina to remove 
triethylammonium salt, and the hexane was remove in vacuo to provide the α-
trifluoroacetoxyazo product as a yellow oil. 
5.4.6 Characterization data of -trifluoroacetoxyazo compounds 
(E)-2-((2-(benzyloxy)phenyl)diazenyl)propan-2-yl 2,2,2-trifluoroacetate (2.54): Yield 
= 56%. 1H NMR (500 MHz, CDCl3) δ 7.46 – 7.42 (m, 2H), 7.42 – 7.33 (m, 4H), 7.30 (t, J 
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= 7.3 Hz, 1H), 7.07 (d, J = 8.3 Hz, 1H), 7.00 – 6.95 (m, 1H), 5.23 (s, 2H), 
1.81 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 155.6, 141.1, 136.8, 132.6, 
128.5, 127.8, 127.0, 121.1, 117.7, 115.1, 106.0, 71.2, 24.4. 
(E)-1-(cyclohex-3-en-1-yl)-1-(phenyldiazenyl)ethyl 2,2,2-
trifluoroacetate (2.74): Yield = 73%. 1H NMR (500 MHz, CDCl3) δ 7.75 – 
7.66 (m, 2H), 7.53 – 7.45 (m, 3H), 5.80 – 5.51 (m, 2H), 2.38 – 2.27 (m, 
1H), 2.27 – 2.04 (m, 4H), 1.97 (d, J = 3.2 Hz, 3H), 1.81 – 1.71 (m, 1H), 
1.54 – 1.40 (m, 1H). 13C NMR (126 MHz, CDCl3) δ 149.4, 146.1, 129.3, 126.8, 126.4, 
119.6, 113.1, 53.5, 42.9, 28.9, 26.6, 25.6, 13.0. 
5.4.7 Experimental information to prepare starting materials for new type of C-H 
amination (Chapter 2) 
5.4.7.1 Preparation and characterization data of 1-hydroxy-1,3-diphenylurea (2.103) 
A solution of phenylisocyanate (1.0 equiv, 0.1191g, 1.0 mmol) in 
CHCl3 (4 mL) was transferred into a solution of phenylhydroxyl amine 
(1.0 equiv, 0.1091g, 1.0 mmol) CHCl3 (4 mL) under a nitrogen 
atmosphere. The mixture was stirred for an hour to give a white precipitate of 1-hydroxy-
1,3-diphenylurea (2.103), which was separated by filtration. Yield = 88%. 1H NMR (500 
MHz, CDCl3) δ 8.23 (s, 1H), 7.84 (s, 1H), 7.37 (ddd, J = 3.4, 2.9, 1.4 Hz, 2H), 7.24 – 
7.21 (m, 4H), 7.18 – 7.12 (m, 2H), 7.10 – 7.00 (m, 2H). 
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5.4.7.2 Preparation and characterization data of 1,3-diphenyl-1-(3-
phenylpropoxy)urea (2.105) 
A mixture of 1-hydroxy-1,3-diphenylurea (2.103) (1 equiv, 0.7614g, 
3.34 mmol), 1-bromo-3-phenyl propane (2.104) (2 equiv, 1.33g, 6.67 
mmol), K2CO3, (2.8 equiv, 1.292g, 9.35 mmol) and DMSO (18 equiv, 
4.74 g, 60.7 mmol) was stirred at 30 °C for 17h. After that, the reaction mixture was 
mixed with water (10 mL) and extracted with CH2Cl2 (15 mL × 3). It was dried with 
sodium sulfate and concentrated in vacuo. The residue was purified by column 
chromatography to yield 2.105 in 98% (1.482g) yield. Rf = 0.66, 9:1 Hexane: EtOAc. 
1H 
NMR (500 MHz, CDCl3) δ 7.88 (s, 1H), 7.50 (d, J = 16.8 Hz, 4H), 7.39 (d, J = 0.8 Hz, 
2H), 7.32 (s, 4H), 7.21 (tt, J = 6.7, 1.2 Hz, 2H), 7.16 (s, 2H), 7.12 – 7.04 (m, 1H), 4.00 (s, 
2H), 2.76 (s, 2H), 2.09 (s, 2H). 13C NMR (126 MHz, CDCl3) δ 153.9, 140.6, 140.3, 
137.8, 129.0, 128.6, 128.6, 128.3, 126.2, 125.9, 123.7, 122.5, 119.5, 74.3, 32.3, 29.7. 
5.4.7.3 Preparation and characterization data of N-phenyl-O-(3-
phenylpropyl)hydroxylamine (2.106) 
A mixture of 2.105 (1 equiv, 1.184 g, 3.42 mmol), hydroquinone 
(0.01 equiv, 4mg, 0.03mmol), DMF (1.5mL) refluxed for 5 hours 
under a nitrogen atmosphere. Then, hydrazine (0.4 mL) was added 
and refluxed for additional 12 hrs. The reaction mixture was cooled to a room 
temperature and the reaction was quenched by water and extracted by CH2Cl2. The DCM 
solution was concentrated in vacuo. The residue was purified by column chromatography 
to yield 2.106 in 71% (0.553g) yield. Rf = 0.66, 9:1 Hexane: EtOAc. 
1H NMR (500 MHz, 
CDCl3) δ 7.32 – 7.14 (m, 7H), 6.94 (dt, J = 9.0, 7.9 Hz, 4H), 3.93 (t, J = 6.5 Hz, 2H), 
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2.76 (t, 2H), 2.18 – 1.85 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 148.8, 141.8, 129.1, 
128.5, 128.5, 126.0, 122.0, 114.2, 74.7, 32.5, 30.3. 
5.4.7.4 Characterization data of 2,2,2-trifluoro-N-phenyl-N-(3-
phenylpropoxy)acetamide (2.108)  
1H NMR (500 MHz, cdcl3) δ 10.50 (d, J = 6.2 Hz, 1H), 7.62 – 6.93 
(m, 9H), 3.94 (t, J = 5.9 Hz, 2H), 2.70 (d, J = 6.5 Hz, 2H), 2.00 (dd, 
J = 14.2, 6.9 Hz, 2H). 
5.4.7.5 Characterization data of 1-(but-3-en-1-yloxy)-1,3-diphenylurea (2.113) 
The procedure used was the same mentioned in section 5.4.7.2. 
Yield = 74%. 1H NMR (500 MHz, CDCl3) δ 8.02 (s, 1H), 7.51 
(ddd, J = 10.3, 6.2, 1.1 Hz, 4H), 7.41 – 7.36 (m, 2H), 7.35 – 7.29 
(m, 2H), 7.21 (dd, J = 10.5, 4.3 Hz, 1H), 7.12 – 7.02 (m, 1H), 5.94 (ddt, J = 17.1, 10.4, 
6.7 Hz, 1H), 5.29 (td, J = 8.7, 1.1 Hz, 2H), 4.03 (t, J = 6.0 Hz, 2H), 2.57 – 2.42 (m, 2H). 
13C NMR (126 MHz, CDCl3) δ 153.9, 140.2, 138.0, 134.5, 129.0, 128.6, 125.8, 123.5, 
122.4, 119.3, 118.4, 73.4, 32.2. 
5.4.7.6 Characterization data of O-(but-3-en-1-yl)-N-phenylhydroxylamine (2.114) 
The procedure used was the same mentioned in section 5.4.7.3. Yield 
= 67%. 1H NMR (500 MHz, CDCl3) δ 7.32 – 7.16 (m, 3H), 7.02 – 
6.81 (m, 3H), 5.95 – 5.79 (m, 1H), 5.23 – 4.93 (m, 2H), 3.96 (t, J = 6.7 Hz, 2H), 2.47 (qt, 
J = 6.7, 1.4 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 148.7, 134.9, 128.9, 121.9, 116.8, 
114.1, 74.4, 33.1. 
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5.5 Experimental information for Chapter 3 
5.5.1 Preparation of-chloroazo using acetyl chloride 
(E)-1-(2-chlorohex-5-en-2-yl)-2-phenyldiazene (3.21): A solution of DMSO (2.5 equiv) 
in THF (10 mL) was stirred and cooled to -55 °C in a flame-dried flask 
under a nitrogen atmosphere at which point acetyl chloride (2.0 equiv) 
was added in a dropwise manner. The reaction was maintained at -55 
°C until gas evolution ceased (~20 min) at which point the reaction was cooled further to 
-78 °C. A mixture of Et3N (2.5 equiv) and hydrazone 3.20 (1 equiv) in THF (3 mL) was 
added in a dropwise manner via cannula to give a white precipitate. The reaction mixture 
was maintained at -78 °C for 30 min and was then allowed to warm to room temperature 
at which point the solid was removed by filtration through a medium porosity sintered-
glass funnel. The filtrate was concentrated by rotary evaporation and the residue was 
dissolved in hexane (15 mL). The hexane solution was filtered through a plug of cotton 
in a pasteur pipette to remove insoluble solids. The hexane was removed in vacuo to 
provide clean α-chloroazo product 3.21 (227mg, 70%) as a yellow oil. 
(E)-1-(2-chloro-4-phenylbutan-2-yl)-2-phenyldiazene (3.23): The 
procedure used was the same mentioned in the preparation of 3.21 (section 
5.5.1). Yield = 81%. 
5.5.2 General experimental procedure for preparation of aryl hydrazones 
The hydrazones prepared in this section were prepared with the same method used 
to prepare the hydrazone in the section 5.4.1. 
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5.5.3 Characterization data for aryl hydrazones 
(E)-1-(hex-5-en-2-ylidene)-2-(p-tolyl)hydrazine: Yield = 75% (152 mg); E/Z  1:0.14; 
major diastereomer: 1H NMR (500 MHz, CDCl3) δ = 7.04 (d, J = 8.1, 
2H), 6.97 – 6.92 (m, 2H), 6.78 (s, broad, 1H), 6.01 – 5.78 (m, 1H), 5.10 
(dd, J = 26.6, 16.4, 1H), 4.98 (d, J = 12.1, 1H), 2.45 – 2.30 (m, 4H), 2.27 
(s, 3H), 1.85 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 145.4, 143.7, 138.1, 129.6, 128.7, 
114.8, 113.0, 38.2, 30.8, 20.5, 14.5. Observable resonances for minor diastereomer: 1H 
NMR (500 MHz, CDCl3) δ = 5.12 (dd, J = 17.1, 1.4, 1H), 2.02 (s, 3H). 13C NMR (126 
MHz, CDCl3) δ 137.1, 115.9, 29.1, 28.7, 23.2. MS (ESI) calcd for [C13H18N2H]+:  
203.1548, found: 203.1552. 
(E)-1-(hex-5-en-2-ylidene)-2-(o-tolyl)hydrazine: Yield = 83% (168 mg); E/Z 1:0.18; 
major diastereomer: 1H NMR (500 MHz, CDCl3) δ = 7.46 (d, J = 8.1, 
1H), 7.18 (t, J = 7.7, 1H), 7.06 (d, J = 7.4, 1H), 6.77 (t, J = 7.4, 1H), 
6.7-6.9 (s, broad, 1H), 5.98 – 5.77 (m, 1H), 5.08 (dq, J = 5.9, 1.5, 1H), 
4.99 (ddt, J = 10.2, 1.9, 1.1, 1H), 2.47 – 2.36 (m, 4H), 2.19 (s, 3H), 1.89 (s, 3H). 13C 
NMR (126 MHz, CDCl3) δ 143.5, 138.0, 130.1, 127.2, 120.2, 119.1, 116.2, 114.9, 112.5, 
38.2, 30.7, 16.9, 14.5. Observable resonances for minor diastereomer: 1H NMR (500 
MHz, CDCl3) δ = 7.42 (d, J=8.1, 2H), 5.14 (dd, J=17.1, 1.5, 1H), 2.17 (s, 3H), 2.07 (s, 
3H). 13C NMR (126 MHz, CDCl3) δ 34.7. MS (ESI) calcd for [C13H18N2H]+:  203.1548, 
found: 203.1548. 
(E)-1-(hex-5-en-2-ylidene)-2-(4-methoxyphenyl)hydrazine: Yield = 64% (140 mg); 
E/Z 1:0.18; major diastereomer: 1H NMR (500 MHz, CDCl3) δ = 7.00 (d, J = 8.9, 2H), 
6.83 (d, J = 8.9, 2H), 6.68 (s, broad, 1H), 5.93 – 5.80 (m, 1H), 5.07 (dd, J = 17.1, 1.5, 
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1H), 4.98 (dd, J = 10.2, 0.8, 1H), 3.77 (s, 3H), 2.55 – 2.23 (m, 4H), 1.85 
(s, 3H). 13C NMR (126 MHz, CDCl3) δ 153.5, 145.7, 140.2, 138.1, 124.4, 
114.6, 114.3, 55.7, 38.2, 30.8, 14.5. Observable resonances for minor 
diastereomer: 1H NMR (500 MHz, CDCl3) δ = 5.12 (d, J = 17.2, 1H), 3.88 (s, 3H), 2.02 – 
1.99 (m, 3H). 13C NMR (126 MHz, CDCl3) δ 137.1, 115.9, 55.6, 34.7, 23.1, 19.5. MS 
(ESI) calcd for [C13H18N2OH]
+:  219.1497, found: 219.1503. 
(E)-1-(4-chlorophenyl)-2-(hex-5-en-2-ylidene)hydrazine: Yield = 68% (152 mg); E/Z 
1:0.17; major diastereomer: 1H NMR (500 MHz, CDCl3) δ = 7.18 (d, J = 
8.8, 2H), 6.98 (d, J = 8.8, 2H), 6.87 (s, broad, 1H), 5.88 (ddt, J = 16.4, 
10.2, 6.3, 1H), 5.07 (dd, J = 17.1, 1.5, 1H), 4.98 (d, J = 10.0, 1H), 2.46 – 
2.25 (m, 4H), 1.85 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 146.6, 144.5, 137.9, 129.0, 
124.0, 114.9, 114.0, 38.1, 30.6, 14.6. Observable resonances for minor diastereomer: 1H 
NMR (500 MHz, CDCl3) δ = 5.14 (d, J = 17.2, 1H), 2.04 (s, 3H). 13C NMR (126 MHz, 
CDCl3) δ 136.9, 129.4, 123.8, 116.0, 114.0, 25.2, 15.5. MS (ESI) calcd for 
[C12H15ClN2H]
+:  223.1002, found: 223.1008. 
(E)-1-(hex-5-en-2-ylidene)-2-(4-nitrophenyl)hydrazine: Yield = 65% (151 mg); E/Z 
1:0.13; major diastereomer: 1H NMR (500 MHz, CDCl3) δ = 8.14 (d, J = 
9.3, 2H), 7.44 (s, broad, 1H), 7.05 (d, J = 9.2, 2H), 5.88 (ddt, J = 16.6, 
10.1, 6.4, 1H), 5.09 (dd, J = 17.1, 1.7, 1H), 5.01 (dd, J = 10.2, 1.8, 1H), 
2.54 – 2.19 (m, 4H), 1.92 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 150.3, 149.7, 139.97, 
137.5, 126.1, 115.2, 111.6, 38.2, 30.4, 14.79. 13C NMR (126 MHz, CDCl3) δ 144.6, 
136.5, 129.0, 129.0, 127.6, 123.9, 114.0, 39.8, 39.5, 35.0, 32.7, 28.6, 25.5, 19.8, 19.5, 
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14.7. Observable resonances for minor diastereomer: 1H NMR (500 MHz, CDCl3) δ = 
5.15 (dd, J = 17.1, 1.5, 1H), 2.07 (s, 3H). 
(E)-1-(hex-5-en-2-ylidene)-2-(3-nitrophenyl)hydrazine: Yield = 78 % (182 mg); E/Z 
1:0.19; major diastereomer: 1H NMR (500 MHz, CDCl3) δ = 7.88 (dd, J 
= 4.8, 2.7, 1H), 7.69 – 7.61 (m, 1H), 7.36 – 7.29 (m, 2H), 7.12 (s, broad, 
1H), 5.88 (ddt, J = 16.5, 10.1, 6.3, 1H), 5.09 (dd, J = 17.1, 1.7, 1H), 5.01 
(dd, J = 10.1, 1.6, 1H), 2.48 – 2.32 (m, 4H), 1.90 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 
149.3, 148.1, 146.7, 137.7, 129.7, 118.5, 115.1, 114.0, 107.4, 38.1, 30.6, 14.7. 
Observable resonances for minor diastereomer: 1H NMR (500 MHz, CDCl3) δ = 5.15 
(dd, J = 17.1, 1.4, 1H), 2.06 (s, 3H). MS (ESI) calcd for [C12H15N3O2H]
+:  234.1243, 
found: 234.1246. 
(E)-1-(2,6-dimethylphenyl)-2-(hex-5-en-2-ylidene)hydrazine: Yield = 92 %; E/Z 
1:0.27; major diastereomer: 1H NMR (500 MHz, CDCl3) δ 7.00 (d, J = 
7.5 Hz, 2H), 6.86 (t, J = 7.5 Hz, 1H), 5.90 – 5.80 (m, 1H), 5.04 (dd, J = 
17.1, 1.4 Hz, 1H), 4.96 (dd, J = 10.2, 1.1 Hz, 1H), 2.45 – 2.29 (m, 
10H), 1.91 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 138.2, 129.1, 129.0, 123.0, 114.9, 
87.6, 86.8, 85.16, 38.2, 31.0, 18.9, 14.4. 
Observable resonances for minor diastereomer: 1H NMR (500 MHz, CDCl3) δ 5.96 – 
5.89 (m, 1H), 5.18 – 5.08 (m, 2H), 2.48 – 2.42 (m, 4H). 
(E)-1-phenyl-2-(4-(2,6,6-trimethylcyclohex-1-en-1-yl)butan-2-ylidene)hydrazine 
(3.26): Yield = 72% (204 mg); E/Z 1:0.25; major diastereomer: 1H NMR (500 MHz, 
CDCl3) δ = 7.24 (dd, J = 8.6, 7.4, 2H), 7.06 (dd, J = 8.6, 1.1, 2H), 6.88 (s, broad, 1H), 
6.86 – 6.75 (m, 1H), 2.36 (ddd, J = 7.3, 6.5, 2.9, 2H), 2.31 – 2.25 (m, 2H), 1.94 (dd, J = 
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14.1, 7.7, 2H), 1.89 (s, 3H), 1.64 (s, 3H), 1.62 – 1.53 (m, 2H), 1.47 – 
1.42 (m, 2H), 1.03 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 146.8, 146.0, 
136.6, 129.1, 127.5, 119.5, 112.9, 39.8, 39.5, 35.0, 32.8, 28.6, 25.6, 
19.8, 19.5, 14.6. Observable resonances for minor diastereomer: 1H 
NMR (500 MHz, CDCl3) δ = 7.01 (d, J = 7.5, 2H), 1.70 (s, 3H), 1.05 (s, 6H). 13C NMR 
(126 MHz, CDCl3) δ 136.2, 131.2, 128.5, 122.5, 112.8, 35.6, 30.2, 23.6, 23.2, 21.8, 20.0, 
19.4. MS (ESI) calcd for [C19H28N2H]
+:  285.2331, found: 285.2335. 
(E)-1-(p-tolyl)-2-(4-(2,6,6-trimethylcyclohex-1-en-1-yl)butan-2-ylidene)hydrazine: 
Yield = 76% (227 mg); E/Z 1:0.24; major diastereomer: 1H NMR (500 
MHz, CDCl3) δ = 7.04 (d, J = 8.4, 2H), 6.97 (d, J = 8.4, 2H), 6.78 (s, 
broad, 1H), 2.37 – 2.24 (m, 7H), 1.98 – 1.82 (m, 5H), 1.66 – 1.53 (m, 
5H), 1.48 – 1.38 (m, 2H), 1.03 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 
143.8, 136.7, 129.6, 128.7, 127.5, 113.0, 39.8, 39.5, 35.0, 32.8, 28.6, 25.6, 20.5, 19.8, 
19.5, 14.6. Observable resonances for minor diastereomer: 1H NMR (500 MHz, CDCl3) δ 
= 6.91 (d, J = 8.4, 2H), 2.42 (s, 3H), 2.05 (s, 3H), 1.69 (s, 3H), 1.05 (s, 6H). 13C NMR 
(126 MHz, CDCl3) δ 31.6. MS (ESI) calcd for [C20H30N2H]+:  299.2487, found: 
299.2491. 
(E)-1-(o-tolyl)-2-(4-(2,6,6-trimethylcyclohex-1-en-1-yl)butan-2-ylidene)hydrazine: 
Yield = 85% (254 mg); E/Z 1:0.18; major diastereomer: 1H NMR (500 
MHz, CDCl3) δ = 7.49 (d, J = 8.1, 1H), 7.18 (t, J = 7.4, 1H), 7.06 (d, J 
= 7.2, 1H), 6.76 (t, J = 7.4, 1H), 6.71 (s, broad, 1H), 2.41 – 2.27 (m, 
4H), 2.19 (d, J = 5.3, 3H), 1.97 – 1.84 (m, 5H), 1.65 (s, 3H), 1.59 (ddd, 
J = 9.0, 7.3, 2.5, 2H), 1.48 – 1.40 (m, 2H), 1.04 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 
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147.6, 143.7, 136.6, 130.1, 127.5, 127.2, 120.23, 119.0, 112.5, 39.8, 39.6, 35.0, 32.8, 
28.6, 25.6, 19.8, 19.5, 17.0, 14.5. Observable resonances for minor diastereomer: 1H 
NMR (500 MHz, CDCl3) δ = 7.46 (d, J = 8.0, 1H), 2.08 (s, 3H), 1.71 (s, 3H), 1.06 (s, 
6H). 13C NMR (126 MHz, CDCl3) δ 136.0, 112.4, 39.6, 35.8, 30.3, 28.4, 25.3, 17.2, 15.4. 
MS (ESI) calcd for [C20H30N2H]
+:  299.2487, found: 299.2481. 
(E)-1-(4-methoxyphenyl)-2-(4-(2,6,6-trimethylcyclohex-1-en-1-yl)butan-2-
ylidene)hydrazine: Yield = 57% (180 mg); E/Z 1:0.19; major diastereomer: 1H NMR  
(500 MHz, CDCl3) δ = 7.02 (d, J = 9.0, 2H), 6.83 (d, J = 9.0, 2H), 6.67 
(s, broad, 1H), 3.77 (s, 3H), 2.38 – 2.20 (m, 4H), 1.93 (dd, J = 13.6, 7.0, 
2H), 1.87 (s, 3H), 1.64 (s, 3H), 1.62 – 1.52 (m, 2H), 1.47 – 1.39 (m, 
2H), 1.03 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 153.4, 146.7, 140.4, 
136.7, 127.5, 114.6, 114.2, 55.7, 39.8, 39.5, 35.0, 32.8, 28.6, 25.7, 19.8, 19.5, 14.6. 
Observable resonances for minor diastereomer: 1H NMR (500 MHz, CDCl3) δ = 6.99 (d, 
J = 5.5, 2H), 3.81 (s, 3H), 1.69 (s, 3H), 1.05 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 
124.4, 44.5, 39.7, 28.4, 22.3. MS (ESI) calcd for [C20H30N2OH]
+:  315.2436, found: 
315.2431. 
(E)-1-(4-chlorophenyl)-2-(4-(2,6,6-trimethylcyclohex-1-en-1-yl)butan-2-
ylidene)hydrazine: Yield = 55% (175 mg); E/Z 1:0.25; major diastereomer: 1H NMR  
(500 MHz, CDCl3) δ = 7.21 (d, J = 8.5, 2H), 7.02 (d, J = 8.6, 2H), 6.88 
(s, 1H), 2.41 – 2.22 (m, 4H), 2.01 – 1.85 (m, 5H), 1.68 – 1.54 (m, 5H), 
1.49 – 1.44 (m, 2H), 1.05 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 144.6, 
136.5, 129.0, 129.0, 127.6, 123.9, 114.0, 39.8, 39.5, 35.0, 32.7, 28.6, 
25.5, 19.8, 19.5, 14.7. Observable resonances for minor diastereomer: 1H NMR (500 
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MHz, CDCl3) δ = 6.96 (d, J = 8.2, 2H) δ = 1.71 (s, 3H), 1.10 (s, 6H). 13C NMR (126 
MHz, CDCl3) δ 129.42, 113.90. MS (ESI) calcd for [C19H27ClN2H]+:  319.1941, found: 
319.1937. 
(E)-1-(2,4-dichlorophenyl)-2-(4-(2,6,6-trimethylcyclohex-1-en-1-yl)butan-2-
ylidene)hydrazine: Yield = 53%. E/Z 1:0.17; major diastereomer: 1H NMR (500 MHz, 
CDCl3) δ 7.44 (t, J = 9.5 Hz, 1H), 7.26 – 7.24 (m, 1H), 7.18 – 7.14 (m, 
1H), 2.40 – 2.20 (m, 4H), 1.97 – 1.88 (m, 5H), 1.67 – 1.56 (m, 4H), 
1.45 (dt, J = 6.1, 4.9 Hz, 2H), 1.04 (d, J = 12.6 Hz, 6H), 0.87 (ddd, J = 
11.0, 10.4, 5.8 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 149.8, 140.6, 
136.6, 128.5, 128.1, 127.8, 123.4, 117.5, 115.0, 39.9, 39.6, 35.2, 32.9, 28.7, 25.6, 20.0, 
19.6, 15.0. Observable resonances for minor diastereomer: 1H NMR (500 MHz, CDCl3) δ 
2.06 (d, J = 12.9 Hz, 1H), 1.70 (s, 3H), 1.06 (s, 6H), 0.98 – 0.85 (m, 1H). 13C NMR (126 
MHz, CDCl3) δ 150.9, 135.9, 135.2, 128.8, 114.9, 39.8, 31.7, 30.7, 28.7, 23.6, 23.5, 20.1, 
19.5, 14.2. 
 (E)-1-(4-nitrophenyl)-2-(4-(2,6,6-trimethylcyclohex-1-en-1-yl)butan-2-
ylidene)hydrazine: Yield = 79%. E/Z 1:0.24; major diastereomer: 1H 
NMR (500 MHz, CDCL3) δ 8.16 (d, J = 9.1 Hz, 2H), 7.07 (d, J = 9.0 
Hz, 2H), 2.45 – 2.21 (m, 3H), 2.01 – 1.89 (m, 5H), 1.71 – 1.36 (m, 
7H), 1.17 – 0.83 (m, 7H). 13C NMR (126 MHz, CDCl3) δ 150.80, 
150.49, 139.87, 136.27, 127.92, 126.21, 126.17, 111.65, 39.81, 39.59, 35.07, 32.80, 
28.63, 28.43, 25.39, 19.88, 19.50, 14.89. Observable resonances for minor diastereomer: 
1H NMR (500 MHz, CDCl3) δ 2.52 – 2.47 (m, 2H), 1.70 (s, 2H), 1.05 (s, 6H). 13C NMR 
(126 MHz, CDCl3) δ 135.97, 111.43, 44.54, 29.80, 22.30, 19.72.  
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(E)-1-(3-nitrophenyl)-2-(4-(2,6,6-trimethylcyclohex-1-en-1-yl)butan-2-
ylidene)hydrazine: Yield = 73%. E/Z 1:0.19; major diastereomer: 1H 
NMR (500 MHz, CDCL3) δ 7.84 (d, J = 16.1 Hz, 1H), 7.65 (d, J = 4.6 
Hz, 1H), 7.34 (dd, J = 10.8, 6.5 Hz, 2H), 2.44 – 2.36 (m, 2H), 2.31 – 
2.21 (m, 2H), 1.94 (dd, J = 31.5, 21.4 Hz, 6H), 1.67 (d, J = 17.3 Hz, 
2H), 1.59 (dd, J = 12.5, 6.5 Hz, 2H), 1.48 – 1.39 (m, 2H), 1.04 (s, 6H). 13C NMR (126 
MHz, CDCl3) δ 149.2, 146.8, 136.4, 129.7, 127.8, 118.5, 113.9, 107.4, 39.8, 39.5, 35.0, 
32.8, 28.6, 25.5, 19.9, 19.5, 14.8. Observable resonances for minor diastereomer: 1H 
NMR (500 MHz, CDCl3) δ 1.70 (s, 3H), 1.05 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 
39.6, 35.1, 30.4, 23.1, 8.4. 
(E)-1-(2,4,6-trichlorophenyl)-2-(4-(2,6,6-trimethylcyclohex-1-en-1-yl)butan-2-
ylidene)hydrazine (3.32): Yield = 68%. E/Z 1:0.22; major diastereomer: 1H NMR (500 
MHz, CDCl3) δ 7.28 (t, J = 9.1 Hz, 2H), 2.37 – 2.30 (m, 2H), 2.26 
(dt, J = 8.2, 5.8 Hz, 2H), 1.97 (s, 3H), 1.65 – 1.53 (m, 4H), 1.48 – 
1.38 (m, 2H), 1.35 – 1.21 (m, 3H), 1.01 (s, 6H). 13C NMR (126 
MHz, CDCl3) δ 153.9, 139.3, 136.6, 128.8, 127.8, 127.2, 126.6, 
39.9, 39.4, 35.1, 32.9, 28.7, 25.5, 22.4, 20.0, 19.6, 15.2, 14.2. Observable resonances for 
minor diastereomer: 1H NMR (500 MHz, CDCl3) δ 2.44 – 2.38 (m, 2H), 1.70 (s, 3H), 
1.48 – 1.44 (m, 2H), 1.06 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 39.8, 34.2, 31.1, 23.7, 
23.1, 20.1, 19.5. 
(E)-1-(hex-5-en-2-ylidene)-2-(2,4,6-trichlorophenyl)hydrazine (3.30): Yield = 81%. 
E/Z 1:0.17; major diastereomer: 1H NMR (500 MHz, CDCl3) δ 7.30 (d, J = 1.7 Hz, 2H), 
5.86 (ddt, J = 16.5, 10.1, 6.4 Hz, 1H), 5.10 – 4.92 (m, 2H), 2.45 – 2.29 (m, 4H), 1.95 (s, 
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3H). 13C NMR (126 MHz, CDCl3) δ 152.9, 139.1, 137.7, 128.7, 
128.6, 126.9, 115.0, 38.0, 30.6, 15.0. Observable resonances for 
minor diastereomer: 1H NMR (500 MHz, CDCl3) δ 5.17 – 5.09 (m, 
2H), 2.48 (d, J = 8.1 Hz, 2H), 2.01 (d, J = 0.6 Hz, 3H). 13C NMR (126 
MHz, CDCl3) δ 136.7, 116.2, 29.5, 29.1, 22.9. 
(E)-1-(2,4-dichlorophenyl)-2-(hex-5-en-2-ylidene)hydrazine (3.36a): Yield = 31%; 
E/Z 1:0.13; major diastereomer: 1H NMR (500 MHz, CDCl3) δ = 7.43 
(d, J = 8.8, 1H), 7.33 (s, broad, 1H), 7.25 (d, J = 2.3, 1H), 7.18 – 7.13 
(m, 1H), 5.88 (ddt, J = 16.4, 10.2, 6.3, 1H), 5.08 (ddd, J = 17.1, 3.3, 
1.6, 1H), 4.99 (ddd, J = 10.2, 3.0, 1.2, 1H), 2.45 – 2.40 (m, 2H), 2.40 – 2.34 (m, 2H), 
1.90 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 148.7, 140.4, 137.7, 128.4, 127.9, 123.3, 
117.3, 115.0, 114.8, 38.1, 30.5, 14.7. Observable resonances for minor diastereomer: 1H 
NMR (500 MHz, CDCl3) δ = 5.14 (dd, J = 17.1, 1.5, 1H), 2.04 (s, 3H). MS (ESI) calcd 
for [C12H14Cl2N2H]
+:  257.0612, found: 257.0616. 
 (E)-1-(2,4-dinitrophenyl)-2-(hex-5-en-2-ylidene)hydrazine (3.37a): Yield = 40%; 1H 
NMR (500 MHz, CDCl3) δ 9.21 – 9.02 (m, 1H), 8.30 (ddd, J = 9.6, 
4.8, 2.6 Hz, 1H), 7.96 (dd, J = 9.6, 2.7 Hz, 1H), 5.87 (ddd, J = 17.0, 
10.2, 6.9 Hz, 1H), 5.22 – 4.97 (m, 2H), 2.53 (ddd, J = 14.8, 8.4, 6.5 
Hz, 2H), 2.48 – 2.33 (m, 2H), 2.11 (d, J = 42.1 Hz, 3H). 
(E )-1-(hex-5-en-2-ylidene)-2-phenylhydrazine: Yield = 71% (133 mg); E/Z 1:0.14;  
major diastereomer: 1H NMR (500 MHz, CDCl3) δ = 7.26 – 7.20 (m, 
2H), 7.04 (dt, J=3.2, 1.7, 2H), 6.87 (s, broad, 1H), 6.84 – 6.79 (m, 1H), 
6.05 – 5.77 (m, 1H), 5.07 (d, J=17.1, 1H), 4.98 (d, J=10.2, 1H), 2.46 – 
 164 
2.25 (m, 4H), 1.85 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 145.9, 138.0, 129.1, 119.6, 
114.8, 112.9, 112.9, 38.2, 30.7, 14.5. Observable resonances for minor diastereomer: 1H 
NMR (500 MHz, CDCl3) δ = 5.13 (dd, J = 17.1, 1.3, 1H), 2.03 (s, 3H). 13C NMR (126 
MHz, CDCl3) δ 122.5, 115.9, 29.1, 23.2. 
5.5.4 Preparation and characterization data of -chloroazo compounds 
(E)-1-(2-chlorohex-5-en-2-yl)-2-(p-tolyl)diazene: The title -chloroazo compound was 
prepared in 94% yield (206 mg) as described in the experimental 
procedure 5.5.1 using the corresponding hydrazone (1 equiv, 188 mg, 
0.93 mmol), oxalyl chloride (2.0 equiv, 0.16 mL, 1.86 mmol), DMSO 
(2.5 equiv, 0.17 mL, 2.33 mmol), and TEA (2.5 equiv, 0.32 mL, 2.33 mmol). 1H NMR 
(500 MHz, CDCl3) δ = 7.68 (d, J = 8.3, 2H), 7.27 (d, J = 8.0, 2H), 5.86 – 5.75 (m, 1H), 
5.04 (dd, J = 17.1, 1.7, 1H), 4.97 (dd, J = 10.2, 1.7, 1H), 2.42 (s, 3H), 2.38 (d, J = 12.9, 
1H), 2.35 – 2.22 (m, 2H), 2.20 – 2.09 (m, 1H), 1.90 (s, 3H). 13C NMR (126 MHz, CDCl3) 
δ 149.0, 141.9, 137.4, 129.6, 122.9, 115.0, 96.1, 42.0, 28.8, 28.5, 21.4. 
(E)-1-(2-chlorohex-5-en-2-yl)-2-(o-tolyl)diazene: The title -chloroazo compound was 
prepared in 95% yield (169 mg) as described in the experimental 
procedure 5.5.1 using the corresponding hydrazone (1 equiv, 152 mg, 
0.75 mmol), oxalyl chloride (2.0 equiv, 0.13 mL, 1.5 mmol), DMSO 
(2.5 equiv, 0.13 mL, 1.87 mmol), and TEA (2.5 equiv, 0.26 mL, 1.87 mmol). 1H NMR 
(500 MHz, CDCl3) δ = 7.40 – 7.27 (m, 3H), 7.22 (t, J = 7.4, 1H), 5.82 (ddt, J = 16.5, 
10.2, 6.2, 1H), 5.01 (dd, J = 34.8, 13.7, 2H), 2.64 (s, 3H), 2.48 – 2.03 (m, 4H), 1.91 (s, 
3H). 13C NMR (126 MHz, CDCl3) δ 149.2, 137.6, 137.4, 131.2, 131.0, 126.3, 116.2, 
115.1, 96.7, 41.9, 28.8, 28.5, 17.2. 
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(E)-1-(2-chlorohex-5-en-2-yl)-2-(4-methoxyphenyl)diazene: The title -chloroazo 
compound was prepared in 95% yield (134 mg) as described in the 
experimental procedure 5.5.2 using the corresponding hydrazone (1 
equiv, 122 mg, 0.56 mmol), oxalyl chloride (2.0 equiv, 0.10 mL, 1.12 
mmol), DMSO (2.5 equiv, 0.10 mL, 1.4 mmol), and TEA (2.5 equiv, 0.20 mL, 1.4 
mmol).  1H NMR (500 MHz, CDCl3) δ = 7.78 (d, J = 9.0, 2H), 6.97 (d, J = 9.0, 2H), 5.88 
– 5.70 (m, 1H), 5.04 (dd, J = 17.1, 1.6, 1H), 4.97 (d, J = 10.1, 1H), 3.87 (s, 3H), 2.43 – 
2.09 (m, 4H), 1.90 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 162.2, 145.1, 137.5, 124.9, 
115.0, 114.12, 96.0, 55.5, 42.1, 28.9, 28.6. 
 (E)-1-(2-chlorohex-5-en-2-yl)-2-(2,6-dimethylphenyl)diazene: Yield = 93%. 1H NMR 
(500 MHz, CDCl3) δ 7.13 (dd, J = 8.6, 6.2 Hz, 1H), 7.09 – 7.05 (m, 
2H), 5.89 – 5.77 (m, 1H), 5.11 – 4.97 (m, 2H), 2.43 – 2.27 (m, 4H), 
2.24 (s, 6H), 1.94 (s, 3H).  
(E)-1-(2-chloro-4-(2,6,6-trimethylcyclohex-1-en-1-yl)butan-2-yl)-2-phenyldiazene  
(3.27): The title -chloroazo compound (3.27) was prepared in 95% 
yield (209 mg) as described in the experimental procedure 5.5.2 using 
the corresponding hydrazone (1 equiv, 196 mg, 0.69 mmol), oxalyl 
chloride (2.0 equiv, 0.12 mL, 1.38 mmol), DMSO (2.5 equiv, 0.12 mL, 
1.72 mmol), and TEA (2.5 equiv, 0.24 mL, 0.17 mmol). 1H NMR (500 MHz, CDCl3) δ = 
7.84 – 7.72 (m, 2H), 7.59 – 7.37 (m, 3H), 2.42 – 2.30 (m, 1H), 2.24 (ddd, J = 12.6, 7.7, 
3.7, 2H), 2.04 (d, J = 4.1, 1H), 1.94 – 1.84 (m, 5H), 1.61 – 1.51 (m, 5H), 1.44 – 1.36 (m, 
2H), 0.99 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 151.0, 135.7, 131.2, 129.0, 128.1, 
122.8, 96.9, 42.7, 39.7, 35.1, 32.7, 28.7, 28.6, 28.5, 23.1, 19.8, 19.4. 
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5.5.5 Representative experimental procedures to prepare of α-trifluoroacetoxyazo 
compounds 
a. At low temperature (-78 °C) 
The -trifluoroacetoxyazo prepared in this section were prepared with the same 
method used to prepare the -trifluoroacetoxyazo in the section 5.4.5. 
b. At high temperature (0 °C) 
TFAA (1.1 or 1.2 equiv) was added dropwise to a 0 °C solution of hydrazone (1.0 
equiv), DMSO (1.2 equiv), TEA (1.15 equiv), and hexane under a nitrogen atmosphere. 
The mixture was stirred for 5 min at 0 °C and for 15 min at room temperature at which 
point it was filtered through a plug of basic alumina to remove triethylammonium salt. 
The hexane was removed in vacuo to provide the α-trifluoroacetoxyazo product as a 
yellow oil.  
5.5.6 Preparation and characterization data of -trifluoroacetoxyazo compounds 
(E)-2-(phenyldiazenyl)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)butan-2-yl 2,2,2-
trifluoroacetate (3.31): The title -trifluoroacetoxyazo 3.31 was 
prepared in 87% (595 mg) yield as described in representative 
experimental procedure 5.5.5 (a) using hydrazone 3.26 (1 equiv, 490 
mg, 1.72 mmol), TFAA (1.1 equiv, 0.27 mL, 1.89 mmol), DMSO (1.2 
equiv, 0.15 mL, 2.06 mmol), and TEA (1.15 equiv, 0.28 mL, 1.98 mmol). Alternatively, 
the title -trifluoroacetoxyazo 3.31 was prepared in 82% yield (267 mg) as described in 
the representative experimental procedure 5.5.5 (b) using hydrazone 3.26 (1 equiv, 233 
mg, 0.82 mmol), TFAA (1.2 equiv, 0.14 mL, 0.98 mmol), DMSO (1.2 equiv, 0.07mL, 
0.98 mmol), and TEA (1.2 equiv, 0.13 mL, 0.94 mmol). 1H NMR (500 MHz, CDCl3) δ = 
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7.74 – 7.64 (m, 2H), 7.52 – 7.45 (m, 3H), 2.29 – 1.97 (m, 4H), 1.94 – 1.86 (m, 5H), 1.60 
– 1.49 (m, 5H), 1.42 – 1.37 (m, 2H), 0.96 (d, J = 2.6, 6H). 13C NMR (126 MHz, CDCl3) δ 
150.7, 135.4, 131.5, 129.1, 128.3, 122.8, 107.6, 39.7, 38.6, 35.0, 32.7, 28.5, 28.4, 21.7, 
21.4, 19.6, 19.4. 
(E)-2-(p-tolyldiazenyl)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)butan-2-yl 2,2,2-
trifluoroacetate: The title -trifluoroacetoxyazo was prepared in 76% 
yield (204 mg) as described in representative experimental procedure 
5.5.5 (a) using hydrazone (1 equiv, 193 mg, 0.65 mmol), TFAA (1.1 
equiv, 0.10 mL, 0.71 mmol), DMSO (1.2 equiv, 0.06 mL, 0.78 mmol), 
and TEA (1.15 equiv, 0.10 mL, 0.75 mmol). 1H NMR (500 MHz, CDCl3) δ = 7.61 (d, J = 
8.3, 2H), 7.26 (d, J = 8.0, 2H), 2.41 (s, 3H), 2.29 – 2.15 (m, 1H), 2.15 – 2.08 (m, 2H), 
2.07 – 1.96 (m, 1H), 1.90 (s, 3H), 1.92 – 1.83 (m, 2H), 1.55 (s, 3H), 1.58 – 1.51 (m, 2H), 
1.43 – 1.37 (m, 2H), 0.99 – 0.94 (m, 6H). 13C NMR (126 MHz, CDCl3) δ 148.8, 142.0, 
135.5, 129.6, 128.3, 122.8, 107.5, 39.7, 38.7, 35.0, 32.7, 28.5, 28.4, 28.4, 21.7, 21.4, 19.6, 
19.4. 
(E)-2-(o-tolyldiazenyl)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)butan-2-yl 2,2,2-
trifluoroacetate: The title -trifluoroacetoxyazo was prepared in 
83% yield (344 mg) as described in representative experimental 
procedure 5.5.5 (a) using hydrazone (1 equiv, 303 mg, 1.01 mmol), 
TFAA (1.1 equiv, 0.16 mL, 1.12 mmol), DMSO (1.2 equiv, 0.09 
mL, 1.21 mmol), and TEA (1.15 equiv, 0.16 mL, 1.2 mmol). 1H NMR (500 MHz, 
CDCl3) δ = 7.35 (dd, J = 11.6, 7.6, 2H), 7.30 (d, J = 7.4, 1H), 7.22 (t, J = 7.6, 1H), 2.55 
(s, 3H), 2.28 – 2.17 (m, 1H), 2.17 – 2.11 (m, 2H), 2.04 – 1.94 (m, 4H), 1.92 – 1.85 (m, 
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2H), 1.59 – 1.54 (m, 5H), 1.43 – 1.36 (m, 2H), 0.97 (d, J = 3.5, 6H). 13C NMR (126 
MHz, CDCl3) δ 149.0, 137.6, 135.4, 131.3, 131.2, 128.3, 126.4, 115.9, 107.4, 39.7, 38.8, 
35.0, 32.7, 28.5, 28.4, 28.4, 21.96, 21.3, 19.6, 19.4, 17.2. 
(E)-2-((4-methoxyphenyl)diazenyl)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)butan-2-yl 
2,2,2-trifluoroacetate: The title -trifluoroacetoxyazo was prepared in 76% yield (287 
mg) as described in representative experimental procedure 5.5.5 (a) 
using hydrazone (1 equiv, 281 mg, 0.89 mmol), TFAA (1.2 equiv, 
0.15 mL, 1.07 mmol), DMSO (1.2 equiv, 0.08 mL, 1.07 mmol), and 
TEA (1.15 equiv, 0.14 mL, 1.02 mmol). Alternatively, the title -
trifluoroacetoxyazo was prepared in 57% yield (360 mg) as described in representative 
experimental procedure 5.5.5 (b) using hydrazone (1 equiv, 465 mg, 1.48 mmol), TFAA 
(1.2 equiv, 0.31 mL, 2.2 mmol), DMSO (1.2 equiv, 0.16 mL, 2.2 mmol), and TEA (1.15 
equiv, 0.24 mL, 1.7 mmol). 1H NMR (500 MHz, CDCl3) δ = 7.71 (d, J = 9.1, 2H), 6.95 
(d, J = 9.0, 2H), 3.87 (s, 3H), 2.31 – 2.17 (m, 1H), 2.17 – 2.07 (m, 2H), 2.07 – 1.96 (m, 
1H), 1.97 – 1.83 (m, 5H), 1.63 – 1.49 (m, 5H), 1.44 – 1.35 (m, 2H), 0.96 (d, J = 2.3, 6H). 
13C NMR (126 MHz, CDCl3) δ 162.3, 144.93, 135.5, 128.26, 124.7, 114.1, 107.4, 55.58, 
39.7, 38.7, 35.0, 32.7, 28.5, 28.4, 21.8, 21.4, 19.6, 19.4. 
(E)-2-((4-chlorophenyl)diazenyl)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)butan-2-yl 
2,2,2-trifluoroacetate: The title -trifluoroacetoxyazo was prepared in 
86% yield (422 mg) as described in representative experimental 
procedure 5.5.5 (a) using hydrazone (1 equiv, 363 mg, 1.14 mmol), 
TFAA (1.1 equiv, 0.18 mL, 1.25 mmol), DMSO (1.2 equiv, 0.10 mL, 
1.37 mmol), and TEA (1.15 equiv, 0.18 mL, 1.13 mmol). 1H NMR (500 MHz, CDCl3) δ 
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= 7.66 (d, J = 8.8, 2H), 7.45 (d, J = 8.8, 2H), 2.29 – 2.17 (m, 1H), 2.16 – 2.07 (m, 2H), 
2.07 – 1.95 (m, 1H), 1.92 – 1.85 (m, 5H), 1.60 – 1.49 (m, 5H), 1.45 – 1.35 (m, 2H), 0.96 
(d, J = 3.1, 6H). 13C NMR (126 MHz, CDCl3) δ 149.03, 137.61, 135.34, 129.38, 128.44, 
124.12, 107.52, 39.68, 38.65, 34.99, 32.75, 28.52, 28.45, 21.68, 21.39, 19.61, 19.41. 
(E)-2-((2,4-dichlorophenyl)diazenyl)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)butan-2-yl 
2,2,2-trifluoroacetate: Yield = 90%. 1H NMR (500 MHz, CDCl3) δ 
7.55 (d, J = 2.1 Hz, 1H), 7.39 (d, J = 8.7 Hz, 1H), 7.29 (d, J = 2.2 Hz, 
1H), 2.30 – 2.18 (m, 1H), 2.13 (ddd, J = 10.3, 7.0, 4.8 Hz, 2H), 1.94 (s, 
3H), 1.90 (dt, J = 8.6, 6.5 Hz, 2H), 1.58 – 1.54 (m, 4H), 1.44 – 1.37 (m, 
2H), 1.32 – 1.24 (m, 2H), 0.99 – 0.94 (m, 6H). 13C NMR (126 MHz, CDCl3) δ 145.6, 
137.8, 135.8, 135.3, 130.4, 128.5, 127.7, 118.8, 107.7, 39.7, 38.7, 35.0, 32.7, 31.6, 28.5, 
28.4, 22.6, 21.8, 21.3, 19.6, 14.1. 
(E)-2-((4-nitrophenyl)diazenyl)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)butan-2-yl 
2,2,2-trifluoroacetate: Yield = 81%. 1H NMR (500 MHz, CDCl3) δ 
8.56 – 8.13 (m, 2H), 8.13 – 7.54 (m, 2H), 2.25 (ddd, J = 17.1, 13.3, 12.7 
Hz, 1H), 2.14 (ddd, J = 12.8, 12.0, 5.0 Hz, 1H), 2.06 – 1.95 (m, 1H), 
1.95 (s, 3H), 1.88 (dd, J = 12.6, 6.3 Hz, 1H), 1.60 – 1.52 (m, 4H), 1.45 – 
1.35 (m, 2H), 1.34 – 1.20 (m, 2H), 1.00 – 0.94 (m, 6H), 0.91 – 0.83 (m, 1H). 13C NMR 
(126 MHz, CDCl3) δ 153.8, 149.2, 135.1, 128.6, 124.7, 123.4, 107.7, 39.6, 38.5, 35.0, 
32.7, 31.6, 28.5, 22.6, 21.6, 21.4, 19.6, 19.3, 14.1. 
(E)-2-((3-nitrophenyl)diazenyl)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)butan-2-yl 
2,2,2-trifluoroacetate: Yield = 95%. 1H NMR (500 MHz, CDCl3) δ 8.54 (t, J = 2.0 Hz, 
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1H), 8.35 (ddd, J = 8.2, 2.3, 1.1 Hz, 1H), 8.06 (ddd, J = 7.9, 1.8, 1.1 Hz, 
1H), 7.69 (t, J = 8.1 Hz, 1H), 2.13 (ddd, J = 18.3, 8.8, 5.5 Hz, 1H), 2.08 
– 1.98 (m, 1H), 1.95 (s, 3H), 1.90 (dd, J = 10.3, 4.1 Hz, 2H), 1.59 – 
1.51 (m, 5H), 1.41 (dt, J = 5.8, 3.2 Hz, 2H), 1.33 – 1.25 (m, 2H), 0.96 
(dd, J = 6.4, 2.8 Hz, 6H). 13C NMR (126 MHz, CDCl3) δ 151.0, 148.9, 135.1, 130.1, 
128.9, 128.6, 125.7, 117.3, 107.5, 39.6, 38.5, 35.0, 32.7, 31.6, 28.5, 22.6, 21.6, 21.4, 19.6, 
19.4, 14.1. 
(E)-2-((2,4,6-trichlorophenyl)diazenyl)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)butan-2- 
yl 2,2,2-trifluoroacetate (3.33): Yield = 95%. 1H NMR (500 MHz, 
CDCl3) δ 7.40 (s, 2H), 2.30 – 2.20 (m, 1H), 2.19 – 2.10 (m, 1H), 
2.00 (s, 3H), 1.91 (t, J = 6.2 Hz, 2H), 1.61 – 1.52 (m, 6H), 1.46 – 
1.38 (m, 2H), 1.02 – 0.93 (m, 7H). 13C NMR (126 MHz, CDCl3) δ 
145.1, 135.3, 134.2, 129.2, 128.8, 127.6, 108.2, 77.1, 39.8, 38.4, 35.2, 32.9, 28.7, 28.6, 
28.6, 22.1, 21.6, 19.7, 19.5. 
(E)-2-((2,6-dimethylphenyl)diazenyl)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)butan-2- 
yl 2,2,2-trifluoroacetate (3.35): Yield = 84%. 1H NMR (500 MHz, 
CDCL3) δ 7.00 (d, J = 7.5 Hz, 2H), 6.84 (t, J = 7.5 Hz, 1H), 2.36 – 
2.28 (m, 8H), 2.24 (dd, J = 16.1, 6.6 Hz, 2H), 1.92 (d, J = 8.9 Hz, 
5H), 1.62 – 1.52 (m, 5H), 1.50 – 1.38 (m, 2H), 0.99 (d, J = 13.0 Hz, 6H). 
(E)-2-(p-tolyldiazenyl)hex-5-en-2-yl 2,2,2-trifluoroacetate : The title -
trifluoroacetoxyazo was prepared in 69% yield (340 mg) as described in 
representative experimental procedure 5.5.5 (a) using hydrazone (1 
equiv, 318 mg, 1.58 mmol), TFAA (1.1 equiv, 0.24 mL, 1.73 mmol), 
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DMSO (1.2 equiv, 0.13 mL, 1.88 mmol), and TEA (1.15 equiv, 0.25 mL, 1.81 mmol). 1H 
NMR (500 MHz, CDCl3) δ = 7.61 (d, J = 8.3, 2H), 7.26 (d, J = 6.7, 2H), 5.85 – 5.72 (m, 
1H), 5.04 (dd, J = 17.1, 1.5, 1H), 4.98 (dd, J = 10.2, 1.5, 1H), 2.41 (s, 3H), 2.36 – 2.04 
(m, 4H), 1.88 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 148.6, 142.2, 137.0, 129.7, 122.8, 
115.3, 107.0, 37.6, 27.0, 22.09, 21.4. 
(E)-2-(o-tolyldiazenyl)hex-5-en-2-yl 2,2,2-trifluoroacetate: The title -
trifluoroacetoxyazo was prepared in 65% yield (137 mg) as described 
in representative experimental procedure 5.5.5 (a) using hydrazone (1 
equiv, 136 mg, 0.67 mmol), TFAA (1.1 equiv, 0.10 mL, 0.74 mmol), 
DMSO (1.2 equiv, 0.06 mL, 0.80 mmol), and TEA (1.15 equiv, 0.10 mL, 0.77 mmol). 
Alternatively, the title -trifluoroacetoxyazo was prepared in 62% yield (180 mg) as 
described in representative experimental procedure 5.5.5 (b) using hydrazone (1 equiv, 
186 mg, 0.92 mmol), TFAA (1.1 equiv, 0.14 mL, 1.01 mmol), DMSO (1.2 equiv, 0.08 
mL, 1.10 mmol), and TEA (1.15 equiv, 0.15 mL, 1.06 mmol). 1H NMR (500 MHz, 
CDCl3) δ = 7.36 (t, J = 7.7, 2H), 7.30 (d, J = 7.4, 1H), 7.22 (t, J = 7.6, 1H), 5.79 (dd, J = 
17.1, 10.2, 1H), 5.05 (dd, J = 17.1, 1.6, 1H), 4.99 (dd, J = 10.3, 1.6, 1H), 2.54 (s, 3H), 
2.34 – 2.03 (m, 4H), 1.93 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 148.9, 137.7, 136.9, 
131.4, 131.3, 126.4, 116.0, 115.4, 107.0, 37.6, 26.9, 22.2, 17.2. 
(E)-2-((4-methoxyphenyl)diazenyl)hex-5-en-2-yl 2,2,2-trifluoroacetate: The title -
trifluoroacetoxyazo was prepared in 74% yield (143 mg) as described in 
representative experimental procedure 5.5.5 (a) using hydrazone (1 equiv, 
130 mg, 0.59 mmol), TFAA (1.1 equiv, 0.09 mL, 0.66 mmol), DMSO 
(1.2 equiv, 0.05 mL, 0.72 mmol), and TEA (1.15 equiv, 0.10 mL, 0.09 mmol). 1H NMR 
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(500 MHz, CDCl3) δ = 7.71 (d, J = 9.1, 2H), 6.96 (d, J = 9.1, 2H), 5.85 – 5.72 (m, 1H), 
5.04 (dd, J = 17.1, 1.6, 1H), 4.98 (dd, J = 10.2, 1.6, 1H), 3.87 (s, 3H), 2.35 – 2.02 (m, 
4H), 1.87 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 162.45, 144.81, 137.10, 124.85, 
115.33, 114.14, 106.96, 55.61, 37.68, 27.07, 22.14. 
(E)-2-((4-nitrophenyl)diazenyl)hex-5-en-2-yl 2,2,2-trifluoroacetate: The title -
rifluoroacetoxyazo was prepared in 82% yield (298 mg) as described in 
representative experimental procedure 5.5.5 (a) using hydrazone (1 
equiv, 244 mg, 1.05 mmol), TFAA (1.1 equiv, 0.16 mL, 1.15 mmol), 
DMSO (1.2 equiv, 0.09 mL, 1.26 mmol), and TEA (1.15 equiv, 0.17 
mL, 1.21 mmol). 1H NMR (500 MHz, CDCl3) δ = 8.35 (d, J = 9.0, 2H), 7.83 (d, J = 9.1, 
2H), 5.78 (dd, J = 17.1, 10.2, 1H), 5.03 (ddd, J = 13.7, 11.7, 1.5, 2H), 2.33 – 2.08 (m, 
4H), 1.92 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 153.6, 149.3, 136.5, 124.7, 123.5, 
115.7, 107.2, 37.4, 26.9, 21.9. 
(E)-2-((3-nitrophenyl)diazenyl)hex-5-en-2-yl 2,2,2-trifluoroacetate: The title -
trifluoroacetoxyazo was prepared in 88% yield (207 mg) as described in 
representative experimental procedure 5.5.5 (a) using hydrazone (1 
equiv, 159 mg, 0.68 mmol), TFAA (1.1 equiv, 0.11 mL, 0.75 mmol), 
DMSO (1.2 equiv, 0.06 mL, 0.82 mmol), and TEA (1.15 equiv, 0.11 mL, 0.78 mmol). 
Alternatively, the title -trifluoroacetoxyazo was prepared in 79% yield (209 mg) as 
described in representative experimental procedure 5.5.5 (b)using hydrazone (1 equiv, 
180 mg, 0.77 mmol), TFAA (1.2 equiv, 0.13 mL, 0.92 mmol), DMSO (1.2 equiv, 0.07 
mL, 0.92 mmol), and TEA (1.15 equiv, 0.89 mL, 0.12 mmol). 1H NMR (500 MHz, 
CDCl3) δ = 8.53 (t, J=2.0, 1H), 8.36 (ddd, J=8.2, 2.3, 1.1, 1H), 8.06 (ddd, J=7.9, 1.9, 1.1, 
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1H), 7.69 (t, J = 8.1, 1H), 5.78 (ddt, J=16.5, 10.2, 6.3, 1H), 5.03 (ddq, J = 21.4, 10.1, 1.3, 
2H), 2.39 – 2.04 (m, 4H), 1.94 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 150.9, 148.9, 
136.5, 130.1, 129.1, 125.8, 117.3, 115.7, 107.0, 37.5, 26.9, 22.0. 
(E)-2-((4-chlorophenyl)diazenyl)hex-5-en-2-yl 2,2,2-trifluoroacetate: The title -
trifluoroacetoxyazo was prepared in 80% yield (428 mg) as described in 
representative experimental procedure 5.5.5 (a) using hydrazone (1 
equiv, 353 mg, 1.59 mmol), TFAA (1.1 equiv, 0.25 mL, 1.75 mmol), 
DMSO (1.2 equiv, 0.14 mL, 1.91 mmol), and TEA (1.15 equiv, 0.25 
mL, 1.83 mmol). 1H NMR (500 MHz, CDCl3) δ = 7.66 (d, J = 8.8, 2H), 7.45 (d, J = 8.8, 
2H), 5.77 (ddt, J = 13.4, 10.2, 6.2, 1H), 5.04 (dd, J = 17.1, 1.6, 1H), 4.99 (dd, J = 10.2, 
1.5, 1H), 2.33 – 2.03 (m, 4H), 1.89 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 148.9, 137.7, 
136.8, 129.3, 124.1, 115.5, 107.0, 37.5, 27.0, 22.0.  
(E)-2-(phenyldiazenyl)hex-5-en-2-yl 2,2,2-trifluoroacetate: The title -
trifluoroacetoxyazo was prepared in 80% yield (171 mg) as described in 
representative experimental procedure 5.5.5 (a) using hydrazone (1 
equiv, 336 mg, 0.71 mmol), TFAA (1.1 equiv, 0.11 mL, 0.78 mmol), 
DMSO (1.2 equiv, 0.06 mL, 0.85 mmol), and TEA (1.15 equiv, 0.11 mL, 0.82 mmol). 
Alternatively, the title -trifluoroacetoxyazo was prepared in 87% yield (391 mg) as 
described in representative experimental procedure 5.5.5 (a) using hydrazone (1 equiv, 
281 mg, 1.5 mmol), TFAA (1.1 equiv, 0.23 mL, 1.65 mmol), DMSO (1.2 equiv, 0.13 mL, 
1.65 mmol), and TEA (1.15 equiv, 0.24 mL, 1.71 mmol). 1H NMR (500 MHz, CDCL3) δ 
= 7.73 – 7.66 (m, 2H), 7.50 – 7.43 (m, 3H), 5.90 – 5.62 (m, 1H), 5.11 – 4.90 (m, 2H), 
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2.31 – 2.02 (m, 4H), 1.90 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 150.6, 136.9, 131.6, 
129.1, 122.8, 115.4, 107.0, 37.58, 2.02, 22.0. 
(E)-2-((2,4,6-trichlorophenyl)diazenyl)hex-5-en-2-yl 2,2,2-
trifluoroacetate (3.30b): Yield = 83%. 1H NMR (500 MHz, CDCl3) 
δ 7.30 (s, 1H), 7.26 (s, 1H), 5.94 – 5.74 (m, 1H), 5.18 – 4.81 (m, 2H), 
2.43 – 2.17 (m, 4H), 1.96 (d, J = 6.0 Hz, 3H).  
(E)-2-((2,4-dichlorophenyl)diazenyl)hex-5-en-2-yl 2,2,2-trifluoroacetate (3.36b): The 
title -trifluoroacetoxyazo 3.36b was prepared in 80% yield (186 mg) 
as described in representative experimental procedure 5.5.5 (a) using 
hydrazone (1 equiv, 161 mg, 0.63 mmol), TFAA (1.1 equiv, 0.10 mL, 
0.69 mmol), DMSO (1.2 equiv, 0.06 mL, 0.76 mmol), and TEA (1.15 
equiv, 0.10 mL, 0.72 mmol). 1H NMR (500 MHz, CDCl3) δ = 7.55 (d, J = 2.1, 1H), 7.39 
(d, J = 8.6, 1H), 7.28 (dd, J = 8.7, 2.2, 1H), 5.78 (ddt, J = 16.4, 10.2, 6.3, 1H), 5.05 (dd, J 
= 17.1, 1.6, 1H), 5.00 (dd, J = 10.3, 1.5, 1H), 2.46 – 2.05 (m, 4H), 1.91 (s, 3H). 13C NMR 
(126 MHz, CDCl3) δ 145.4, 137.9, 136.7, 135.9, 130.4, 127.7, 118.8, 115.6, 107.2, 37.5, 
26.9, 22.1. 
(E)-2-((2,4-dinitrophenyl)diazenyl)hex-5-en-2-yl 2,2,2-trifluoroacetate (3.37b): Yield 
= 39%. 1H NMR (500 MHz, CDCl3) δ 9.11 (dt, J = 22.4, 2.3 Hz, 
1H), 8.59 (dd, J = 8.2, 2.2 Hz, 1H), 7.96 (dd, J = 9.6, 2.7 Hz, 1H), 
5.87 (tdd, J = 10.1, 8.5, 4.9 Hz, 1H), 5.31 – 4.79 (m, 2H), 2.62 – 
2.27 (m, 4H), 2.13 (dd, J = 43.9, 11.0 Hz, 3H). 
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5.6 Experimental information for Chapter 4 
5.6.1 Experimental information of 1,3-dipolar cycloaddition reactions 
A solution of a protonated azomethine amine salt 4.55 (1 equiv, 0.178 mmol) in an 
organic solvent (7 mL) was brought to the desired temperature (Table 5.1) in a flame-
dried flask under a nitrogen atmosphere. Dimethyl maleate 4.56 (1.2 equiv, 0.21 mmol) 
and triethylamine (1.3 – 2.0 equiv) were added successively in a dropwise manner. The 
reaction was stirred for the amount of time shown in the Table 5.1 and concentrated in 
vacuo. The residue was purified by silica gel flash chromatography.  
Table 5.1. Optimization of 1,3-dipolar cycloaddition of protonated azomethine imine 
 
entry reagent 
(equiv) 
Et3N 
(equiv) 
solvent time 
(h) 
temp diastereoisomers (yield) total 
yield fraction-1 fraction-2 
1  1.2 2.0 DCM 1 -78 °C 1% (1 mg) 22% (15 mg) 23% 
2  1.2 2.0 DCM 2 rt 20% (12.5 mg) 55% (35 mg) 75% 
3  1.2 2.0 CH3CN 2 rt 10 % (6.5 mg) 60% (38 mg) 70% 
4  1.2 2.0 CH3CN 16 rt 11% (6.5 mg) 59% (37.5 mg) 70% 
5  1.2 2.0 THF 2 rt 15% (10 mg) 50% (32 mg) 65% 
6  1.2 2.0 THF 16 rt 15% (9.5 mg) 51% (32.5 mg) 66% 
7  1.2 2.0 DCM 2 30 °C 21% (16.5 mg) 51% (35 mg) 72% 
8  1.2 2.0 CH3CN 1 55 °C 13% (13 mg) 63% (40 mg) 76% 
9  1.2 2.0 CH3CN 2 55 °C 13% (8 mg) 67% (43 mg) 80% 
10  1.2 1.3 CH3CN 2 55 °C 16% (10 mg) 74% (47 mg) 90% 
5.6.2 Representative experimental procedure for 1,3-dipolar cycloaddition reactions 
A solution of a protonated azomethine amine salt (1 equiv, 0.178 mmol) in 
acetonitrile (7 mL) was heated to 55 °C in a flame-dried flask under a nitrogen 
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atmosphere. Dimethyl maleate (1.2 equiv, 0.21 mmol) and triethylamine (1.3 equiv, 0.22 
mmol) were added successively in a dropwise manner. The reaction was stirred at 55 °C 
for 2 hours and concentrated in vacuo. The residue was purified by silica gel flash 
chromatography.  
5.6.3 Characterization data for 1,3-dipolar cycloaddition reactions 
Diethyl 2a-methyl-2,2a,3,4,4a,5-hexahydro-1H-2a1,9b-diazapentaleno[1,6-
ab]naphthalene-1,2-dicarboxylate (4.57a, fraction-1): Rf = 0.53 in 
Hexane/EtOAc = 3:1. Yield 16% (10 mg). 1H NMR (500 MHz, CDCl3) 
δ = 7.05 (t, J=7.8, 2H), 6.87 (d, J=7.8, 1H), 6.81 (tt, J=5.9, 2.9, 1H), 
4.96 (d, J=9.3, 1H), 4.22 – 4.10 (m, 2H), 4.02 – 3.82 (m, 2H), 3.62 (dd, 
J=9.1, 4.7, 1H), 3.45 (ddt, J=11.5, 9.1, 4.5, 1H), 2.85 – 2.72 (m, 2H), 2.39 (td, J=12.3, 
6.9, 1H), 2.01 (ddd, J=11.3, 6.7, 4.5, 1H), 1.88 (dd, J=12.9, 6.6, 1H), 1.64 – 1.45 (m, 
4H), 1.26 (t, J=7.1, 3H), 0.97 (t, J=7.1, 3H). 13C NMR (126 MHz, CDCl3) δ 171.1, 170.2, 
143.5, 141.8, 130.0, 126.4, 125.8, 121.0, 119.5, 69.0, 68.0, 60.9, 60.2, 55.9, 35.7, 35.4, 
32.5, 29.1, 14.3, 13.8. MS (ESI) calcd for [C20H26N2O4H]
+: 359.1971, found: 359.1956. 
Diethyl 2a-methyl-2,2a,3,4,4a,5-hexahydro-1H-2a1,9b-diazapentaleno[1,6-
ab]naphthalene-1,2-dicarboxylate (4.57b, fraction-2): Rf = 0.45 in 
Hexane/EtOAc = 3:1. Yield 74% (47 mg). 1H NMR (500 MHz, 
CDCl3) δ 7.08 (dd, J = 16.0, 7.7 Hz, 2H), 6.88 (td, J = 7.5, 1.1 Hz, 
1H), 6.78 (dd, J = 8.1, 0.7 Hz, 1H), 4.40 (dq, J = 10.8, 7.2 Hz, 1H), 
4.34 – 4.26 (m, 2H), 4.24 – 4.11 (m, 2H), 3.65 (d, J = 11.3 Hz, 1H), 2.90 – 2.76 (m, 2H), 
2.61 (ddd, J = 10.2, 7.9, 4.5 Hz, 1H), 2.37 (dt, J = 13.6, 9.4 Hz, 1H), 2.16 (dddd, J = 10.9, 
9.3, 5.4, 1.3 Hz, 1H), 1.92 (ddd, J = 13.4, 10.5, 1.3 Hz, 1H), 1.69 (dt, J = 21.8, 10.9 Hz, 
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1H), 1.52 (s, 3H), 1.35 (t, J = 7.2 Hz, 3H), 1.28 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, 
CDCl3) δ 171.6, 169.3, 146.1, 129.7, 126.8, 124.7, 121.7, 118.9, 70.9, 69.5, 61.5, 61.0, 
56.9, 56.0, 35.4, 35.4, 28.7, 23.3, 14.3, 14.1. MS (ESI) calcd for [C20H26N2O4H]
+: 
359.1971, found: 359.1955. 
Diethyl 2a,7-dimethyl-2,2a,3,4,4a,5-hexahydro-1H-2a1,9b-diazapentaleno[1,6-
ab]naphthalene-1,2-dicarboxylate (4.61, fraction-1): Rf = 0.44 in 
Hexane/EtOAc = 3:1. Yield 17% (11 mg). 1H NMR (500 MHz, 
CDCl3) δ 6.86 (d, J = 7.7 Hz, 2H), 6.77 (d, J = 8.2 Hz, 1H), 4.92 (d, J 
= 9.3 Hz, 1H), 4.16 (dtt, J = 10.8, 7.2, 3.7 Hz, 2H), 3.97 (dq, J = 10.8, 
7.1 Hz, 1H), 3.89 (dq, J = 10.8, 7.1 Hz, 1H), 3.61 (d, J = 9.3 Hz, 1H), 
3.45 (ddt, J = 11.5, 9.1, 4.5 Hz, 1H), 2.75 – 2.72 (m, 2H), 2.36 (td, J = 12.3, 6.9 Hz, 1H), 
2.23 (s, 3H), 1.99 (ddd, J = 11.3, 6.8, 4.5 Hz, 1H), 1.87 (dd, J = 13.0, 6.7 Hz, 1H), 1.57 – 
1.49 (m, 4H), 1.26 (t, J = 7.1 Hz, 3H), 0.99 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, 
CDCl3) δ 171.0, 170.1, 140.8, 130.3, 130.1, 126.5, 126.1, 119.2, 68.8, 68.0, 60.7, 60.7, 
60.1, 55.8, 35.5, 35.1, 32.4, 28.9, 20.7, 14.1, 13.7. MS (ESI) calcd for [C21H28N2O4H]
+: 
373.2127, found: 373.2107. 
Diethyl 2a,7-dimethyl-2,2a,3,4,4a,5-hexahydro-1H-2a1,9b-diazapentaleno[1,6-
ab]naphthalene-1,2-dicarboxylate (4.61, fraction-2): Rf = 0.23 in 
Hexane/EtOAc = 3:1. Yield 66% (43.5 mg). 1H NMR (500 MHz, 
CDCl3) δ 6.94 – 6.82 (m, 2H), 6.70 (d, J = 8.2 Hz, 1H), 4.39 (dq, J = 
10.6, 7.1 Hz, 1H), 4.30 (ddd, J = 14.3, 10.8, 7.2 Hz, 1H), 4.25 – 4.11 
(m, 3H), 3.65 (d, J = 11.4 Hz, 1H), 2.79 (qd, J = 15.0, 6.9 Hz, 2H), 
2.67 – 2.55 (m, 1H), 2.36 (dt, J = 13.5, 9.3 Hz, 1H), 2.25 (s, 3H), 2.19 – 2.09 (m, 1H), 
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1.91 (dd, J = 12.7, 11.4 Hz, 1H), 1.74 – 1.59 (m, 1H), 1.50 (s, 3H), 1.35 (t, J = 7.2 Hz, 
3H), 1.28 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 171.7, 169.4, 143.9, 131.2, 
130.1, 127.6, 124.7, 119.1, 70.9, 69.6, 61.5, 61.0, 57.0, 55.8, 35.3, 28.6, 23.3, 20.7, 20.7, 
14.3, 14.2. MS (ESI) calcd for [C21H28N2O4H]
+: 373.2127, found: 373.2114. 
Diethyl 2a,9-dimethyl-2,2a,3,4,4a,5-hexahydro-1H-2a1,9b-diazapentaleno[1,6-
ab]naphthalene-1,2-dicarboxylate (4.62, fraction-1): Rf = 0.63 in 
Hexane/EtOAc = 3:1. Yield 53% (35 mg). 1H NMR (500 MHz, cdcl3) 
δ = 6.93 (dd, J=11.6, 7.4, 2H), 6.84 (t, J=7.4, 1H), 4.99 (d, J=9.8, 1H), 
4.17 (q, J=7.1, 2H), 3.92 (dq, J=10.8, 7.1, 1H), 3.83 (dq, J=10.8, 7.1, 
1H), 3.61 (d, J=9.8, 1H), 3.45 – 3.33 (m, 1H), 2.92 (dd, J=15.3, 3.4, 1H), 2.75 (dd, 
J=15.2, 11.1, 1H), 2.36 – 2.25 (m, 1H), 2.23 (s, 3H), 2.05 – 1.94 (m, 1H), 1.89 (dd, 
J=13.4, 7.9, 1H), 1.56 – 1.43 (m, 4H), 1.27 (t, J=7.1, 3H), 0.91 (t, J=7.1, 3H).13C NMR 
(126 MHz, CDCl3) δ 171.2, 170.9, 142.2, 128.7, 128.2, 127.5, 127.4, 122.3, 68.6, 66.2, 
60.9, 60.8, 60.7, 55.6, 35.5, 34.4, 31.8, 29.1, 19.5, 14.3, 13.7. MS (ESI) calcd for 
[C21H28N2O4H]
+: 373.2127, found: 373.2118. 
Diethyl 2a,9-dimethyl-2,2a,3,4,4a,5-hexahydro-1H-2a1,9b-diazapentaleno[1,6-
ab]naphthalene-1,2-dicarboxylate (4.62, fraction-2): Rf = 0.44 in 
Hexane/EtOAc = 3:1. Yield 11% (7 mg). 1H NMR (500 MHz, CDCl3) 
δ = 7.02 – 6.77 (m, 3H), 4.35 – 4.05 (m, 5H), 3.73 (d, J=11.0, 1H), 
3.02 – 2.91 (m, 1H), 2.85 – 2.71 (m, 2H), 2.41 (ddd, J=13.5, 9.7, 8.8, 
1H), 2.23 (s, 3H), 2.20 – 2.08 (m, 1H), 1.87 (ddd, J=13.3, 11.0, 2.0, 1H), 1.72 – 1.59 (m, 
4H), 1.30 (dt, J=16.8, 7.2, 6H). 13C NMR (126 MHz, CDCl3) δ 171.9, 169.4, 144.9, 
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131.0, 130.1, 127.6, 126.7, 122.9, 70.7, 68.3, 61.20, 61.0, 56.5, 56.5, 35.9, 34.4, 28.2, 
22.6, 19.9, 14.3, 13.9. MS (ESI) calcd for [C21H28N2O4H]
+: 373.2127, found: 373.2122. 
Diethyl 7-chloro-2a-methyl-2,2a,3,4,4a,5-hexahydro-1H-2a1,9b-diazapentaleno[1,6-
ab]naphthalene-1,2-dicarboxylate (4.63, fraction-1): Rf = 0.51 in 
Hexane/EtOAc = 3:1. Yield 14% (10 mg). 1H NMR (500 MHz, 
CDCl3) δ 7.06 (d, J = 2.3 Hz, 1H), 7.02 (dd, J = 8.6, 2.4 Hz, 1H), 6.79 
(d, J = 8.6 Hz, 1H), 4.93 (d, J = 9.4 Hz, 1H), 4.20 – 4.13 (m, 2H), 4.02 
– 3.87 (m, 2H), 3.62 (d, J = 9.4 Hz, 1H), 3.41 (ddt, J = 11.4, 9.1, 4.4 
Hz, 1H), 2.82 – 2.71 (m, 2H), 2.40 – 2.30 (m, 1H), 2.02 (ddd, J = 11.4, 6.8, 4.5 Hz, 1H), 
1.88 (dd, J = 13.0, 6.7 Hz, 1H), 1.57 – 1.48 (m, 4H), 1.27 (t, J = 7.1 Hz, 3H), 1.02 (t, J = 
7.1 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 170.8, 170.1, 142.2, 129.7, 128.2, 125.9, 
125.9, 120.5, 69.1, 68.0, 61.1, 61.0, 60.2, 55.6, 35.6, 35.4, 32.4, 29.0, 14.3, 13.9. MS 
(ESI) calcd for [C20H25 ClN2O4H]
+: 393.1581, found: 393.1578. 
Diethyl 7-chloro-2a-methyl-2,2a,3,4,4a,5-hexahydro-1H-2a1,9b-diazapentaleno[1,6-
ab]naphthalene-1,2-dicarboxylate (4.63, fraction-2): Rf = 0.36 in 
Hexane/EtOAc = 3:1. Yield 70% (49 mg).1H NMR (500 MHz, CDCl3) 
δ 7.06 – 7.00 (m, 2H), 6.73 – 6.68 (m, 1H), 4.38 (dq, J = 10.8, 7.2 Hz, 
1H), 4.29 (dq, J = 10.8, 7.2 Hz, 1H), 4.25 – 4.08 (m, 3H), 3.64 (d, J = 
11.3 Hz, 1H), 2.80 (qd, J = 15.3, 6.8 Hz, 2H), 2.62 – 2.53 (m, 1H), 
2.37 (dt, J = 13.7, 9.3 Hz, 1H), 2.37 (dt, J = 13.7, 9.3 Hz, 1H), 2.20 – 2.12 (m, 1H), 1.96 
– 1.88 (m, 1H), 1.73 – 1.61 (m, 1H), 1.50 (s, J = 7.1 Hz, 3H), 1.34 (t, J = 7.2 Hz, 3H), 
1.28 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 171.3, 169.1, 144.8, 129.3, 
 180 
126.9, 126.7, 126.5, 120.0, 70.9, 69.4, 61.6, 61.1, 56.9, 55.7, 35.5, 35.3, 28.5, 23.2, 14.3, 
14.1. MS (ESI) calcd for [C20H25 ClN2O4H]
+: 393.1581, found: 393.1578. 
(1S,2S)-Dimethyl 2a-methyl-2,2a,3,4,4a,5-hexahydro-1H-2a1,9b-diazapentaleno[1,6-
ab]naphthalene-1,2-dicarboxylate (6.65, fraction-1): Rf = 0.41 in 
Hexane/EtOAc = 3:1. Yield 15% (9 mg). 1H NMR (500 MHz, CDCl3) 
δ 7.06 (dd, J = 15.2, 7.5 Hz, 2H), 6.85 – 6.80 (m, 2H), 5.00 (d, J = 9.7 
Hz, 1H), 3.71 (s, 3H), 3.68 (d, J = 9.7 Hz, 1H), 3.55 – 3.46 (m, 4H), 
2.81 (qd, J = 14.9, 7.0 Hz, 2H), 2.28 – 2.19 (m, 1H), 2.03 (ddd, J = 11.4, 6.8, 4.4 Hz, 
1H), 1.86 (dd, J = 13.0, 6.7 Hz, 1H), 1.59 – 1.48 (m, 4H). 13C NMR (126 MHz, CDCl3) δ 
171.3, 170.8, 143.5, 130.1, 126.3, 126.0, 121.1, 118.9, 69.3, 68.0, 60.5, 55.9, 52.1, 52.0, 
35.6, 35.4, 32.4, 29.2. MS (ESI) calcd for [C18H22 N2O4H]
+: 331.1658, found: 331.1656. 
(1S,2S)-Dimethyl 2a-methyl-2,2a,3,4,4a,5-hexahydro-1H-2a1,9b-diazapentaleno[1,6-
ab]naphthalene-1,2-dicarboxylate (6.65, fraction-2): Rf = 0.22 in 
Hexane/EtOAc = 3:1. Yield 77% (45 mg). 1H NMR (500 MHz, CDCl3) 
δ 7.07 (dd, J = 15.3, 7.4 Hz, 2H), 6.89 (td, J = 7.5, 1.1 Hz, 1H), 6.77 – 
6.70 (m, 1H), 4.31 (d, J = 11.3 Hz, 1H), 3.89 (s, 3H), 3.72 (s, 3H), 3.67 
(d, J = 11.3 Hz, 1H), 2.83 (qd, J = 15.1, 6.9 Hz, 2H), 2.65 – 2.54 (m, 1H), 2.36 (dt, J = 
13.6, 9.3 Hz, 1H), 2.20 – 2.09 (m, 1H), 1.92 (ddd, J = 13.5, 10.5, 1.4 Hz, 1H), 1.69 (dt, J 
= 27.6, 10.7 Hz, 1H), 1.48 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 172.1, 169.9, 146.0, 
129.7, 126.8, 124.7, 121.8, 118.9, 71.0, 69.3, 56.9, 56.0, 52.6, 52.1, 35.4, 35.3, 28.6, 23.3. 
MS (ESI) calcd for [C18H22 N2O4H]
+: 331.1658, found: 331.1653. 
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(1S,2S)-dimethyl 2a,7-dimethyl-2,2a,3,4,4a,5-hexahydro-1H-2a1,9b-
diazapentaleno[1,6-ab]naphthalene-1,2-dicarboxylate (4.66, 
fraction-1): Rf = 0.43 in Hexane/EtOAc = 3:1. Yield 9% (5 mg). 
1H 
NMR (500 MHz, CDCl3) δ 6.93 – 6.79 (m, 2H), 6.72 (d, J = 8.1 Hz, 
1H), 4.96 (d, J = 9.7 Hz, 1H), 3.71 (s, 3H), 3.66 (d, J = 9.7 Hz, 1H), 
3.56 – 3.40 (m, 4H), 2.76 (qd, J = 14.9, 7.0 Hz, 2H), 2.29 – 2.15 (m, 
4H), 2.01 (ddd, J = 11.4, 9.2, 5.7 Hz, 1H), 1.84 (dd, J = 13.0, 6.8 Hz, 1H), 1.62 – 1.44 
(m, 4H). 13C NMR (126 MHz, CDCl3) δ 171.5, 170.9, 141.0, 130.5, 130.2, 126.8, 126.2, 
118.8, 69.3, 68.0, 60.6, 55.9, 52.0, 52.0, 35.5, 35.3, 32.4, 29.1, 20.9. MS (ESI) calcd for 
[C19H24 N2O4H]
+: 345.1814, found: 345.1798. 
(1S,2S)-dimethyl 2a,7-dimethyl-2,2a,3,4,4a,5-hexahydro-1H-2a1,9b-
diazapentaleno[1,6-ab]naphthalene-1,2-dicarboxylate (4.66, fraction-
2): Rf = 0.23 in Hexane/EtOAc = 3:1. Yield 69% (42 mg). 
1H NMR 
(500 MHz, CDCl3) δ 6.93 – 6.85 (m, 2H), 6.66 (d, J = 8.1 Hz, 1H), 4.25 
(d, J = 11.4 Hz, 1H), 3.88 (s, 3H), 3.72 (s, 3H), 3.67 (d, J = 11.4 Hz, 
1H), 2.79 (qd, J = 15.1, 6.9 Hz, 2H), 2.65 – 2.54 (m, 1H), 2.35 (dt, J = 
13.7, 9.3 Hz, 1H), 2.24 (s, 3H), 2.18 – 2.09 (m, 1H), 1.91 (ddd, J = 13.5, 10.6, 1.4 Hz, 
1H), 1.72 – 1.60 (m, 1H), 1.47 (s, 3H).13C NMR (126 MHz, CDCl3) δ 172.2, 170.0, 
143.8, 131.3, 130.1, 127.6, 124.7, 119.0, 71.0, 69.4, 57.0, 55.9, 52.6, 52.1, 35.3, 35.3, 
28.5, 23.3, 20.7. MS (ESI) calcd for [C19H24 N2O4H]
+: 345.1814, found: 345.1796. 
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(1S,2S)-dimethyl 2a,9-dimethyl-2,2a,3,4,4a,5-hexahydro-1H-2a1,9b-
diazapentaleno[1,6-ab]naphthalene-1,2-dicarboxylate (4.67, fraction-
1): Rf = 0.40 in Hexane/EtOAc = 3:1. Yield 49% (30 mg). 
1H NMR (500 
MHz, cdcl3) δ = 6.96 (d, J=7.4, 1H), 6.91 (d, J=7.0, 1H), 6.85 (t, J=7.4, 
1H), 5.01 (d, J=10.2, 1H), 3.71 (s, 3H), 3.66 (d, J=10.2, 1H), 3.44 (s, 3H), 
3.44 – 3.36 (m, 1H), 2.97 (dd, J=15.3, 3.5, 1H), 2.75 (dd, J=15.3, 11.0, 1H), 2.20 (s, 3H), 
2.14 (ddd, J=13.4, 10.3, 8.2, 1H), 2.06 – 1.96 (m, 1H), 1.88 (dd, J=13.4, 8.4, 1H), 1.54 (s, 
3H), 1.50 (dt, J=19.9, 6.8, 1H). 13C NMR (126 MHz, CDCl3) δ 171.5, 171.4, 142.0, 
128.4, 128.2, 127.5, 127.4, 122.4, 77.1, 69.0, 66.1, 61.1, 55.5, 52.0, 35.4, 34.3, 31.6, 29.2, 
19.4. MS (ESI) calcd for [C19H24 N2O4H]
+: 345.1814, found: 345.1811. 
(1S,2S)-dimethyl 2a,9-dimethyl-2,2a,3,4,4a,5-hexahydro-1H-2a1,9b-
diazapentaleno[1,6-ab]naphthalene-1,2-dicarboxylate (4.67, fraction-
2): Rf = 0.23 in Hexane/EtOAc = 3:1. Yield 8% (5 mg). 
1H NMR (500 
MHz, CDCl3) δ = 6.97 (d, J=7.2, 1H), 6.93 (d, J=7.2, 1H), 6.88 (t, 
J=7.3, 1H), 4.25 (d, J=11.0, 1H), 3.79 (s, 3H), 3.76 – 3.69 (m, 4H), 2.99 
– 2.91 (m, 1H), 2.84 – 2.69 (m, 2H), 2.43 – 2.33 (m, 1H), 2.20 (s, 3H), 2.18 – 2.10 (m, 
1H), 1.87 (ddd, J=13.3, 11.0, 2.0, 1H), 1.67 (dd, J=12.7, 10.6, 1H), 1.64 (s, 3H). 13C 
NMR (126 MHz, CDCl3) δ 172.4, 170.0, 144.9, 130.9, 130.1, 127.6, 126.7, 123.0, 77.1, 
70.8, 68.0, 56.5, 52.1, 52.0, 35.8, 34.3, 28.1, 22.6, 19.8. MS (ESI) calcd for [C19H24 
N2O4H]
+: 345.1814, found: 345.1808. 
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(1S,2S)-dimethyl 7-chloro-2a-methyl-2,2a,3,4,4a,5-hexahydro-1H-2a1,9b-
diazapentaleno[1,6-ab]naphthalene-1,2-dicarboxylate (4.68, fraction-
1): Rf = 0.48 in Hexane/EtOAc = 3:1. Yield 11% (7 mg). 
1H NMR (500 
MHz, CDCl3) δ 7.06 (dd, J = 5.9, 2.6 Hz, 2H), 6.72 – 6.64 (m, 1H), 4.28 
(d, J = 11.3 Hz, 1H), 3.90 (s, 3H), 3.74 (s, 3H), 3.69 (d, J = 11.3 Hz, 
1H), 2.83 (qd, J = 15.3, 6.9 Hz, 2H), 2.64 – 2.52 (m, 1H), 2.38 (dt, J = 13.7, 9.3 Hz, 1H), 
2.22 – 2.11 (m, 1H), 1.95 (ddd, J = 13.6, 10.5, 1.4 Hz, 1H), 1.76 – 1.59 (m, 1H), 1.49 (s, 
3H). 13C NMR (126 MHz, CDCl3) δ 171.8, 169.7, 144.7, 129.4, 126.9, 126.6, 120.1, 
77.4, 71.0, 69.2, 56.9, 55.7, 52.7, 52.2, 35.4, 35.2, 28.5, 23.3. MS (ESI) calcd for 
[C18H21Cl N2O4H]
+: 365.1268, found: 365.1267. 
(1S,2S)-dimethyl 7-chloro-2a-methyl-2,2a,3,4,4a,5-hexahydro-1H-2a1,9b-
diazapentaleno[1,6-ab]naphthalene-1,2-dicarboxylate (4.68, 
fraction-2): Rf = 0.26 in Hexane/EtOAc = 3:1. Yield 71% (46 mg). 
1H 
NMR (500 MHz, CDCl3) δ = 7.06 (dd, J=5.9, 2.6, 3H), 6.74 – 6.55 (m, 
1H), 4.28 (d, J=11.3, 1H), 3.90 (s, 2H), 3.74 (s, 3H), 3.69 (d, J=11.3, 
1H), 2.83 (qd, J=15.3, 6.9, 2H), 2.65 – 2.52 (m, 1H), 2.38 (dt, J=13.7, 
9.3, 1H), 2.22 – 2.09 (m, 1H), 1.95 (ddd, J=13.6, 10.5, 1.4, 1H), 1.76 – 1.62 (m, 1H), 
1.49 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 171.8, 169.7, 144.7, 129.4, 126.9, 126.9, 
126.6, 120.1, 71.0, 69.2, 56.9, 55.7, 52.7, 52.2, 35.4, 35.2, 28.5, 23.3. MS (ESI) calcd for 
[C18H21Cl N2O4H]
+: 365.1268, found: 365.1261. 
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(1R,2S)-dimethyl 2a-methyl-2,2a,3,4,4a,5-hexahydro-1H-2a1,9b-diazapentaleno[1,6-
ab]naphthalene-1,2-dicarboxylate (4.70, fraction-1): Rf = 0.56 in Hexane/EtOAc = 3:1. 
Yield 43% (25.5 mg). 1H NMR (500 MHz, CDCl3) δ 7.04 (dd, J = 
12.7, 4.6 Hz, 2H), 6.83 (td, J = 7.4, 1.1 Hz, 1H), 6.77 (d, J = 8.1 Hz, 
1H), 5.12 (d, J = 8.9 Hz, 1H), 3.77 (s, 3H), 3.63 (d, J = 9.0 Hz, 1H), 
3.47 (s, 3H), 3.24 – 3.14 (m, 1H), 2.92 (dd, J = 15.2, 3.2 Hz, 1H), 2.74 
(dd, J = 15.2, 10.8 Hz, 1H), 2.43 (dt, J = 13.6, 9.3 Hz, 1H), 2.23 – 
2.14 (m, 1H), 1.92 (ddd, J = 13.5, 10.4, 1.2 Hz, 1H), 1.62 (dq, J = 11.7, 10.6 Hz, 1H), 
1.32 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 172.7, 171.1, 143.3, 129.9, 125.9, 125.4, 
121.5, 119.0, 70.5, 69.6, 59.8, 55.3, 52.3, 52.3, 35.1, 34.8, 28.8, 22.8. MS (ESI) calcd for 
[C18H22N2O4H]
+: 331.1658, found: 331.1651. 
(1R,2S)-dimethyl 2a-methyl-2,2a,3,4,4a,5-hexahydro-1H-2a1,9b-diazapentaleno[1,6-
ab]naphthalene-1,2-dicarboxylate (4.70, fraction-2): Rf = 0.41 in 
Hexane/EtOAc = 3:1. Yield 36% (21 mg). 1H NMR (500 MHz, 
CDCl3) δ 7.08 (dd, J = 12.0, 7.7 Hz, 2H), 6.96 (td, J = 7.4, 1.1 Hz, 
1H), 6.84 (d, J = 8.1 Hz, 1H), 4.59 (d, J = 8.0 Hz, 1H), 3.84 (s, 3H), 
3.75 (s, 3H), 3.36 (d, J = 8.0 Hz, 1H), 3.04 (tdd, J = 11.1, 4.8, 3.4 Hz, 
1H), 2.86 (dd, J = 15.3, 3.2 Hz, 1H), 2.76 (dd, J = 15.3, 10.9 Hz, 1H), 2.03 – 1.94 (m, 
1H), 1.86 (dt, J = 9.7, 4.8 Hz, 2H), 1.61 (s, 3H), 1.55 (ddd, J = 21.1, 11.4, 9.7 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ 172.7, 172.6, 145.5, 130.0, 126.6, 126.4, 123.2, 121.1, 
70.7, 70.2, 63.7, 53.7, 52.7, 52.3, 35.1, 33.7, 30.9, 28.4. MS (ESI) calcd for 
[C18H22N2O4H]
+: 331.1658, found: 331.1649. 
 185 
(1R,2S)-dimethyl 2a,7-dimethyl-2,2a,3,4,4a,5-hexahydro-1H-2a1,9b-
diazapentaleno[1,6-ab]naphthalene-1,2-dicarboxylate (4.71, fraction-1): Rf = 0.49 in 
Hexane/EtOAc = 3:1. Yield 35% (21.5 mg). 1H NMR (500 MHz, 
CDCl3) δ 6.84 (d, J = 9.5 Hz, 2H), 6.67 (d, J = 8.0 Hz, 1H), 5.09 (d, J 
= 8.9 Hz, 1H), 3.76 (s, 3H), 3.62 (d, J = 8.9 Hz, 1H), 3.48 (s, 3H), 
3.19 (tdd, J = 11.1, 5.3, 3.4 Hz, 1H), 2.86 (dd, J = 15.2, 3.2 Hz, 1H), 
2.69 (dd, J = 15.2, 10.8 Hz, 1H), 2.42 (dt, J = 13.6, 9.3 Hz, 1H), 2.22 
(s, 3H), 2.20 – 2.14 (m, 1H), 1.91 (ddd, J = 13.5, 10.4, 1.3 Hz, 1H), 1.66 – 1.55 (m, 1H), 
1.31 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 172.8, 171.2, 140.9, 130.7, 130.3, 126.7, 
125.2, 118.9, 70.5, 69.6, 59.8, 55.3, 52.3, 52.3, 35.0, 34.8, 28.8, 22.8, 20.8. MS (ESI) 
calcd for [C19H24N2O4H]
+: 345.1814, found: 345.1808. 
(1R,2S)-dimethyl 2a,7-dimethyl-2,2a,3,4,4a,5-hexahydro-1H-2a1,9b-
diazapentaleno[1,6-ab]naphthalene-1,2-dicarboxylate (4.71, 
fraction-2): Rf = 0.35 in Hexane/EtOAc = 3:1. Yield 32% (20 mg). 
1H 
NMR (500 MHz, CDCl3) δ 6.93 – 6.82 (m, 2H), 6.73 (d, J = 8.1 Hz, 
1H), 4.53 (d, J = 8.3 Hz, 1H), 3.82 (s, 3H), 3.74 (s, 3H), 3.36 (d, J = 
8.3 Hz, 1H), 3.04 (tdd, J = 11.1, 4.8, 3.5 Hz, 1H), 2.81 (dd, J = 15.3, 
3.3 Hz, 1H), 2.71 (dd, J = 15.2, 10.9 Hz, 1H), 2.25 (s, 3H), 2.01 – 1.94 (m, 1H), 1.89 – 
1.78 (m, 2H), 1.60 (s, 3H), 1.58 – 1.48 (m, 1H). 13C NMR (126 MHz, CDCl3) δ 172.7, 
172.6, 143.0, 132.7, 130.4, 127.2, 126.5, 121.2, 70.6, 70.3, 63.8, 53.6, 52.6, 52.3, 34.9, 
33.7, 30.9, 28.3, 20.8. MS (ESI) calcd for [C19H24N2O4H]
+: 345.1814, found: 345.1805. 
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(1R,2S)-dimethyl 2a,9-dimethyl-2,2a,3,4,4a,5-hexahydro-1H-2a1,9b-
diazapentaleno[1,6-ab]naphthalene-1,2-dicarboxylate (4.72): Rf = 
0.5 in Hexane/EtOAc = 3:1. Yield 73% (45 mg). 1H NMR (500 MHz, 
CDCl3) δ 6.94 – 6.90 (m, 2H), 6.87 – 6.81 (m, 1H), 5.09 (d, J = 8.3 Hz, 
1H), 3.78 (s, 3H), 3.69 (d, J = 8.3 Hz, 1H), 3.39 (s, 3H), 3.38 – 3.31 
(m, 1H), 3.00 (dd, J = 15.5, 3.6 Hz, 1H), 2.73 (s, 1H), 2.42 (dt, J = 13.6, 9.3 Hz, 1H), 
2.30 (s, 3H), 2.22 – 2.12 (m, 1H), 1.94 – 1.87 (m, 1H), 1.67 – 1.51 (m, 1H), 1.34 (s, 3H). 
13C NMR (126 MHz, CDCl3) δ 172.9, 171.4, 141.7, 129.8, 128.3, 127.2, 126.7, 122.9, 
70.3, 68.1, 60.1, 54.9, 52.3, 52.3, 35.0, 34.6, 28.6, 22.5, 18.9. MS (ESI) calcd for [C19H24 
N2O4H]
+: 345.1814, found: 345.1798. 
(1R,2S)-dimethyl 7-chloro-2a-methyl-2,2a,3,4,4a,5-hexahydro-1H-2a1,9b-
diazapentaleno[1,6-ab]naphthalene-1,2-dicarboxylate (4.73, 
fraction-1): Rf = 0.37 in Hexane/EtOAc = 3:1. Yield 43% (28 mg). 
1H 
NMR (500 MHz, CDCl3) δ 7.10 – 6.96 (m, 2H), 6.70 (d, J = 8.6 Hz, 
1H), 5.09 (d, J = 8.9 Hz, 1H), 3.77 (s, 3H), 3.62 (d, J = 8.9 Hz, 1H), 
3.51 (s, 3H), 3.16 (tdd, J = 11.1, 5.3, 3.3 Hz, 1H), 2.89 (dd, J = 15.4, 
3.2 Hz, 1H), 2.71 (dd, J = 15.4, 10.8 Hz, 1H), 2.43 (dt, J = 13.7, 9.3 Hz, 1H), 2.19 (s, 
1H), 1.93 (ddd, J = 13.6, 10.4, 1.2 Hz, 1H), 1.68 – 1.50 (m, 1H), 1.30 (s, 3H). 13C NMR 
(126 MHz, CDCl3) δ 172.4, 170.9, 142.0, 129.6, 127.2, 126.4, 126.1, 120.0, 70.5, 69.6, 
59.9, 54.9, 52.4, 52.4, 35.0, 34.9, 28.7, 22.8. MS (ESI) calcd for [C18H21ClN2O4H]
+: 
365.1268, found: 365.1266. 
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(1R,2S)-dimethyl 7-chloro-2a-methyl-2,2a,3,4,4a,5-hexahydro-1H-2a1,9b-
diazapentaleno[1,6-ab]naphthalene-1,2-dicarboxylate (4.73, 
fraction-2): Rf = 0.32 in Hexane/EtOAc = 3:1. Yield 39% (19 mg). 
1H 
NMR (500 MHz, CDCl3) δ 7.10 – 6.99 (m, 2H), 6.80 (d, J = 8.7 Hz, 
1H), 4.55 (d, J = 7.9 Hz, 1H), 3.83 (s, 3H), 3.76 (s, 3H), 3.35 (d, J = 7.9 
Hz, 1H), 3.01 (tdd, J = 11.1, 4.9, 3.4 Hz, 1H), 2.83 (dd, J = 15.5, 3.2 
Hz, 1H), 2.73 (dd, J = 15.4, 10.9 Hz, 1H), 2.03 – 1.95 (m, 1H), 1.91 – 1.80 (m, 2H), 1.62 
– 1.47 (m, 4H). 13C NMR (126 MHz, CDCl3) δ 172.6, 172.4, 144.2, 129.6, 128.5, 128.3, 
126.6, 122.2, 70.7, 70.3, 63.6, 53.4, 52.8, 52.4, 35.0, 33.6, 30.8, 28.2. MS (ESI) calcd for 
[C18H21ClN2O4H]
+: 365.1268, found: 365.1248. 
(1R,2S)-dimethyl 7,9-dichloro-2a-methyl-2,2a,3,4,4a,5-hexahydro-1H-2a1,9b-
diazapentaleno[1,6-ab]naphthalene-1,2-dicarboxylate (4.74): Rf = 0.45 in 
Hexane/EtOAc = 3:1. Yield 99% (70 mg). 1H NMR (500 MHz, 
CDCl3) δ = 7.13 (d, J=2.1, 1H), 7.06 – 6.97 (m, 1H), 5.46 (d, J=9.0, 
1H), 3.79 (s, 3H), 3.54 (s, 3H), 3.50 (d, J=8.9, 1H), 3.15 (tdd, J=11.1, 
5.5, 3.6, 1H), 3.00 (dd, J=15.7, 3.5, 1H), 2.75 (dd, J=15.7, 10.8, 1H), 
2.41 (dt, J=13.7, 9.3, 1H), 2.25 – 2.11 (m, 1H), 1.96 – 1.87 (m, 1H), 
1.67 – 1.49 (m, 1H), 1.32 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 172.9, 170.6, 140.1, 
130.1, 128.0, 127.2, 127.0, 125.4, 69.9, 67.8, 60.0, 55.3, 52.6, 52.4, 35.4, 34.7, 28.5, 22.5. 
MS (ESI) calcd for [C18H20Cl2N2O4H]
+: 399.0878, found: 399.0877. 
Dimethyl 2a-methyl-3,4,4a,5-tetrahydro-2aH-2a1,9b-diazapentaleno[1,6-
ab]naphthalene-1,2-dicarboxylate (4.76, fraction-1): Rf = 0.60 in Hexane/EtOAc = 3:1. 
Yield 63% (37 mg). 1H NMR (500 MHz, CDCl3) δ 7.15 (d, J = 7.6 Hz, 1H), 7.11 (td, J = 
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8.0, 1.4 Hz, 1H), 7.04 (td, J = 7.4, 1.2 Hz, 1H), 6.97 (dd, J = 8.1, 0.9 
Hz, 1H), 3.86 (s, 3H), 3.72 (s, 3H), 3.12 – 3.04 (m, 1H), 2.97 – 2.89 
(m, 2H), 2.49 (ddd, J = 13.4, 11.4, 8.4 Hz, 1H), 2.11 (dd, J = 13.4, 8.3 
Hz, 1H), 1.97 (ddd, J = 12.3, 8.2, 4.5 Hz, 1H), 1.65 – 1.48 (m, 1H), 
1.43 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 164.7, 163.0, 145.3, 138.1, 130.2, 127.6, 
126.7, 124.5, 119.1, 110.4, 71.0, 62.6, 53.2, 51.4, 37.6, 34.0, 27.7, 26.1. MS (ESI) calcd 
for [C18H20N2O4H]
+: 329.1501, found: 329.1501. 
Dimethyl 2a-methyl-3,4,4a,5-tetrahydro-2aH-2a1,9b-diazapentaleno[1,6- 
ab]naphthalene-1,2-dicarboxylate (4.76, fraction-2): Rf = 0.38 in 
Hexane/EtOAc = 3:1. Yield 36% (21 mg). 1H NMR (500 MHz, CDCl3) 
δ 7.10 (dddd, J = 18.6, 12.0, 8.9, 4.4 Hz, 4H), 3.84 (s, 3H), 3.77 – 3.67 
(m, 4H), 3.19 (dd, J = 16.2, 7.8 Hz, 1H), 2.71 (dd, J = 16.2, 6.3 Hz, 
1H), 2.47 (ddd, J = 12.9, 7.1, 2.5 Hz, 1H), 2.19 – 2.08 (m, 1H), 1.91 (ddd, J = 12.9, 11.2, 
6.5 Hz, 1H), 1.79 – 1.69 (m, 1H), 1.60 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 164.4, 
162.7, 144.0, 137.4, 129.8, 128.4, 126.8, 125.8, 119.4, 104.4, 76.0, 65.3, 53.2, 51.0, 39.5, 
32.8, 30.7, 27.2. MS (ESI) calcd for [C18H20N2O4H]
+: 329.1501, found: 329.1504. 
Dimethyl 2a,7-dimethyl-3,4,4a,5-tetrahydro-2aH-2a1,9b-diazapentaleno[1,6-
ab]naphthalene-1,2-dicarboxylate (4.77, fraction-1): Rf = 0.33 in 
Hexane/EtOAc = 3:1. Yield 54% (33 mg). 1H NMR (500 MHz, 
CDCl3) δ 6.95 (s, 1H), 6.91 (dd, J = 8.3, 1.4 Hz, 1H), 6.86 (d, J = 8.3 
Hz, 1H), 3.85 (s, 3H), 3.71 (s, 3H), 3.12 – 3.04 (m, 1H), 2.88 (d, J = 
6.9 Hz, 2H), 2.49 (ddd, J = 13.4, 11.4, 8.4 Hz, 1H), 2.27 (s, 3H), 2.09 
(dd, J = 13.4, 8.1 Hz, 1H), 1.95 (ddd, J = 12.3, 8.1, 4.5 Hz, 1H), 1.64 – 1.51 (m, 1H), 
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1.42 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 164.8, 163.1, 145.5, 135.6, 134.1, 130.7, 
127.4, 127.4, 118.9, 110.0, 70.9, 62.7, 53.2, 51.3, 37.6, 33.9, 27.7, 26.1, 20.9. MS (ESI) 
calcd for [C19H22N2O4H]
+: 343.1658, found: 343.1653. 
Dimethyl 2a,7-dimethyl-3,4,4a,5-tetrahydro-2aH-2a1,9b-diazapentaleno[1,6- 
ab]naphthalene-1,2-dicarboxylate (4.77, fraction-2): Rf = 0.18 in 
Hexane/EtOAc = 3:1. Yield 36% (22 mg). 1H NMR (500 MHz, 
CDCl3) δ 6.98 – 6.91 (m, 3H), 3.82 (s, 3H), 3.75 – 3.66 (m, 4H), 3.12 
(dd, J = 16.1, 7.6 Hz, 1H), 2.67 (dd, J = 16.0, 6.7 Hz, 1H), 2.47 (ddd, 
J = 12.9, 7.1, 2.6 Hz, 1H), 2.29 (s, 3H), 2.17 – 2.09 (m, 1H), 1.91 
(ddd, J = 12.9, 11.1, 6.5 Hz, 1H), 1.77 – 1.67 (m, 1H), 1.58 (s, 3H). 13C NMR (126 MHz, 
CDCl3) δ 164.3, 162.6, 144.3, 135.7, 134.8, 129.9, 128.7, 127.3, 119.4, 103.8, 75.8, 65.3, 
53.0, 50.8, 39.1, 32.7, 30.8, 26.9, 21.0. MS (ESI) calcd for [C19H22N2O4H]
+: 343.1658, 
found: 343.1653. 
Dimethyl 2a,9-dimethyl-3,4,4a,5-tetrahydro-2aH-2a1,9b-diazapentaleno[1,6- 
ab]naphthalene-1,2-dicarboxylate (4.78, fraction-1): Rf = 0.41 in 
Hexane/EtOAc = 3:1. Yield 12% (7 mg). 1H NMR (500 MHz, CDCl3) 
δ 7.06 – 6.89 (m, 3H), 3.78 (s, 3H), 3.73 (s, 3H), 3.25 – 3.14 (m, 1H), 
3.03 (dd, J = 16.0, 3.7 Hz, 1H), 2.86 (dd, J = 16.0, 11.6 Hz, 1H), 2.48 
(ddd, J = 13.6, 10.6, 9.1 Hz, 1H), 2.18 (s, 3H), 2.06 – 1.99 (m, 1H), 
1.97 – 1.91 (m, 1H), 1.58 – 1.45 (m, 4H). 13C NMR (126 MHz, CDCl3) δ 164.8, 162.7, 
145.4, 137.3, 130.8, 129.4, 128.9, 127.4, 125.2, 112.8, 70.9, 61.2, 53.0, 51.4, 36.1, 34.1, 
27.5, 24.9, 18.0. MS (ESI) calcd for [C19H22N2O4H]
+: 343.1658, found: 343.1655. 
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Dimethyl 2a,9-dimethyl-3,4,4a,5-tetrahydro-2aH-2a1,9b-diazapentaleno[1,6- 
ab]naphthalene-1,2-dicarboxylate (4.78, fraction-2): Rf = 0.24 in 
Hexane/EtOAc = 3:1. Yield 74% (45 mg). 1H NMR (500 MHz, 
CDCl3) δ 7.12 (t, J = 7.5 Hz, 1H), 7.09 – 7.05 (m, 1H), 6.98 (d, J = 
7.2 Hz, 1H), 3.69 (s, 3H), 3.68 – 3.60 (m, 4H), 2.95 (dd, J = 14.5, 5.5 
Hz, 1H), 2.81 (ddd, J = 12.9, 7.0, 1.8 Hz, 1H), 2.65 (dd, J = 14.3, 
11.4 Hz, 1H), 2.32 (s, 3H), 2.24 – 2.14 (m, 1H), 2.06 – 1.95 (m, 1H), 1.66 (tdd, J = 12.1, 
9.2, 7.2 Hz, 1H), 1.55 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 164.0, 162.5, 149.8, 137.7, 
136.7, 134.6, 128.9, 128.1, 124.7, 107.2, 75.2, 67.9, 52.8, 51.1, 36.0, 34.7, 34.1, 24.4, 
16.9. MS (ESI) calcd for [C19H22N2O4H]
+: 343.1658, found: 343.1656. 
Dimethyl 7-chloro-2a-methyl-3,4,4a,5-tetrahydro-2aH-2a1,9b-diazapentaleno[1,6- 
ab]naphthalene-1,2-dicarboxylate (4.79, fraction-1): Rf = 0.45 in 
Hexane/EtOAc = 3:1. Yield 60% (39 mg). 1H NMR (500 MHz, 
CDCl3) δ 7.15 (d, J = 2.3 Hz, 1H), 7.08 (dd, J = 8.7, 2.4 Hz, 1H), 6.90 
(d, J = 8.7 Hz, 1H), 3.86 (s, 3H), 3.73 (s, 3H), 3.07 – 2.99 (m, 1H), 
2.95 – 2.88 (m, 2H), 2.49 (ddd, J = 13.4, 11.4, 8.4 Hz, 1H), 2.11 (dd, 
J = 13.5, 8.3 Hz, 1H), 1.97 (ddd, J = 12.3, 8.2, 4.5 Hz, 1H), 1.62 – 1.50 (m, 1H), 1.42 (s, 
3H). 13C NMR (126 MHz, CDCl3) δ 164.5, 162.8, 145.1, 136.9, 130.0, 129.7, 129.5, 
126.9, 120.3, 111.2, 71.1, 62.1, 53.3, 51.5, 37.5, 33.9, 27.6, 26.0. MS (ESI) calcd for 
[C18H19ClN2O4H]
+: 363.1112, found: 363.1105. 
Dimethyl 7-chloro-2a-methyl-3,4,4a,5-tetrahydro-2aH-2a1,9b-diazapentaleno[1,6- 
ab]naphthalene-1,2-dicarboxylate (4.79, fraction-2): Rf = 0.27 in Hexane/EtOAc = 3:1. 
Yield 37% (24 mg). 1H NMR (500 MHz, CDCl3) δ 7.15 (s, 1H), 7.10 (ddd, J = 8.5, 2.3, 
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0.7 Hz, 1H), 6.98 (d, J = 8.5 Hz, 1H), 3.84 (s, 3H), 3.75 – 3.68 (m, 
4H), 3.16 (dd, J = 16.4, 7.7 Hz, 1H), 2.68 (dd, J = 16.3, 6.3 Hz, 1H), 
2.47 (ddd, J = 13.0, 7.1, 2.4 Hz, 1H), 2.18 – 2.09 (m, 1H), 1.91 (ddd, 
J = 13.0, 11.2, 6.5 Hz, 1H), 1.71 (dtd, J = 18.3, 11.0, 7.2 Hz, 1H), 
1.59 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 164.2, 162.5, 143.8, 
136.0, 131.6, 131.0, 128.3, 126.9, 120.6, 10.3, 76.1, 65.0, 53.3, 51.1, 
39.4, 32.8, 30.6, 27.0. MS (ESI) calcd for [C18H19ClN2O4H]
+: 363.1112, found: 
363.1106. 
3b-methyl-3b,4,5,5a,6,10c-hexahydro-1H-2-oxa-3b1,10b-
diazacyclopenta[2,3]pentaleno[1,6-ab]naphthalene-1,3(3aH)-dione 
(4.81): Yield 99% (50 mg). 1H NMR (500 MHz, CDCl3) δ 7.62 (dd, J = 
8.1, 0.8 Hz, 1H), 7.27 – 7.22 (m, 1H), 7.10 (d, J = 7.6 Hz, 1H), 7.03 (td, J 
= 7.5, 1.1 Hz, 1H), 4.68 (d, J = 10.0 Hz, 1H), 3.79 (d, J = 10.0 Hz, 1H), 
2.92 (dd, J = 15.4, 3.2 Hz, 1H), 2.81 (dd, J = 15.3, 10.8 Hz, 1H), 2.57 (tdd, J = 11.0, 5.5, 
3.3 Hz, 1H), 2.38 (dt, J = 13.8, 9.3 Hz, 1H), 2.27 – 2.19 (m, 1H), 2.11 – 2.03 (m, 1H), 
1.76 – 1.65 (m, 1H), 1.47 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 170.2, 168.5, 145.2, 
129.4, 127.3, 125.0, 123.5, 121.4, 71.7, 70.9, 57.4, 56.0, 35.7, 34.7, 28.3, 22.5. MS (ESI) 
calcd for [C16H16N2O3H]
+: 285.1239, found: 285.1226. 
3b,8-dimethyl-3b,4,5,5a,6,10c-hexahydro-1H-2-oxa-3b1,10b- 
diazacyclopenta[2,3]pentaleno[1,6-ab]naphthalene-1,3(3aH)-dione 
(4.82): Yield 99% (53 mg). 1H NMR (500 MHz, DMSO) δ 7.31 (d, J = 8.2 
Hz, 1H), 7.02 (d, J = 8.2 Hz, 1H), 6.93 (s, 1H), 4.76 (d, J = 9.7 Hz, 1H), 
4.14 (d, J = 9.8 Hz, 1H), 2.82 (d, J = 12.7 Hz, 1H), 2.62 (ddt, J = 31.1, 
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25.3, 6.7 Hz, 2H), 2.34 (dt, J = 13.3, 9.2 Hz, 1H), 2.23 (s, 3H), 2.13 (ddd, J = 10.5, 9.3, 
5.6 Hz, 1H), 1.87 (dd, J = 12.2, 10.3 Hz, 1H), 1.51 (dt, J = 21.2, 10.6 Hz, 1H), 1.25 (s, 
3H). 13C NMR (126 MHz, DMSO) δ 172.0, 169.9, 143.5, 131.4, 129.7, 127.4, 125.1, 
120.2, 71.9, 70.3, 57.3, 54.8, 34.8, 34.1, 27.9, 22.3, 20.2. MS (ESI) calcd for 
[C17H18N2O3H]
+: 299.1396, found: 299.1397. 
3b,10-dimethyl-3b,4,5,5a,6,10c-hexahydro-1H-2-oxa-3b1,10b- 
diazacyclopenta[2,3]pentaleno[1,6-ab]naphthalene-1,3(3aH)-dione 
(4.83): Yield 53% (28 mg). 1H NMR (500 MHz, CDCl3) δ = 7.10 – 7.05 
(m, 1H), 7.03 – 6.92 (m, 2H), 5.04 (d, J=9.0, 1H), 3.56 (d, J=9.0, 1H), 
2.94 (dd, J=15.6, 3.5, 1H), 2.75 (dt, J=14.7, 9.3, 2H), 2.48 (tdd, J=10.9, 
5.5, 3.6, 1H), 2.37 (s, 3H), 2.14 – 2.06 (m, 1H), 1.97 (ddd, J=14.3, 10.6, 1.8, 1H), 1.67 – 
1.56 (m, 1H), 1.54 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 170.6, 168.1, 139.5, 130.1, 
128.8, 127.5, 126.1, 124.0, 72.0, 63.7, 57.3, 56.6, 35.0, 29.8, 29.6, 28.3, 19.1. MS (ESI) 
calcd for [C17H18N2O3H]
+: 299.1396, found: 299.1403. 
8-chloro-3b-methyl-3b,4,5,5a,6,10c-hexahydro-1H-2-oxa-3b1,10b-
diazacyclopenta[2,3]pentaleno[1,6-ab]naphthalene-1,3(3aH)-dione (4.84): Yield 99%  
(56 mg). 1H NMR (500 MHz, DMSO) δ 7.41 (d, J = 8.7 Hz, 1H), 7.29 
(dd, J = 8.7, 2.4 Hz, 1H), 7.22 (d, J = 2.4 Hz, 1H), 4.86 (d, J = 9.8 Hz, 
1H), 4.17 (d, J = 9.8 Hz, 1H), 2.95 – 2.85 (m, 1H), 2.67 – 2.57 (m, 2H), 
2.36 (dt, J = 13.2, 9.3 Hz, 1H), 2.19 – 2.09 (m, 1H), 1.89 (dd, J = 12.3, 
10.5 Hz, 1H), 1.57 – 1.45 (m, 1H), 1.25 (s, 3H). 13C NMR (126 MHz, DMSO) δ 171.9, 
169.6, 144.7, 128.9, 127.6, 126.7, 126.4, 121.7, 71.8, 70.3, 57.3, 54.6, 34.9, 34.0, 27.9, 
22.3. MS (ESI) calcd for [C16H15ClN2O3H]
+: 319.0849, found: 319.0859. 
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2,3b-dimethyl-3b,4,5,5a,6,10c-hexahydro-2,3b1,10b-
triazacyclopenta[2,3]pentaleno[1,6-ab]naphthalene-1,3(2H,3aH)-
dione (4.86): Rf = 0.59 in Hexane/EtOAc = 1:1. Yield 80% (43 mg). 
Mixture of two diastereoisomers. 1H NMR (500 MHz, CDCl3) δ 7.81 
(dd, J = 8.2, 0.9 Hz, 1H), 7.27 – 7.15 (m, 3H), 7.08 (t, J = 6.6 Hz, 
2H), 7.01 – 6.88 (m, 2H), 4.90 (d, J = 8.2 Hz, 1H), 4.45 (d, J = 9.4 Hz, 1H), 3.60 (d, J = 
9.4 Hz, 1H), 3.34 (d, J = 8.2 Hz, 1H), 3.05 (s, 3H), 2.90 (dd, J = 15.2, 3.2 Hz, 1H), 2.84 – 
2.76 (m, 5H), 2.75 – 2.64 (m, 2H), 2.64 – 2.56 (m, 1H), 2.42 – 2.31 (m, 2H), 2.24 – 2.16 
(m, 1H), 2.06 – 1.97 (m, 2H), 1.91 (ddd, J = 14.1, 9.7, 1.1 Hz, 1H), 1.72 – 1.62 (m, 1H), 
1.61 – 1.50 (m, 4H), 1.33 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 176.4, 175.6, 174.9, 
174.9, 146.1, 142.0, 129.9, 129.4, 127.2, 126.0, 125.3, 125.1, 122.9, 122.5, 122.0, 72.9, 
70.5, 70.4, 70.2, 66.6, 57.6, 57.2, 56.6, 55.7, 36.3, 35.3, 35.1, 31.1, 30.8, 28.9, 28.6, 25.1, 
24.9, 22.1. MS (ESI) calcd for [C17H19N3O2H]
+: 298.1556, found: 298.1549. 
2,3b,8-trimethyl-3b,4,5,5a,6,10c-hexahydro-2,3b1,10b-
triazacyclopenta[2,3]pentaleno[1,6-ab]naphthalene-1,3(2H,3aH)-
dione (4.87, DCM- fraction): Yield 38% (21 mg). 1H NMR (500 MHz, 
CD2Cl2) δ 7.62 (d, J = 8.2 Hz, 1H), 7.02 (d, J = 8.2 Hz, 1H), 6.91 (s, 
1H), 4.37 (d, J = 9.4 Hz, 1H), 3.60 (d, J = 9.4 Hz, 1H), 2.99 (s, 3H), 
2.84 (d, J = 12.3 Hz, 1H), 2.78 – 2.56 (m, 2H), 2.34 (dt, J = 13.4, 9.3 
Hz, 1H), 2.27 (s, 3H), 2.19 (dd, J = 15.3, 6.8 Hz, 1H), 1.99 (t, J = 11.9 Hz, 1H), 1.69 – 
1.56 (m, 1H), 1.27 (s, 3H). 13C NMR (126 MHz, CD2Cl2) δ 176.1, 175.1, 144.3, 132.5, 
130.1, 128.0, 125.6, 121.8, 71.0, 70.4, 57.5, 55.9, 36.5, 35.3, 28.8, 24.9, 22.1, 20.7. MS 
(ESI) calcd for [C18H21N3O2H]
+: 312.1712, found: 312.1711. 
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2,3b,8-trimethyl-3b,4,5,5a,6,10c-hexahydro-2,3b1,10b-
triazacyclopenta[2,3]pentaleno[1,6-ab]naphthalene-1,3(2H,3aH)-
dione (4.87, CHCl3- fraction): Rf = 0.66 in Hexane/EtOAc = 1:1. Yield 
34% (19 mg). 1H NMR (500 MHz, CDCl3) δ 7.12 (d, J = 8.2 Hz, 1H), 
7.00 (dd, J = 8.3, 1.6 Hz, 1H), 6.88 (s, 1H), 4.86 (d, J = 8.2 Hz, 1H), 
3.32 (d, J = 8.2 Hz, 1H), 2.82 (s, 3H), 2.77 (dd, J = 15.4, 3.4 Hz, 1H), 
2.70 – 2.54 (m, 2H), 2.38 – 2.28 (m, 1H), 2.27 (s, J = 8.0 Hz, 3H), 2.05 – 1.94 (m, 1H), 
1.90 (ddd, J = 14.1, 9.7, 1.2 Hz, 1H), 1.61 – 1.53 (m, 1H), 1.52 (s, 3H). 13C NMR (126 
MHz, CDCl3) δ 176.6, 175.1, 139.5, 131.8, 130.2, 127.0, 125.0, 121.8, 70.5, 66.7, 57.7, 
56.7, 35.2, 31.1, 30.8, 28.9, 25.1, 21.0. MS (ESI) calcd for [C18H21N3O2H]
+: 312.1712, 
found: 312.1702. 
2,3b,10-trimethyl-3b,4,5,5a,6,10c-hexahydro-2,3b1,10b-
triazacyclopenta[2,3]pentaleno[1,6-ab]naphthalene-1,3(2H,3aH)-
dione (4.88): Rf = 0.26 in Hexane/EtOAc = 3:1. Yield 78% (43 mg). 
1H NMR (500 MHz, CDCl3) δ = 7.09 – 7.01 (m, 1H), 6.99 – 6.85 (m, 
2H), 4.88 (d, J=8.4, 1H), 3.32 (d, J=8.4, 1H), 2.87 (dd, J=15.5, 3.5, 
1H), 2.80 (s, 3H), 2.79 – 2.64 (m, 2H), 2.40 (s, 3H), 2.38 – 2.25 (m, 1H), 2.07 – 1.94 (m, 
1H), 1.90 (ddd, J=14.0, 10.3, 1.5, 1H), 1.62 – 1.49 (m, 4H). 13C NMR (126 MHz, CDCl3) 
δ 176.8, 174.7, 140.5, 130.2, 128.4, 127.3, 125.8, 123.2, 69.9, 63.9, 57.1, 56.7, 35.4, 30.1, 
29.8, 28.6, 25.1, 19.5. MS (ESI) calcd for [C18H21N3O2H]
+: 312.1712, found: 312.1712. 
8-chloro-2,3b-dimethyl-3b,4,5,5a,6,10c-hexahydro-2,3b1,10b-
triazacyclopenta[2,3]pentaleno[1,6-ab]naphthalene-1,3(2H,3aH)-dione (4.89, DCM-
fraction): Yield 52% (31 mg). 1H NMR (500 MHz, CD2Cl2) δ 7.73 (d, J = 8.8 Hz, 1H), 
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7.18 (d, J = 8.7 Hz, 1H), 7.09 (s, 1H), 4.41 (d, J = 9.4 Hz, 1H), 3.62 
(d, J = 9.4 Hz, 1H), 3.00 (s, 3H), 2.90 – 2.81 (m, 1H), 2.78 – 2.69 (m, 
1H), 2.68 – 2.59 (m, 1H), 2.36 (dt, J = 13.3, 9.3 Hz, 1H), 2.20 (t, J = 
13.0 Hz, 1H), 2.00 (dd, J = 21.5, 9.3 Hz, 1H), 1.69 – 1.57 (m, 1H), 
1.27 (s, 3H). 13C NMR (126 MHz, CD2Cl2) δ 175.9, 174.8, 145.4, 
129.3, 127.9, 127.7, 127.3, 123.2, 70.8, 70.5, 57.5, 55.6, 36.6, 35.3, 28.7, 25.0, 22.1. MS 
(ESI) calcd for [C17H18ClN3O2H]
+: 332.1166, found: 332.1167. 
8-chloro-2,3b-dimethyl-3b,4,5,5a,6,10c-hexahydro-2,3b1,10b-
triazacyclopenta[2,3]pentaleno[1,6-ab]naphthalene-1,3(2H,3aH)-
dione (4.89, CHCl3-fraction): Rf = 0.50 in Hexane/EtOAc = 1:1. Yield 
44% (26 mg). 1H NMR (500 MHz, CDCl3) δ 7.16 (s, 2H), 7.06 (s, 1H), 
4.87 (d, J = 8.2 Hz, 1H), 3.34 (d, J = 8.3 Hz, 1H), 2.83 (s, 3H), 2.79 
(dd, J = 15.6, 3.3 Hz, 1H), 2.73 – 2.57 (m, 2H), 2.34 – 2.26 (m, 1H), 
2.06 – 1.97 (m, 1H), 1.92 (dd, J = 14.2, 9.7 Hz, 1H), 1.62 – 1.53 (m, 1H), 1.52 (s, 3H). 
13C NMR (126 MHz, CDCl3) δ 176.2, 174.7, 140.7, 129.5, 127.5, 127.0, 126.3, 123.1, 
70.5, 66.5, 57.6, 56.4, 35.2, 31.1, 30.8, 28.8, 25.2. MS (ESI) calcd for [C17H18ClN3O2H]
+: 
332.1166, found: 332.1159. 
1-(2a-methyl-2,2a,3,4,4a,5-hexahydro-1H-2a1,9b-diazapentaleno[1,6-ab]naphthalen-
1-yl)ethenone (4.92a): Rf = 0.44 in Hexane/EtOAc/Et3N = 70:30:1. 
Yield 55% (25 mg). 1H NMR (500 MHz, CDCl3) δ = 7.12 (t, J = 7.7 Hz, 
1H), 7.05 (d, J = 7.5 Hz, 1H), 6.88 – 6.80 (m, 2H), 4.39 (dd, J = 8.6, 7.1 
Hz, 1H), 3.45 (dt, J = 18.8, 10.1 Hz, 2H), 2.89 – 2.76 (m, 2H), 2.72 – 
2.65 (m, 1H), 2.42 (dt, J = 13.2, 9.3 Hz, 1H), 2.25 (s, 3H), 2.22 (ddd, J = 12.7, 5.9, 3.2 
 196 
Hz, 1H), 2.07 – 2.01 (m, 1H), 1.77 – 1.67 (m, 1H), 1.25 (s, 3H). 13C NMR (126 MHz, 
CDCl3) δ = 205.1, 147.2, 129.6, 126.6, 123.74, 120.4, 119.2, 70.15, 61.3, 55.4, 54.7, 
36.0, 35.2, 30.6, 29.0, 23.2. MS (ESI) calcd for [C16H20N2OH]
+: 257.1654, found: 
257.1651. 
1-(2a-methyl-2,2a,3,4,4a,5-hexahydro-1H-2a1,9b-diazapentaleno[1,6-ab]naphthalen-
2-yl)ethenone (4.92b): Rf = 0.44 in Hexane/EtOAc/Et3N = 70:30:1. Yield 
43% (20 mg). 1H NMR (500 MHz, CDCl3) δ = 7.12 – 7.03 (m, 2H), 6.95 (d, 
J=7.8, 1H), 6.91 – 6.86 (m, 1H), 3.70 (dt, J=17.8, 9.9, 2H), 3.41 (dd, J=10.4, 
8.0, 1H), 2.90 (ddd, J=11.3, 8.9, 4.5, 1H), 2.80 – 2.74 (m, 2H), 2.22 (s, 3H), 
1.98 (ddd, J=12.9, 7.5, 4.1, 1H), 1.82 – 1.75 (m, 2H), 1.63 (s, 3H), 1.61 – 1.50 (m, 1H). 
13C NMR (126 MHz, CDCl3) δ 206.7, 146.6, 129.7, 126.1, 125.9, 121.5, 121.0, 68.8, 
64.8, 55.0, 52.0, 34.8, 34.0, 31.8, 31.3, 28.3. MS (ESI) calcd for [C16H20N2OH]
+: 
257.1654, found: 257.1656. 
1-(2a,7-dimethyl-2,2a,3,4,4a,5-hexahydro-1H-2a1,9b-diazapentaleno[1,6-
ab]naphthalen-1-yl)ethenone (4.93a): Rf = 0.30 in Hexane/EtOAc/Et3N 
= 80:20:1. Yield 52% (25 mg). 1H NMR (500 MHz, CDCl3) δ = 6.94 (d, 
J=8.0, 1H), 6.86 (s, 1H), 6.78 (d, J=8.1, 1H), 4.38 – 4.26 (m, 1H), 3.46 
(dd, J=16.4, 6.6, 1H), 3.35 (t, J=9.9, 1H), 2.85 – 2.61 (m, 3H), 2.40 (dt, 
J=13.1, 9.3, 1H), 2.27 – 2.12 (m, 7H), 2.04 (dd, J=22.8, 11.3, 1H), 1.70 (dt, J=21.3, 10.5, 
1H), 1.25 (s, 3H). 13C NMR (126 MHz, CDCl3) δ = 205.3, 144.9, 129.95, 129.9, 127.4, 
123.8, 119.4, 70.2, 61.5, 55.6, 54.4, 35.9, 35.1, 30.6, 28.9, 23.2, 20.6. MS (ESI) calcd for 
[C17H22N2OH]
+: 271.1810, found: 271.1801. 
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1-(2a,7-dimethyl-2,2a,3,4,4a,5-hexahydro-1H-2a1,9b-diazapentaleno[1,6-
ab]naphthalen-2-yl)ethenone (4.93b): Rf = 0.31 in Hexane/EtOAc/Et3N = 
80:20:1. Yield 31% (15 mg). 1H NMR (500 MHz, CDCl3) δ = 6.93 – 6.86 
(m, 2H), 6.84 (d, J = 8.1 Hz, 1H), 3.64 (dt, J = 17.8, 9.9 Hz, 2H), 3.38 (dd, J 
= 10.4, 8.0 Hz, 1H), 2.94 – 2.86 (m, 1H), 2.72 (d, J = 6.3 Hz, 2H), 2.25 (s, 
3H), 2.20 (s, 3H), 1.96 (ddd, J = 12.5, 6.1, 1.9 Hz, 1H), 1.80 – 1.74 (m, 2H), 
1.61 (s, 3H), 1.58 – 1.48 (m, 1H).13C NMR (126 MHz, CDCl3) δ = 207.2, 144.4, 131.2, 
130.3, 127.1, 126.3, 121.2, 69.1, 65.3, 55.4, 52.2, 34.9, 34.3, 32.1, 31.7, 28.6, 20.8. MS 
(ESI) calcd for [C17H22N2OH]
+: 271.1810, found: 271.1811. 
1-(7-chloro-2a-methyl-2,2a,3,4,4a,5-hexahydro-1H-2a1,9b-diazapentaleno[1,6-
ab]naphthalen-1-yl)ethenone (4.94a): Rf = 0.38 in Hexane/EtOAc/Et3N 
= 80:20:1. Yield 29% (15 mg). 1H NMR (500 MHz, CDCl3) δ = 7.08 (dd, 
J = 8.6, 2.3 Hz, 1H), 7.02 (d, J = 2.2 Hz, 1H), 6.77 (d, J = 8.6 Hz, 1H), 
4.36 (dd, J = 9.5, 8.1 Hz, 1H), 3.46 (dd, J = 10.0, 8.2 Hz, 1H), 3.37 (t, J = 
9.9 Hz, 1H), 2.79 (ddd, J = 25.3, 15.2, 6.8 Hz, 1H), 2.69 – 2.59 (m, 1H), 2.42 (dt, J = 
13.2, 9.3 Hz, 1H), 2.28 – 2.18 (m, 4H), 2.09 – 2.00 (m, 1H), 1.75 – 1.65 (m, 1H), 1.25 (d, 
J = 7.8 Hz, 4H).13C NMR (126 MHz, CDCl3) δ = 204.8, 145.8, 129.1, 126.7, 125.5, 
125.3, 120.2, 70.2, 61.2, 55.7, 54.4, 35.9, 35.1, 30.6, 28.90, 23.1. MS (ESI) calcd for 
[C16H19ClN2OH]
+: 291.1264, found: 291.1259. 
1-(7-chloro-2a-methyl-2,2a,3,4,4a,5-hexahydro-1H-2a1,9b-diazapentaleno[1,6-
ab]naphthalen-2-yl)ethenone (4.94b): Rf = 0.32 in Hexane/EtOAc/Et3N = 80:20:1. 
Yield 48% (25 mg). 1H NMR (500 MHz, CDCl3) δ = 7.06 (dd, J = 4.2, 1.9 Hz, 2H), 6.88 
– 6.85 (m, 1H), 3.71 – 3.62 (m, 2H), 3.40 (dd, J = 10.3, 8.1 Hz, 1H), 2.86 (ddd, J = 11.3, 
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9.5, 4.8 Hz, 1H), 2.77 – 2.73 (m, 2H), 2.22 (s, 3H), 2.03 – 1.95 (m, 1H), 
1.84 – 1.74 (m,  2H), 1.62 (s, 3H), 1.30 – 1.24 (m, 1H). 13C NMR (126 
MHz, CDCl3) δ = 206.9, 145.5, 129.5, 128.2, 126.4, 122.4, 113.0, 69.2, 
65.1, 55.3, 52.0, 34.9, 34.2, 32.0, 31.6, 28.4.  MS (ESI) calcd for 
[C16H19ClN2OH]
+: 291.1264, found: 291.1262. 
1-(7-methoxy-2a-methyl-2,2a,3,4,4a,5-hexahydro-1H-2a1,9b-diazapentaleno[1,6-
ab]naphthalen-1-yl)ethenone (4.95a): Rf = 0.47 in Hexane/EtOH/Et3N 
= 70:30:1. Yield 39% (20 mg). 1H NMR (500 MHz, CDCl3) δ = 6.84 (d, 
J = 8.8 Hz, 1H), 6.76 – 6.71 (m, 1H), 6.63 – 6.59 (m, 1H), 4.30 (dd, J = 
9.7, 7.4 Hz, 1H), 3.77 – 3.71 (m, 5H), 3.47 (dd, J = 10.3, 7.4 Hz, 1H), 
3.30 (t, J = 10.0 Hz, 1H), 2.86 – 2.68 (m, 3H), 2.47 – 2.36 (m, 1H), 2.25 (s, 3H), 2.09 – 
2.00 (m, 1H), 1.25 (s, 3H).13C NMR (126 MHz, CDCl3) δ = 205.3, 154.1, 141.1, 125.3, 
120.9, 114.2, 112.9, 70.3, 61.8, 55.6, 55.4, 53.7, 36.1, 35.3, 30.6, 28.8, 23.2. MS (ESI) 
calcd for [C17H22N2O2H]
+: 287.1760, found: 287.1751. 
1-(7-methoxy-2a-methyl-2,2a,3,4,4a,5-hexahydro-1H-2a1,9b-diazapentaleno[1,6-
ab]naphthalen-2-yl)ethenone (4.95b): Rf = 0.39 in Hexane/EtOH/Et3N = 
70:30:1. Yield 49% (25 mg). 1H NMR (500 MHz, CDCl3) δ = 6.87 (d, J = 
8.8 Hz, 1H), 6.69 (dd, J = 8.8, 2.8 Hz, 1H), 6.60 (d, J = 2.8 Hz, 1H), 3.73 
(s, 3H), 3.60 (dt, J = 17.7, 9.9 Hz, 2H), 3.36 (dd, J = 10.4, 7.9 Hz, 1H), 
2.96 – 2.88 (m, 1H), 2.73 (d, J = 6.4 Hz, 2H), 2.19 (s, 3H), 1.98 – 1.92 (m, 
1H), 1.80 – 1.72 (m, 2H), 1.60 (s, 3H), 1.52 (qd, J = 11.2, 8.6 Hz, 1H). 13C NMR (126 
MHz, CDCl3) δ = 207.3, 154.8, 140.2, 127.5, 122.4, 114.2, 112.9, 69.2, 65.3, 55.6, 55.5, 
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51.8, 35.1, 34.2, 32.1, 31.7, 28.5. MS (ESI) calcd for [C17H22N2O2H]
+: 287.1760, found: 
287.1761 
4b-methyl-2,3,4,4a,4b,5,6,6a,7,11c-decahydro-1H-4b1,11b-
diazabenzo[c]cyclopenta[lm]fluoren-1-one (4.97): Rf = 0.45 in 
Hexane/EtOAc/Et3N = 80:20:1. Yield 50% (25 mg). 
1H NMR (500 MHz, 
CDCl3) δ = 7.11 (t, J = 7.6 Hz, 1H), 7.05 (dd, J = 16.4, 7.6 Hz, 2H), 6.90 
– 6.84 (m, 1H), 3.85 (td, J = 10.7, 6.8 Hz, 1H), 3.17 (d, J = 10.6 Hz, 1H), 
2.85 (dd, J = 15.1, 3.1 Hz, 1H), 2.76 (dd, J = 15.0, 10.7 Hz, 1H), 2.62 (tdd, J = 10.9, 5.4, 
3.2 Hz, 1H), 2.54 – 2.44 (m, 3H), 2.29 – 2.19 (m, 1H), 2.17 – 1.92 (m, 3H), 1.86 – 1.78 
(m, 1H), 1.71 – 1.57 (m, 2H), 1.36 (s, 3H).13C NMR (126 MHz, CDCl3) δ = 212.2, 146.9, 
129.9, 126.5, 124.7, 121.2, 118.8, 71.4, 67.3, 59.4, 56.2, 41.3, 35.8, 35.4, 33.73, 28.5, 
24.5, 20.9.  MS (ESI) calcd for [C18H22N2OH]
+: 283.1810, found: 283.1809. 
9-chloro-4b-methyl-2,3,4,4a,4b,5,6,6a,7,11c-decahydro-1H-4b1,11b-
diazabenzo[c]cyclopenta[lm]fluoren-1-one (4.98): Rf = 0.45 in 
Hexane/EtOAc/Et3N = 80:20:1. Yield 53% (30 mg). 
1H NMR (500 MHz, 
CDCl3) δ = 7.09 – 7.04 (m, 2H), 6.96 (d, J = 8.5 Hz, 1H), 3.82 (td, J = 
10.7, 6.9 Hz, 1H), 3.18 (d, J = 10.7 Hz, 1H), 2.83 (dd, J = 15.2, 3.2 Hz, 
1H), 2.78 – 2.70 (m, 1H), 2.64 – 2.41 (m, 4H), 2.25 (ddd, J = 17.6, 13.3, 5.8 Hz, 1H), 
2.18 – 2.02 (m, 2H), 1.97 (tdd, J = 13.6, 10.9, 3.0 Hz, 1H), 1.87 – 1.80 (m, 1H), 1.72 – 
1.58 (m, 2H), 1.35 (s, 3H).13C NMR (126 MHz, CDCl3) δ = 211.9, 145.5, 129.5, 126.6, 
126.7, 126.2, 119.9, 71.5, 67.6, 59.4, 55.9, 41.2, 35.9, 35.3, 33.6, 28.4, 24.4, 20.8. MS 
(ESI) calcd for [C18H21ClN2OH]
+: 317.1421, found: 317.1417. 
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7-chloro-2a-methyl-2,2a,3,4,4a,5-hexahydro-1H-2a1,9b-diazapentaleno[1,6-
ab]naphthalene-1-carbonitrile or, 7-chloro-2a-methyl-2,2a,3,4,4a,5-hexahydro-1H-
2a1,9b-diazapentaleno[1,6-ab]naphthalene-2-carbonitrile (4.103, fraction-2): Rf = 
0.35 in Hexane/EtOAc = 3:1. Yield 4% (2 mg). 1H NMR (500 
MHz, CDCl3) δ = 7.16 – 7.07 (m, 2H), 6.75 – 6.63 (m, 1H), 4.17 
(dd, J=9.3, 5.4, 1H), 3.75 – 3.60 (m, 1H), 3.26 (dd, J=17.1, 8.2, 
1H), 2.79 – 2.70 (m, 1H), 2.70 – 2.69 (m, 1H), 2.61 (ddd, 
J=22.1, 12.8, 7.4, 2H), 2.21 – 2.12 (m, 1H), 2.11 – 1.95 (m, 2H), 1.83 (ddd, J=12.8, 8.9, 
7.3, 1H), 1.28 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 142.8, 128.6, 126.5, 126.0, 125.7, 
118.1, 113.2, 70.1, 60.2, 46.3, 44.1, 38.2, 31.4, 29.4, 26.3. MS (ESI) calcd for 
[C15H16ClN3H]
+: 274.1111, found: 2574.1102. 
4-(1,4-dihydrocinnolin-3-yl)butan-2-one (4.104): Rf = 0.47 in Hexane/EtOAc = 1:1. 
Yield 34% (12 mg). 1H NMR (500 MHz, CDCl3) δ = 7.22 (s, 1H), 7.11 (td, 
J=7.9, 1.3, 1H), 7.01 (d, J=7.5, 1H), 6.92 (td, J=7.4, 1.1, 1H), 6.67 (d, J=7.9, 
1H), 3.27 (s, 2H), 2.76 (t, J=7.0, 2H), 2.58 (t, J=7.1, 2H), 2.19 (s, 3H). 13C 
NMR (126 MHz, CDCl3) δ 207.9, 145.2, 140.1, 127.5, 127.0, 122.1, 116.1, 
111.7, 77.1, 39.1, 30.1, 30.0. MS (ESI) calcd for [C12H14N2OH]
+: 203.1184, found: 
203.1182. 
4-(3,4-dihydrocinnolin-3-yl)butan-2-one (4.105): Rf = 0.26 in Hexane/EtOAc = 1:1. 
Yield 17% (6 mg). 1H NMR (500 MHz, CDCl3) δ = 8.14 (d, J=8.1, 1H), 7.50 
(td, J=7.5, 1.2, 1H), 7.42 (t, J=7.8, 1H), 7.26 (d, J=8.9, 1H), 3.83 (ddt, J=14.1, 
9.7, 4.3, 1H), 2.92 – 2.79 (m, 3H), 2.78 – 2.64 (m, 1H), 2.20 – 2.10 (m, 4H), 
2.01 (ddt, J=14.0, 9.9, 6.4, 1H). 13C NMR (126 MHz, CDCl3) δ 208.1, 140.3, 132.7, 
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131.4, 128.2, 127.3, 122.3, 59.1, 39.2, 30.1, 27.9, 27.7. MS (ESI) calcd for 
[C12H14N2OH]
+: 203.1184, found: 203.1172. 
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